{
    "input_instrument": "LLY",
    "company_of_interest": "LLY",
    "instrument_profile": {
        "input_symbol": "LLY",
        "normalized_symbol": "LLY",
        "primary_symbol": "LLY",
        "display_name": "LLY",
        "display_name_kr": null,
        "display_name_en": "LLY",
        "exchange": "US",
        "country": "US",
        "timezone": "US/Eastern",
        "currency": "USD",
        "yahoo_symbol": "LLY",
        "krx_code": null,
        "dart_corp_code": null,
        "aliases": [
            "LLY"
        ]
    },
    "trade_date": "2026-04-16",
    "analysis_date": "2026-04-17",
    "market_report": "**\uc2dc\uc7a5 \uccb4\uc81c \ud310\ub2e8**\n\nLLY\ub294 2026-04-16 \uc9c0\ud45c \uae30\uc900\uc73c\ub85c **\uace0\ubcc0\ub3d9\uc131 \ud558\ub77d \uc870\uc815 \uad6d\uba74**\uc785\ub2c8\ub2e4. \uc911\uae30 \ucd94\uc138\ub294 \uc57d\uc138\uc774\uace0, \uc7a5\uae30 \ucd94\uc138\uc120 \ubc14\ub85c \uc704\uc5d0\uc11c \ubc29\uc5b4 \uc5ec\ubd80\ub97c \uc2dc\ud5d8\ud558\ub294 \uad6c\uc870\uc785\ub2c8\ub2e4. 2026-04-15 \uc885\uac00 905.03\uc740 50\uc77c \ub2e8\uc21c\uc774\ub3d9\ud3c9\uade0 978.66 \ubc0f 10\uc77c \uc9c0\uc218\uc774\ub3d9\ud3c9\uade0 927.51 \uc544\ub798\uc5d0 \uc788\uc5b4 \ub2e8\uae30\u00b7\uc911\uae30 \ub9e4\ub3c4 \uc555\ub825\uc774 \uc6b0\uc138\ud569\ub2c8\ub2e4. \ub2e4\ub9cc 200\uc77c \ub2e8\uc21c\uc774\ub3d9\ud3c9\uade0 901.99\uc640 \ub9e4\uc6b0 \uac00\uae4c\uc6cc \uc7a5\uae30 \ucd94\uc138 \uc9c0\uc9c0\uc120 \uadfc\ucc98\uc5d0\uc11c \ubc29\ud5a5\uc131\uc774 \uacb0\uc815\ub420 \uac00\ub2a5\uc131\uc774 \ud07d\ub2c8\ub2e4.\n\n\ucd5c\uadfc \uac00\uaca9 \ud750\ub984\uc740 2026-03-17\uc758 \uae09\ub77d \uc774\ud6c4 878.24\uae4c\uc9c0 \ubc00\ub838\ub2e4\uac00 2026-04-01\uc5d0 954.52\uae4c\uc9c0 \ubc18\ub4f1\ud588\uc9c0\ub9cc, 2026-04-15\uc5d0\ub294 \ub2e4\uc2dc 905.03\uc73c\ub85c \ud558\ub77d\ud588\uc2b5\ub2c8\ub2e4. 2026-04-15 \uac70\ub798\ub7c9\uc740 4,233,400\uc73c\ub85c \uc804\uc77c 2,360,200\ubcf4\ub2e4 \ud06c\uac8c \uc99d\uac00\ud588\uace0, \ub2f9\uc77c \uc800\uac00\uac00 888.03\uae4c\uc9c0 \ub0b4\ub824\uac00\uba70 \uc7a5\uc911 \ubcc0\ub3d9\uc131\uc774 \ud655\ub300\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ub2e8\uc21c\ud55c \uc800\ubcc0\ub3d9 \ud6a1\ubcf4\uac00 \uc544\ub2c8\ub77c, 200\uc77c\uc120 \ubc29\uc5b4\uc640 \uc774\ud0c8\uc774 \ub3d9\uc2dc\uc5d0 \uac78\ub9b0 \ubbfc\uac10\ud55c \uad6c\uac04\uc785\ub2c8\ub2e4.\n\n\uc120\ud0dd\ud55c \ud575\uc2ec \uc9c0\ud45c\ub294 `close_50_sma`, `close_200_sma`, `close_10_ema`, `macd`, `macdh`, `rsi`, `atr`, `vwma`\uc785\ub2c8\ub2e4. \ud604\uc7ac\ucc98\ub7fc \ucd94\uc138\uac00 \ud6fc\uc190\ub418\uace0 \ubcc0\ub3d9\uc131\uc774 \ub192\uc740 \uad6c\uac04\uc5d0\uc11c\ub294 \ucd94\uc138\uc120, \ubaa8\uba58\ud140, \ubcc0\ub3d9\uc131, \uac70\ub798\ub7c9 \uac00\uc911 \uac00\uaca9\uc744 \ud568\uaed8 \ud655\uc778\ud574\uc57c \ud558\uba70, \ubcfc\ub9b0\uc800 \ubc34\ub4dc\ub294 \uc774\ubc88 \ud310\ub2e8\uc5d0\uc11c ATR\uacfc \uac00\uaca9\ub300 \ubd84\uc11d\ubcf4\ub2e4 \uc6b0\uc120\uc21c\uc704\uac00 \ub0ae\uc2b5\ub2c8\ub2e4.\n\n**\ucd94\uc138\uc640 \uac00\uaca9 \uc704\uce58**\n\n50\uc77c \ub2e8\uc21c\uc774\ub3d9\ud3c9\uade0\uc740 2026-03-17\uc758 1033.18\uc5d0\uc11c 2026-04-16\uc758 976.71\uae4c\uc9c0 \uafb8\uc900\ud788 \ud558\ub77d\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc911\uae30 \ucd94\uc138\uac00 \uc544\uc9c1 \ud68c\ubcf5\ub418\uc9c0 \uc54a\uc558\uc74c\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uac00\uaca9\uc774 \uc774 \ud3c9\uade0 \uc544\ub798\uc5d0 \uba38\ubb34\ub294 \ub3d9\uc548 \ubc18\ub4f1\uc740 \ucd94\uc138 \uc804\ud658\ubcf4\ub2e4\ub294 \ub418\ub3cc\ub9bc\uc73c\ub85c \ud574\uc11d\ud558\ub294 \ud3b8\uc774 \uc548\uc804\ud569\ub2c8\ub2e4.\n\n200\uc77c \ub2e8\uc21c\uc774\ub3d9\ud3c9\uade0\uc740 2026-03-17\uc758 887.62\uc5d0\uc11c 2026-04-16\uc758 902.63\uae4c\uc9c0 \uc0c1\uc2b9\ud588\uc2b5\ub2c8\ub2e4. \uc7a5\uae30 \ucd94\uc138\uc120 \uc790\uccb4\ub294 \uc544\uc9c1 \uc0c1\uc2b9 \uc911\uc774\uc9c0\ub9cc, 2026-04-15 \uc885\uac00 905.03\uc740 200\uc77c\uc120\uacfc\uc758 \uac70\ub9ac\uac00 \uc57d 2.40\uc5d0 \ubd88\uacfc\ud569\ub2c8\ub2e4. \uc774 \uad6c\uac04\uc744 \uc885\uac00 \uae30\uc900\uc73c\ub85c \uc783\uc73c\uba74 \uc7a5\uae30 \ucd94\uc138 \uc9c0\uc9c0 \uc2e4\ud328\ub85c \ud574\uc11d\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n10\uc77c \uc9c0\uc218\uc774\ub3d9\ud3c9\uade0\uc740 2026-04-10\uc758 935.87\uc5d0\uc11c 2026-04-16\uc758 923.23\uc73c\ub85c \ub0ae\uc544\uc84c\uc2b5\ub2c8\ub2e4. \ub2e8\uae30 \ubc18\ub4f1\uc120\uc774 \ub2e4\uc2dc \uc544\ub798\ub85c \uaebe\uc600\uace0, \uac00\uaca9\uc774 10\uc77c\uc120 \uc544\ub798\uc5d0 \uc788\ub2e4\ub294 \uc810\uc740 \ub9e4\uc218\uc138\uac00 \uc544\uc9c1 \uc8fc\ub3c4\uad8c\uc744 \ub418\ucc3e\uc9c0 \ubabb\ud588\ub2e4\ub294 \ub73b\uc785\ub2c8\ub2e4.\n\n**\ubaa8\uba58\ud140**\n\nMACD\ub294 2026-04-16\uc5d0 -14.38\ub85c \uc5ec\uc804\ud788 \uc74c\uc218\uc785\ub2c8\ub2e4. \uc774\ub294 \ucd94\uc138 \ubaa8\uba58\ud140\uc774 \uc544\uc9c1 \uc57d\uc138\uad8c\uc5d0 \uc788\ub2e4\ub294 \ub73b\uc785\ub2c8\ub2e4. \ub2e4\ub9cc 2026-03-30\uc758 -35.49\uc5d0\uc11c \uac1c\uc120\ub418\uc5c8\uae30 \ub54c\ubb38\uc5d0 \uae09\ub77d \ubaa8\uba58\ud140\uc740 \uc644\ud654\ub418\uc5c8\uc2b5\ub2c8\ub2e4.\n\nMACD \ud788\uc2a4\ud1a0\uadf8\ub7a8\uc740 2026-03-31\uc758 -2.30\uc5d0\uc11c 2026-04-09\uc758 8.42\uae4c\uc9c0 \ud68c\ubcf5\ub41c \ub4a4, 2026-04-16\uc5d0\ub294 1.75\ub85c \ub454\ud654\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc989, \ubc18\ub4f1 \ubaa8\uba58\ud140\uc740 \uc788\uc5c8\uc9c0\ub9cc \ucd5c\uadfc\uc5d0\ub294 \ud798\uc774 \uc57d\ud574\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774 \uc0c1\ud0dc\uc5d0\uc11c \uac00\uaca9\uc774 923~925 \ubd80\uadfc\uc744 \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud558\uba74 \ubc18\ub4f1 \uc2e4\ud328 \uac00\ub2a5\uc131\uc774 \ucee4\uc9d1\ub2c8\ub2e4.\n\nRSI\ub294 2026-04-16\uc5d0 39.85\uc785\ub2c8\ub2e4. \uacfc\ub9e4\ub3c4\uad8c\uc778 30 \uc544\ub798\ub294 \uc544\ub2c8\uc9c0\ub9cc, 50\uc744 \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud558\uace0 \uc788\uc5b4 \uac15\ud55c \uc0c1\uc2b9 \uc804\ud658 \uc2e0\ud638\ub294 \uc544\ub2d9\ub2c8\ub2e4. 2026-03-27\uc758 29.19\uc5d0\uc11c \ud68c\ubcf5\ub41c \uc810\uc740 \ub9e4\ub3c4 \uc555\ub825\uc774 \uc77c\ubd80 \uc644\ud654\ub418\uc5c8\uc74c\uc744 \ub73b\ud558\uc9c0\ub9cc, \ud604\uc7ac \uc218\uce58\ub294 \uc5ec\uc804\ud788 \ubc29\uc5b4\uc801\uc785\ub2c8\ub2e4.\n\n**\ubcc0\ub3d9\uc131\u00b7\uac70\ub798\ub7c9\u00b7\uc704\ud5d8 \uad00\ub9ac**\n\nATR\uc740 2026-04-16\uc5d0 28.13\uc785\ub2c8\ub2e4. 2026-04-15 \uc885\uac00 905.03 \ub300\ube44 \uc57d 3.1% \uc218\uc900\uc73c\ub85c, \ud558\ub8e8 \ubcc0\ub3d9\ud3ed\uc774 \ud070 \ud3b8\uc785\ub2c8\ub2e4. \ub530\ub77c\uc11c \uc9c4\uc785 \uc2dc \uc190\uc808\ud3ed\uc744 \ub108\ubb34 \uc881\uac8c \uc7a1\uc73c\uba74 \uc815\uc0c1\uc801\uc778 \ud754\ub4e4\ub9bc\uc5d0 \uac78\ub9b4 \uac00\ub2a5\uc131\uc774 \ub192\uc2b5\ub2c8\ub2e4. \uc2e0\uaddc \ub9e4\uc218\ub294 200\uc77c\uc120 \uadfc\ucc98\uc5d0\uc11c \ub2e8\uc21c\ud788 \uc2f8 \ubcf4\uc778\ub2e4\ub294 \uc774\uc720\ubcf4\ub2e4, \uc885\uac00 \ud68c\ubcf5\uacfc \uac70\ub798\ub7c9 \ud655\uc778\uc744 \ub3d9\ubc18\ud574\uc57c \ud569\ub2c8\ub2e4.\n\nVWMA\ub294 2026-04-16\uc5d0 924.83\uc785\ub2c8\ub2e4. 2026-04-15 \uc885\uac00 905.03\uc740 VWMA \uc544\ub798\uc5d0 \uc788\uc73c\uba70, \uac70\ub798\ub7c9\uc744 \ubc18\uc601\ud55c \ud3c9\uade0 \uac00\uaca9\ubcf4\ub2e4 \ub0ae\uac8c \uac70\ub798\ub418\uace0 \uc788\ub2e4\ub294 \ub73b\uc785\ub2c8\ub2e4. \uc720\ub3d9\uc131 \uae30\uc900\uc73c\ub85c\ub3c4 \ub9e4\uc218 \uc6b0\uc704\uac00 \ud655\uc2e4\ud558\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \uac00\uaca9\uc774 924~925 \uc704\ub85c \uc62c\ub77c\uc11c\uace0 \uadf8 \uc704\uc5d0\uc11c \uc885\uac00\ub97c \uc720\uc9c0\ud574\uc57c \ub2e8\uae30 \ubc18\ub4f1 \uc2e0\ub8b0\ub3c4\uac00 \ub192\uc544\uc9d1\ub2c8\ub2e4.\n\n\uc774 \uc885\ubaa9\uc740 \ub300\ud615 \uc81c\uc57d\u00b7\ubc14\uc774\uc624 \ud2b9\uc131\uc0c1 \uc2e4\uc801, \uc784\uc0c1, \uaddc\uc81c, \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \uc218\uc694 \uad00\ub828 \ub274\uc2a4\uc5d0 \ub530\ub77c \uae09\uaca9\ud55c \uc7ac\ud3c9\uac00\uac00 \ub098\uc62c \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ucd5c\uadfc\uc758 \ud070 \uac70\ub798\ub7c9 \ub3d9\ubc18 \uae09\ub4f1\ub77d\uc740 \uc774\ubca4\ud2b8 \uc704\ud5d8\uc774 \uac00\uaca9\uc5d0 \ubc18\uc601\ub418\uace0 \uc788\uc74c\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4. \ub2e4\ub9cc \uc81c\uacf5\ub41c \ub3c4\uad6c\uc5d0\uc11c\ub294 \ub274\uc2a4\ub098 \uc2e4\uc2dc\uac04 \uc7a5\uc911 \uc790\ub8cc\uac00 \ud655\uc778\ub418\uc9c0 \uc54a\uc558\uace0, \uc7a5\uc911 \uc2a4\ub0c5\uc0f7 \ud638\ucd9c\uc740 \uc0ac\uc6a9 \uac00\ub2a5\ud55c \ub3c4\uad6c\ub85c \ucc98\ub9ac\ub418\uc9c0 \uc54a\uc558\uc2b5\ub2c8\ub2e4. \ub530\ub77c\uc11c \ub2f9\uc77c \ub3cc\ud30c\u00b7\uc9c0\uc9c0 \ud0c0\uc774\ubc0d\uc740 \ud655\uc815\uc774 \uc544\ub2c8\ub77c \uc870\uac74\ubd80\ub85c \ud45c\ud604\ud574\uc57c \ud569\ub2c8\ub2e4.\n\n**\uac70\ub798 \uc804\ub7b5**\n\n\uacf5\uaca9\uc801 \ub9e4\uc218\ub294 \uc544\uc9c1 \uc774\ub985\ub2c8\ub2e4. \uc6b0\uc120 902.63 \ubd80\uadfc\uc758 200\uc77c\uc120\uacfc 888.03\uc758 2026-04-15 \uc800\uac00\uac00 \ud575\uc2ec \ubc29\uc5b4 \uad6c\uac04\uc785\ub2c8\ub2e4. \uc774 \uad6c\uac04\uc5d0\uc11c \uc885\uac00\uac00 \uc720\uc9c0\ub418\uace0, \uc774\ud6c4 923~925\uc758 10\uc77c\uc120\u00b7VWMA \uad6c\uac04\uc744 \ud68c\ubcf5\ud558\uba74 \ub2e8\uae30 \ubc18\ub4f1 \uc2dc\ub098\ub9ac\uc624\uac00 \uc5f4\ub9bd\ub2c8\ub2e4. \uadf8 \ub2e4\uc74c \uc800\ud56d\uc740 939~955 \uad6c\uac04\uc774\uba70, \ub354 \uac15\ud55c \ucd94\uc138 \ud68c\ubcf5 \uae30\uc900\uc740 976~979\uc758 50\uc77c\uc120\uc785\ub2c8\ub2e4.\n\n\ubcf4\uc218\uc801 \ub9e4\uc218\uc790\ub294 923~925 \ud68c\ubcf5 \ud6c4 \ub20c\ub9bc\uc774 \ud574\ub2f9 \uac00\uaca9\ub300\ub97c \uc9c0\uc9c0\ud558\ub294\uc9c0 \ud655\uc778\ud558\ub294 \uc811\uadfc\uc774 \uc801\ud569\ud569\ub2c8\ub2e4. \uc190\uc808 \uae30\uc900\uc740 \uc9c4\uc785\uac00\uc5d0\uc11c \ucd5c\uc18c 1 ATR, \uc989 \uc57d 28\ud3ec\uc778\ud2b8\ub97c \uac10\uc548\ud558\uac70\ub098, \ub354 \uba85\ud655\ud558\uac8c\ub294 888 \uc774\ud0c8 \ub610\ub294 200\uc77c\uc120 \uc7ac\uc774\ud0c8\uc744 \uae30\uc900\uc73c\ub85c \uc124\uc815\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n\ud558\ub77d \ucd94\uc885 \uad00\uc810\uc5d0\uc11c\ub294 902 \uc544\ub798 \uc885\uac00 \ub9c8\uac10, \ud2b9\ud788 888 \uc774\ud0c8\uc774 \ud655\uc778\ub418\uba74 878.24 \uc7ac\uc2dc\ud5d8 \uac00\ub2a5\uc131\uc774 \ucee4\uc9d1\ub2c8\ub2e4. \uc774 \uacbd\uc6b0 \ubc18\ub4f1 \uc2e4\ud328 \uad6c\uac04\uc778 923~925\uac00 \ub418\ub3cc\ub9bc \uc800\ud56d\uc73c\ub85c \uc791\ub3d9\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ub2e4\ub9cc 200\uc77c\uc120 \ubc14\ub85c \uadfc\ucc98\uc5d0\uc11c \uc2e0\uaddc \uacf5\ub9e4\ub3c4\ub294 \ubc18\ub4f1 \uc704\ud5d8\ub3c4 \ud568\uaed8 \ud06c\ubbc0\ub85c, \uc7a5\uc911 \uac70\ub798\ub7c9\uacfc \uc885\uac00 \ud655\uc778\uc774 \ud544\uc694\ud569\ub2c8\ub2e4.\n\n| \uad6c\ubd84 | \ud575\uc2ec \uc218\uce58 | \ud574\uc11d | \uc2e4\ud589 \ud3ec\uc778\ud2b8 |\n|---|---:|---|---|\n| \uc2dc\uc7a5 \uccb4\uc81c | \uace0\ubcc0\ub3d9\uc131 \ud558\ub77d \uc870\uc815 | \ub2e8\uae30\u00b7\uc911\uae30 \uc57d\uc138, \uc7a5\uae30 \uc9c0\uc9c0\uc120 \uc2dc\ud5d8 | 200\uc77c\uc120 \ubc29\uc5b4 \uc5ec\ubd80 \uc6b0\uc120 \ud655\uc778 |\n| \ucd5c\uc2e0 \ud655\uc778 \uc885\uac00 | 905.03 | 2026-04-15 \uae30\uc900, 50\uc77c\uc120\u00b710\uc77c\uc120 \uc544\ub798 | \ucd94\uc138 \ud68c\ubcf5 \uc804 \ucd94\uaca9 \ub9e4\uc218 \uc790\uc81c |\n| 50\uc77c \ub2e8\uc21c\uc774\ub3d9\ud3c9\uade0 | 976.71 | \uc911\uae30 \ucd94\uc138 \uc800\ud56d | 976~979 \ud68c\ubcf5 \uc804 \uc911\uae30 \uc0c1\uc2b9 \uc804\ud658 \ubd88\ucda9\ubd84 |\n| 200\uc77c \ub2e8\uc21c\uc774\ub3d9\ud3c9\uade0 | 902.63 | \uc7a5\uae30 \ucd94\uc138 \ud575\uc2ec \uc9c0\uc9c0 | \uc885\uac00 \uc774\ud0c8 \uc2dc \ubc29\uc5b4 \uc2e4\ud328 \uc2e0\ud638 |\n| 10\uc77c \uc9c0\uc218\uc774\ub3d9\ud3c9\uade0 | 923.23 | \ub2e8\uae30 \ubc18\ub4f1 \uae30\uc900\uc120 | 923~925 \ud68c\ubcf5 \uc2dc \ub2e8\uae30 \ub9e4\uc218\uc138 \uac1c\uc120 |\n| \uac70\ub798\ub7c9\uac00\uc911\ud3c9\uade0 | 924.83 | \uac70\ub798\ub7c9 \ubc18\uc601 \ud3c9\uade0 \uac00\uaca9 | \uac00\uaca9\uc774 \uc544\ub798\uc5d0 \uc788\uc5b4 \uc720\ub3d9\uc131 \uc6b0\uc704 \uc57d\ud568 |\n| MACD | -14.38 | \uc57d\uc138\uad8c\uc774\ub098 \ud558\ub77d \ubaa8\uba58\ud140\uc740 \uc644\ud654 | 0\uc120 \ud68c\ubcf5 \uc804 \ucd94\uc138 \uc804\ud658 \ud310\ub2e8 \ubcf4\ub958 |\n| MACD \ud788\uc2a4\ud1a0\uadf8\ub7a8 | 1.75 | \ubc18\ub4f1 \ubaa8\uba58\ud140 \ub454\ud654 | \uc591\uc218 \uc720\uc9c0 \uc5ec\ubd80 \ud655\uc778 \ud544\uc694 |\n| RSI | 39.85 | \uacfc\ub9e4\ub3c4 \ud0c8\ucd9c \ud6c4 \uc57d\uc138\uad8c | 50 \ud68c\ubcf5 \uc804 \uac15\uc138 \uc2e0\ud638 \ubd80\uc871 |\n| ATR | 28.13 | \ubcc0\ub3d9\uc131 \ub192\uc74c | \uc190\uc808\u00b7\ud3ec\uc9c0\uc158 \ud06c\uae30 \ubcf4\uc218\uc801\uc73c\ub85c \uc870\uc815 |\n| \uc8fc\uc694 \uc9c0\uc9c0 | 902.63 / 888.03 / 878.24 | \uc7a5\uae30\uc120, \ucd5c\uadfc \uc800\uac00, \uc9c1\uc804 \uc800\uc810 | \uc21c\ucc28 \uc774\ud0c8 \uc2dc \ud558\ub77d \uc704\ud5d8 \ud655\ub300 |\n| \uc8fc\uc694 \uc800\ud56d | 923~925 / 939~955 / 976~979 | \ub2e8\uae30 \ud3c9\uade0, \ucd5c\uadfc \ubc18\ub4f1 \uad6c\uac04, 50\uc77c\uc120 | \uc800\ud56d \ub3cc\ud30c \uc804 \ubd84\ud560 \uc811\uadfc \uc6b0\uc120 |",
    "sentiment_report": "Source type: news-derived sentiment\n\nLLY\uc5d0 \ub300\ud55c \ucd5c\uadfc 30\uc77c \uacf5\uacf5 \ub0b4\ub7ec\ud2f0\ube0c\ub294 \uc804\ubc18\uc801\uc73c\ub85c \uae0d\uc815 \ucabd\uc73c\ub85c \uae30\uc6b8\uc5b4\uc838 \uc788\uc2b5\ub2c8\ub2e4. \ub2e4\ub9cc \uc804\uc6a9 \uc0ac\ud68c\uad00\uacc4\ub9dd \uc81c\uacf5\uc790\ub294 \uc0ac\uc6a9\ud560 \uc218 \uc5c6\uc5c8\uc73c\ubbc0\ub85c, \uc774 \ud3c9\uac00\ub294 \uc2e4\uc81c \uac8c\uc2dc\ubb3c \ud750\ub984\uc774 \uc544\ub2c8\ub77c \ub274\uc2a4 \uae30\ubc18 \uac10\uc131 \ubc0f \uae30\uc5c5 \uad00\ub828 \ubcf4\ub3c4\uc5d0\uc11c \uad00\ucc30\ub418\ub294 \uc5ec\ub860\u00b7\ud22c\uc790\uc790 \ub0b4\ub7ec\ud2f0\ube0c\uc785\ub2c8\ub2e4.\n\n\uac00\uc7a5 \uac15\ud55c \uac10\uc131 \ub3d9\uc778\uc740 \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c Foundayo \uad00\ub828 \uc784\uc0c1 \ub370\uc774\ud130\uc785\ub2c8\ub2e4. 2026-04-16 \ubcf4\ub3c4\uc5d0\uc11c Foundayo\uac00 \uc81c2\ud615 \ub2f9\ub1e8\uc640 \ube44\ub9cc \ud658\uc790\uad70\uc5d0\uc11c \uc8fc\uc694 \uc2ec\ud608\uad00 \uc0ac\uac74 \uc704\ud5d8\uc744 \uc7a5\uae30 \uc9c0\uc18d\ud615 \uc778\uc290\ub9b0 \ub300\ube44 \ube44\uc5f4\ub4f1\ud558\uac8c \ub0ae\ucdc4\uace0, \uc804\uccb4 \uc0ac\ub9dd \uc704\ud5d8\uc744 57% \ub0ae\ucdc4\ub2e4\ub294 \ub0b4\uc6a9\uc774 \ubc18\ubcf5\uc801\uc73c\ub85c \ubd80\uac01\ub410\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \uac04 \uc548\uc804\uc131 \uc2e0\ud638\uac00 \uc5c6\uc5c8\ub2e4\ub294 \uc810\uc740 \ucd5c\uadfc \uc6b0\ub824\ub97c \uc644\ud654\ud558\ub294 \uc694\uc18c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \uc774\ub294 LLY\uc758 \ud575\uc2ec \uc131\uc7a5\ucd95\uc778 GLP-1 \ubc0f \ube44\ub9cc \uce58\ub8cc\uc81c \ud504\ub79c\ucc28\uc774\uc988\uc5d0 \ub300\ud55c \uc2e0\ub8b0\ub97c \uac15\ud654\ud558\ub294 \uc7ac\ub8cc\uc785\ub2c8\ub2e4.\n\n\ud1a4 \ubcc0\ud654\ub294 4\uc6d4 \uc911\uc21c\ubd80\ud130 \ub354 \ub69c\ub837\ud558\uac8c \uae0d\uc815\uc801\uc73c\ub85c \uc804\ud658\ub41c \ubaa8\uc2b5\uc785\ub2c8\ub2e4. \uc774\uc804\uc5d0\ub294 \uacbd\uc7c1 \uc2ec\ud654, \ubc38\ub958\uc5d0\uc774\uc158 \ubd80\ub2f4, FDA\uc758 \ucd94\uac00 \uc694\uad6c \uac00\ub2a5\uc131 \uac19\uc740 \uc6b0\ub824\uac00 \uacf5\uc874\ud588\uc9c0\ub9cc, Foundayo\uc758 \uc2ec\ud608\uad00 \ub370\uc774\ud130\uac00 \uacf5\uac1c\ub418\uba74\uc11c \u201c\uc548\uc804\uc131 \uc6b0\ub824 \uc644\ud654\u201d, \u201c\uc801\uc751\uc99d \ud655\ub300 \uac00\ub2a5\uc131\u201d, \u201c\ub2f9\ub1e8 \uc2dc\uc7a5 \uc9c4\uc785 \uac00\uc18d\u201d\uc774\ub77c\ub294 \ubb38\uad6c\uac00 \uc804\uba74\uc5d0 \ub4f1\uc7a5\ud588\uc2b5\ub2c8\ub2e4. Wall Street Journal, USA Today, GuruFocus \ub4f1 \ub2e4\uc591\ud55c \ub9e4\uccb4\uac00 \uac19\uc740 \ubc29\ud5a5\uc758 \uba54\uc2dc\uc9c0\ub97c \ub0b4\uba74\uc11c \ub2e8\uc77c \ud638\uc7ac\uac00 \uc5ec\ub7ec \ucc44\ub110\uc5d0\uc11c \uc99d\ud3ed\ub418\ub294 \uad6c\uc870\uc785\ub2c8\ub2e4.\n\n\ub0b4\ub7ec\ud2f0\ube0c \uc9d1\uc911\ub3c4\ub294 \uc0c1\ub2f9\ud788 \ub192\uc2b5\ub2c8\ub2e4. \ucd5c\uadfc \ubcf4\ub3c4\uc758 \uc911\uc2ec\uc740 \uac70\uc758 \uc138 \uac08\ub798\ub85c \ubaa8\uc785\ub2c8\ub2e4. \uccab\uc9f8, Foundayo\uc758 \uc784\uc0c1 \ubc0f \ud5c8\uac00 \ud655\uc7a5 \uac00\ub2a5\uc131\uc785\ub2c8\ub2e4. \ub458\uc9f8, \ube44\ub9cc \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uc804\uccb4\uc758 \uacbd\uc7c1 \uad6c\ub3c4\uc785\ub2c8\ub2e4. Viking Therapeutics, Novo Nordisk, Kailera \ub4f1 \uacbd\uc7c1\u00b7\ud6c4\ubc1c \uc8fc\uc790 \ubcf4\ub3c4\uac00 \ud568\uaed8 \uc99d\uac00\ud558\uba74\uc11c \uc2dc\uc7a5 \uad00\uc2ec\uc774 \ube44\ub9cc \uce58\ub8cc\uc81c \uc139\ud130\uc5d0 \uc9d1\uc911\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc14b\uc9f8, LLY\uc758 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5\uc785\ub2c8\ub2e4. Centessa Pharmaceuticals \uc778\uc218 \ubcf4\ub3c4\uc640 \uc218\uba74\u00b7\uc2e0\uacbd\uacfc\ud559 \uad00\ub828 \uc790\uc0b0 \ud655\ubcf4 \uac00\ub2a5\uc131\uc740 LLY\uac00 \ube44\ub9cc \uce58\ub8cc\uc81c \uc678 \uc131\uc7a5 \ub3d9\ub825\ub3c4 \uac15\ud654\ud558\ub824 \ud55c\ub2e4\ub294 \uc778\uc0c1\uc744 \uc90d\ub2c8\ub2e4.\n\n\uac1c\uc120\ub418\ub294 \ubd80\ubd84\uc740 \uba85\ud655\ud569\ub2c8\ub2e4. Foundayo\uc758 \uc2ec\ud608\uad00 \uacb0\uacfc\ub294 \uaddc\uc81c\u00b7\uc0c1\uc5c5\ud654\u00b7\uc758\uc0ac \ucc98\ubc29 \uc2e0\ub8b0\ub3c4 \uce21\uba74\uc5d0\uc11c \ubaa8\ub450 \uae0d\uc815\uc801\uc785\ub2c8\ub2e4. \ub610\ud55c \ubd84\uc11d\uac00 \ubcf4\ub3c4\uc5d0\uc11c\ub294 LLY\uc5d0 \ub300\ud574 \ub9e4\uc218 \ub610\ub294 Strong \ub9e4\uc218 \uacc4\uc5f4\uc758 \ud3c9\uac00\uac00 \uc720\uc9c0\ub418\uace0, \ubaa9\ud45c\uac00 $1300.00 \ubc0f \ud3c9\uade0 \ubaa9\ud45c\uac00 $1,224.59 \uac19\uc740 \ub192\uc740 \uc218\uce58\uac00 \uc5b8\uae09\ub429\ub2c8\ub2e4. \uae30\uad00 \ubcf4\ub3c4\ub3c4 \ud63c\uc7ac\ub3fc \uc788\uc9c0\ub9cc Greenup Street Wealth Management\uc758 \uc2e0\uaddc \uc9c0\ubd84 \ucde8\ub4dd\ucc98\ub7fc \ub300\ud615 \uc131\uc7a5\uc8fc\ub85c\uc11c\uc758 \uc218\uc694\uac00 \uc5ec\uc804\ud788 \uc874\uc7ac\ud568\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.\n\n\uc545\ud654\ub418\uac70\ub098 \uc8fc\uc758\ud574\uc57c \ud560 \ubd80\ubd84\ub3c4 \uc788\uc2b5\ub2c8\ub2e4. Clinical Trials Arena \ubcf4\ub3c4\uc5d0\uc11c\ub294 FDA\uac00 Foundayo\uc758 \u201cunexpected serious\u201d \uc704\ud5d8 \ud3c9\uac00\ub97c \uc704\ud55c \uc2dc\ud310 \ud6c4 \uc2dc\ud5d8\uc744 \uc694\uad6c\ud588\ub2e4\ub294 \uc810\uc774 \uc5b8\uae09\ub410\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ub2f9\uc7a5 \ubd80\uc815\uc801 \uacb0\ub860\uc774\ub77c\uae30\ubcf4\ub2e4, \ud5a5\ud6c4 \uc548\uc804\uc131 \ucd94\uc801 \ubd80\ub2f4\uc774 \ub0a8\uc544 \uc788\ub2e4\ub294 \uc2e0\ud638\uc785\ub2c8\ub2e4. \ub610\ud55c Altfest L J & Co. Inc.\uc758 \uc9c0\ubd84 \ucd95\uc18c \ubcf4\ub3c4\ub294 \uc77c\ubd80 \ud22c\uc790\uc790\uac00 \ub192\uc740 \ubc38\ub958\uc5d0\uc774\uc158 \ub610\ub294 \ud3ec\uc9c0\uc158 \uc870\uc808\uc5d0 \ub098\uc11c\uace0 \uc788\uc74c\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4. \ube44\ub9cc \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\ub294 Viking Therapeutics, Novo Nordisk, Kailera \ub4f1 \uacbd\uc7c1 \ud6c4\ubcf4\ub4e4\uc774 \uacc4\uc18d \ubd80\uac01\ub418\uace0 \uc788\uc5b4 LLY\uc758 \ub9ac\ub354\uc2ed\uc740 \uac15\ud558\uc9c0\ub9cc \ub3c5\uc810\uc801 \ub0b4\ub7ec\ud2f0\ube0c\ub294 \uc544\ub2d9\ub2c8\ub2e4.\n\n\uac70\ub798 \uad00\uc810\uc5d0\uc11c \ud575\uc2ec \uc2dc\uc0ac\uc810\uc740 \u201c\uae0d\uc815 \ubaa8\uba58\ud140\uc740 \uac15\ud558\uc9c0\ub9cc \uae30\ub300\uce58\ub3c4 \ub192\ub2e4\u201d\ub294 \uc810\uc785\ub2c8\ub2e4. Foundayo \ub370\uc774\ud130\ub294 \ub2e8\uae30 \uc8fc\uac00 \uc9c0\uc9c0 \uc694\uc778\uc774\uace0, \ube44\ub9cc\u00b7\ub2f9\ub1e8 \ud504\ub79c\ucc28\uc774\uc988\uc758 \uc7a5\uae30 \ub9e4\ucd9c \uae30\ub300\ub97c \uac15\ud654\ud569\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc774\ubbf8 \uc2dc\uc7a5\uc774 LLY\ub97c \uace0\uc131\uc7a5 \ub300\ud615 \uc81c\uc57d\uc8fc\ub85c \ud3c9\uac00\ud558\uace0 \uc788\uae30 \ub54c\ubb38\uc5d0, \ucd94\uac00 \uc0c1\uc2b9\uc740 \uc784\uc0c1 \ub370\uc774\ud130\uc758 \uc9c0\uc18d\uc131, \uc2e4\uc81c \ud5c8\uac00 \ud655\uc7a5 \uc18d\ub3c4, \uacf5\uae09 \ub2a5\ub825, \uacbd\uc7c1 \uc57d\ubb3c \ub300\ube44 \ucc28\ubcc4\uc131\uc5d0 \ub2ec\ub824 \uc788\uc2b5\ub2c8\ub2e4. \ub2e8\uae30\uc801\uc73c\ub85c\ub294 \ub274\uc2a4 \ud750\ub984\uc774 \ub9e4\uc218 \uc2ec\ub9ac\ub97c \uc9c0\uc9c0\ud558\uc9c0\ub9cc, FDA \uc0ac\ud6c4 \uc5f0\uad6c \uc694\uad6c\ub098 \uacbd\uc7c1\uc0ac \uc784\uc0c1 \uc774\ubca4\ud2b8\uac00 \ub098\uc624\uba74 \ubcc0\ub3d9\uc131\uc774 \ucee4\uc9c8 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n\uc885\ud569\ud558\uba74 LLY\uc758 \ub274\uc2a4 \uae30\ubc18 \uacf5\uacf5 \uac10\uc131\uc740 \uae0d\uc815\uc801\uc774\uba70, \ud2b9\ud788 2026-04-16 Foundayo \uad00\ub828 \ubcf4\ub3c4 \uc774\ud6c4 \uae0d\uc815 \ub0b4\ub7ec\ud2f0\ube0c\uac00 \uac15\ud654\ub410\uc2b5\ub2c8\ub2e4. \ub2e4\ub9cc \uc774 \uae0d\uc815\ub860\uc740 \ub9e4\uc6b0 \uc9d1\uc911\ub41c \ud14c\ub9c8, \uc989 \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \uc131\uacf5 \uae30\ub300\uc5d0 \ud06c\uac8c \uc758\uc874\ud569\ub2c8\ub2e4. \ub530\ub77c\uc11c \ud22c\uc790\uc790 \uc2ec\ub9ac\ub294 \uc6b0\ud638\uc801\uc774\uc9c0\ub9cc, \ub2e8\uc77c \ud504\ub79c\ucc28\uc774\uc988 \uae30\ub300\uac00 \uacfc\ub3c4\ud558\uac8c \uac00\uaca9\uc5d0 \ubc18\uc601\ub420 \uacbd\uc6b0 \ud638\uc7ac\uc5d0\ub3c4 \uc8fc\uac00 \ubc18\uc751\uc774 \uc81c\ud55c\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n| \uc2e0\ud638 | \uc99d\uac70 | \ud574\uc11d | \uc2e0\ub8b0\ub3c4 |\n|---|---|---|---|\n| \uac10\uc131 \ubc29\ud5a5 | Foundayo \uc2ec\ud608\uad00 \ub370\uc774\ud130, \uc0ac\ub9dd \uc704\ud5d8 57% \uac10\uc18c, \uac04 \uc548\uc804\uc131 \uc2e0\ud638 \ubd80\uc7ac | \ud575\uc2ec \uc131\uc7a5 \uc81c\ud488\uc5d0 \ub300\ud55c \uc2e0\ub8b0 \uac1c\uc120 | \ub192\uc74c |\n| \uc8fc\uc694 \uae0d\uc815 \ub3d9\uc778 | 2026-04-16 USA Today, Wall Street Journal, GuruFocus \ubcf4\ub3c4 | \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uc801\uc751\uc99d \ud655\ub300 \uae30\ub300 \uac15\ud654 | \ub192\uc74c |\n| \uc8fc\uc694 \ubd80\ub2f4 \uc694\uc778 | FDA \uc2dc\ud310 \ud6c4 \uc2dc\ud5d8 \uc694\uad6c, \u201cunexpected serious\u201d \uc704\ud5d8 \ud3c9\uac00 \uc5b8\uae09 | \uc548\uc804\uc131 \ubaa8\ub2c8\ud130\ub9c1 \uc774\uc288\ub294 \ub0a8\uc544 \uc788\uc74c | \uc911\uac04 |\n| \ub0b4\ub7ec\ud2f0\ube0c \uc9d1\uc911\ub3c4 | Foundayo, GLP-1, \ube44\ub9cc \uce58\ub8cc\uc81c \uacbd\uc7c1 \uad00\ub828 \ubcf4\ub3c4 \uc9d1\uc911 | \ud22c\uc790 \uc2ec\ub9ac\uac00 \ud2b9\uc815 \ud14c\ub9c8\uc5d0 \ud06c\uac8c \uc758\uc874 | \ub192\uc74c |\n| \uacbd\uc7c1 \uad6c\ub3c4 | Viking Therapeutics, Novo Nordisk, Kailera \uad00\ub828 \ubcf4\ub3c4 \uc99d\uac00 | \uc2dc\uc7a5 \uaddc\ubaa8\ub294 \ud06c\uc9c0\ub9cc \uacbd\uc7c1 \uc555\ub825\ub3c4 \ud655\ub300 | \uc911\uac04 |\n| \uae30\uad00\u00b7\ubd84\uc11d\uac00 \ubd84\uc704\uae30 | \ub9e4\uc218, Strong \ub9e4\uc218, \ubaa9\ud45c\uac00 $1300.00 \ubc0f \ud3c9\uade0 $1,224.59 \uc5b8\uae09 | \uace0\uc131\uc7a5 \ud504\ub9ac\ubbf8\uc5c4 \uc720\uc9c0 | \uc911\uac04 |\n| \uac70\ub798 \uc2dc\uc0ac\uc810 | \ud638\uc7ac\uc131 \uc784\uc0c1 \ub274\uc2a4\uc640 \ub192\uc740 \uae30\ub300\uce58 \uacf5\uc874 | \uc0c1\uc2b9 \ud3b8\ud5a5\uc774\ub098 \ub274\uc2a4 \ubbfc\uac10\ub3c4\uc640 \ubcc0\ub3d9\uc131 \ud655\ub300 \uac00\ub2a5 | \uc911\uac04 |",
    "news_report": "**LLY \ub274\uc2a4 \ubc0f \uc774\ubca4\ud2b8 \uc810\uac80**\n\n\ucd5c\uadfc 7\uc77c\uac04 \ud655\uc778\ub41c LLY \uad00\ub828 \ud575\uc2ec \ud750\ub984\uc740 \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \uc784\uc0c1/\ud5c8\uac00 \uae30\ub300, \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5, \uc560\ub110\ub9ac\uc2a4\ud2b8\uc758 \ub192\uc740 \ubaa9\ud45c\uac00 \uc720\uc9c0, \uc5d0\ub108\uc9c0 \uc778\ud504\ub77c \ud611\ub825\uc785\ub2c8\ub2e4. \uacf5\uc2dc \uc790\ub8cc\ub294 \uc81c\uacf5\ucc98 \ubbf8\uac00\uc6a9\uc73c\ub85c \ud655\uc778\ub418\uc9c0 \uc54a\uc558\uc2b5\ub2c8\ub2e4.\n\n**\ud575\uc2ec \uc0ac\uac74**\n\n1. **\uc0ac\uac74 \uc720\ud615: \uc784\uc0c1\u00b7\ud5c8\uac00 \uae30\ub300**  \n   **\ucd9c\ucc98:** USA Today, 2026-04-16  \n   LLY\uc758 \ube44\ub9cc \uce58\ub8cc\uc81c Foundayo\uac00 \uc81c2\ud615 \ub2f9\ub1e8 \ubc0f \ube44\ub9cc \ud658\uc790\uc5d0\uc11c \uc8fc\uc694 \uc2ec\ud608\uad00 \uc0ac\uac74 \uc704\ud5d8\uacfc \uc0ac\ub9dd \uc704\ud5d8 \uac1c\uc120\uc744 \ubcf4\uc600\uace0, \ud68c\uc0ac\uac00 2\ubd84\uae30 \ub9d0\uae4c\uc9c0 \uc81c2\ud615 \ub2f9\ub1e8 \uc801\uc751\uc99d\uc758 \ubbf8\uad6d \uc2b9\uc778 \uc2e0\uccad\uc744 \uacc4\ud68d\ud55c\ub2e4\uace0 \ubcf4\ub3c4\ub418\uc5c8\uc2b5\ub2c8\ub2e4.  \n   **\uc911\uc694\uc131:** LLY\uc758 \ud575\uc2ec \uc131\uc7a5\ucd95\uc778 \ube44\ub9cc\u00b7\ub2f9\ub1e8 \ud504\ub79c\ucc28\uc774\uc988\uc758 \uc801\uc751\uc99d \ud655\ub300 \uac00\ub2a5\uc131\uc744 \uac15\ud654\ud569\ub2c8\ub2e4.  \n   **\uac15\uc138 \uc2dc\uc0ac\uc810:** \uc2b9\uc778 \uac00\ub2a5\uc131\uc774 \ub192\uc544\uc9c8 \uacbd\uc6b0 \ub9e4\ucd9c \ucd94\uc815\uce58\uc640 \uc7a5\uae30 \uc131\uc7a5 \ud504\ub9ac\ubbf8\uc5c4\uc774 \uc0c1\ud5a5\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.  \n   **\uc57d\uc138 \uc2dc\uc0ac\uc810:** \ud5c8\uac00 \uc9c0\uc5f0, \ub77c\ubca8 \uc81c\ud55c, \uc548\uc804\uc131 \ub17c\uc7c1\uc774 \ubc1c\uc0dd\ud558\uba74 \uae30\ub300\uac00 \uc120\ubc18\uc601\ub41c \ubc38\ub958\uc5d0\uc774\uc158\uc5d0 \ubd80\ub2f4\uc774 \ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.  \n   **\uc2e0\ub8b0\ub3c4:** \ub192\uc74c\n\n2. **\uc0ac\uac74 \uc720\ud615: \uc778\uc218\u00b7\ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5**  \n   **\ucd9c\ucc98:** MSN, 2026-04-15  \n   LLY\uac00 \uc2e0\uacbd\uacfc\ud559 \ubc14\uc774\uc624\ud14d Centessa Pharmaceuticals\ub97c $7.8B\uc5d0 \uc778\uc218\ud560 \uc608\uc815\uc774\ub77c\ub294 \ubcf4\ub3c4\uac00 \uc788\uc5c8\uc2b5\ub2c8\ub2e4.  \n   **\uc911\uc694\uc131:** \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uc911\uc2ec \uc131\uc7a5\uc5d0 \ub354\ud574 \uc2e0\uacbd\uacfc\ud559 \ud30c\uc774\ud504\ub77c\uc778\uc744 \ubcf4\uac15\ud558\ub824\ub294 \uc804\ub7b5\uc73c\ub85c \ud574\uc11d\ub429\ub2c8\ub2e4.  \n   **\uac15\uc138 \uc2dc\uc0ac\uc810:** \uc911\uc7a5\uae30 \ud30c\uc774\ud504\ub77c\uc778 \ub2e4\ubcc0\ud654\uc640 \uc2e0\uc57d \ud6c4\ubcf4 \ud655\ubcf4\uac00 \uc131\uc7a5 \uc9c0\uc18d\uc131 \uc6b0\ub824\ub97c \ub0ae\ucd9c \uc218 \uc788\uc2b5\ub2c8\ub2e4.  \n   **\uc57d\uc138 \uc2dc\uc0ac\uc810:** \uc778\uc218 \uac00\uaca9, \ud1b5\ud569 \ub9ac\uc2a4\ud06c, \uc784\uc0c1 \uc2e4\ud328 \uac00\ub2a5\uc131\uc774 \ud22c\uc790\uc790\uc5d0\uac8c \ubd80\ub2f4\uc73c\ub85c \uc791\uc6a9\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.  \n   **\uc2e0\ub8b0\ub3c4:** \uc911\uac04\n\n3. **\uc0ac\uac74 \uc720\ud615: \uc560\ub110\ub9ac\uc2a4\ud2b8 \uc758\uacac**  \n   **\ucd9c\ucc98:** The Globe and Mail, 2026-04-16  \n   BMO Capital\uc740 LLY\uc5d0 \ub300\ud574 \ub9e4\uc218 \uc758\uacac\uc744 \uc720\uc9c0\ud558\uace0 \ubaa9\ud45c\uac00 $1300.00\uc744 \uc81c\uc2dc\ud588\uc2b5\ub2c8\ub2e4. \uae30\uc0ac\uc5d0\uc11c\ub294 LLY\uc758 \ucee8\uc13c\uc11c\uc2a4\uac00 \uac15\ud55c \ub9e4\uc218\uc5d0 \uac00\uae5d\ub2e4\uace0 \uc5b8\uae09\ud588\uc2b5\ub2c8\ub2e4.  \n   **\uc911\uc694\uc131:** \ucd5c\uadfc \uc8fc\uac00 \ubcc0\ub3d9\uc5d0\ub3c4 \ub300\ud615 \uae30\uad00\uc758 \uc131\uc7a5 \uae30\ub300\uac00 \uc720\uc9c0\ub418\uace0 \uc788\uc74c\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.  \n   **\uac15\uc138 \uc2dc\uc0ac\uc810:** \uace0\uc131\uc7a5 \uc81c\uc57d\uc8fc\ub85c\uc11c \ud504\ub9ac\ubbf8\uc5c4 \ubc38\ub958\uc5d0\uc774\uc158\uc744 \ubc29\uc5b4\ud558\ub294 \uc2ec\ub9ac\uc801 \uc9c0\uc9c0 \uc694\uc778\uc774 \ub429\ub2c8\ub2e4.  \n   **\uc57d\uc138 \uc2dc\uc0ac\uc810:** \ubaa9\ud45c\uac00\uac00 \uc774\ubbf8 \ub192\uc740 \uc131\uc7a5\ub960\uc744 \ubc18\uc601\ud558\uace0 \uc788\uc5b4 \uc2e4\uc801\uc774\ub098 \uc784\uc0c1 \uae30\ub300\uac00 \ub0ae\uc544\uc9c8 \uacbd\uc6b0 \ud558\ub77d \ud0c4\ub825\uc774 \ucee4\uc9c8 \uc218 \uc788\uc2b5\ub2c8\ub2e4.  \n   **\uc2e0\ub8b0\ub3c4:** \ub192\uc74c\n\n4. **\uc0ac\uac74 \uc720\ud615: \uc6b4\uc601\u00b7\uc778\ud504\ub77c \ud611\ub825**  \n   **\ucd9c\ucc98:** Fox 59, 2026-04-16  \n   Indiana \uc8fc\uc9c0\uc0ac Mike Braun\uc774 Eli Lilly and Company\uc640 \uc6d0\uc790\ub825 \uc5d0\ub108\uc9c0 \uc194\ub8e8\uc158 \uac1c\ubc1c \ud611\ub825 \uc758\ud5a5\uc11c\uc5d0 \uc11c\uba85\ud588\uc2b5\ub2c8\ub2e4. \uc18c\ud615 \ubaa8\ub4c8 \uc6d0\uc790\ub85c \ub4f1 \uc7a5\uae30 \uc804\ub825 \uc548\uc815\uc131\uacfc \ubc30\ucd9c \uac10\ucd95 \uac00\ub2a5\uc131\uc744 \uac80\ud1a0\ud558\ub294 \ub0b4\uc6a9\uc785\ub2c8\ub2e4.  \n   **\uc911\uc694\uc131:** \ub300\uaddc\ubaa8 \uc81c\uc870\uc2dc\uc124\uacfc \uc5f0\uad6c\uc2dc\uc124\uc744 \uc6b4\uc601\ud558\ub294 LLY\uc5d0\ub294 \uc548\uc815\uc801 \uc804\ub825 \uacf5\uae09\uacfc \ube44\uc6a9 \uad00\ub9ac\uac00 \uc804\ub7b5\uc801 \uc758\ubbf8\ub97c \uac00\uc9c8 \uc218 \uc788\uc2b5\ub2c8\ub2e4.  \n   **\uac15\uc138 \uc2dc\uc0ac\uc810:** \uc7a5\uae30\uc801\uc73c\ub85c \uc0dd\uc0b0 \uc548\uc815\uc131, \uc5d0\ub108\uc9c0 \ube44\uc6a9 \uc608\uce21 \uac00\ub2a5\uc131, \uc9c0\uc18d\uac00\ub2a5\uc131 \ud3c9\uac00\uc5d0 \uae0d\uc815\uc801\uc785\ub2c8\ub2e4.  \n   **\uc57d\uc138 \uc2dc\uc0ac\uc810:** \uc6d0\uc790\ub825 \ud504\ub85c\uc81d\ud2b8\ub294 \uc778\ud5c8\uac00, \uc8fc\ubbfc \uc218\uc6a9\uc131, \ucd08\uae30 \ube44\uc6a9, \uc2e4\ud589 \uae30\uac04 \ub9ac\uc2a4\ud06c\uac00 \ud07d\ub2c8\ub2e4.  \n   **\uc2e0\ub8b0\ub3c4:** \uc911\uac04\n\n5. **\uc0ac\uac74 \uc720\ud615: \uac70\uc2dc \ud658\uacbd**  \n   **\ucd9c\ucc98:** UBS, WisdomTree, inkl, 2026-04-16  \n   \ucd5c\uadfc \ubbf8\uad6d \uc2dc\uc7a5\uc740 \uc8fc\uc2dd \ub7a0\ub9ac\uc758 \ud3ed\uc774 \uc881\ub2e4\ub294 \uacbd\uacc4, \uc911\ub3d9 \uc804\uc7c1\uc5d0 \ub530\ub978 \uc5d0\ub108\uc9c0\u00b7\uc778\ud50c\ub808\uc774\uc158 \ub9ac\uc2a4\ud06c, \ud488\uc9c8 \ucc44\uad8c \uc120\ud638 \ud655\ub300\uac00 \ud568\uaed8 \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4.  \n   **\uc911\uc694\uc131:** LLY \uac19\uc740 \uace0\uc131\uc7a5 \ub300\ud615 \ud5ec\uc2a4\ucf00\uc5b4\uc8fc\ub294 \ubc29\uc5b4\uc801 \uc131\uaca9\uacfc \uc131\uc7a5\uc8fc \ubc38\ub958\uc5d0\uc774\uc158 \ubbfc\uac10\ub3c4\ub97c \ub3d9\uc2dc\uc5d0 \uac16\uc2b5\ub2c8\ub2e4.  \n   **\uac15\uc138 \uc2dc\uc0ac\uc810:** \uacbd\uae30 \ub454\ud654 \uc6b0\ub824\uac00 \ucee4\uc9c8\uc218\ub85d \ud544\uc218 \uc758\uc57d\ud488 \uc218\uc694\uc640 \ub300\ud615 \uc81c\uc57d\uc8fc\uc758 \ubc29\uc5b4\uc131\uc774 \ubd80\uac01\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.  \n   **\uc57d\uc138 \uc2dc\uc0ac\uc810:** \uae08\ub9ac \uae30\ub300\uac00 \ud754\ub4e4\ub9ac\uac70\ub098 \uc704\ud5d8\uc790\uc0b0 \uc120\ud638\uac00 \uc57d\ud654\ub418\uba74 \uace0\ubc38\ub958\uc5d0\uc774\uc158 \uc885\ubaa9\uc758 \uba40\ud2f0\ud50c \uc555\ubc15\uc774 \ucee4\uc9c8 \uc218 \uc788\uc2b5\ub2c8\ub2e4.  \n   **\uc2e0\ub8b0\ub3c4:** \uc911\uac04\n\n**\uc885\ud569 \ud310\ub2e8**\n\nLLY\uc758 \ucd5c\uadfc \ub274\uc2a4 \ud750\ub984\uc740 \ub300\uccb4\ub85c \uae0d\uc815\uc801\uc785\ub2c8\ub2e4. \ud2b9\ud788 Foundayo\uc758 \uc2ec\ud608\uad00\u00b7\uc0ac\ub9dd \uc704\ud5d8 \uad00\ub828 \ub370\uc774\ud130\uc640 \ub2f9\ub1e8 \uc801\uc751\uc99d \uc2e0\uccad \uacc4\ud68d\uc740 \ud575\uc2ec \uc131\uc7a5 \uc2a4\ud1a0\ub9ac\ub97c \uc9c1\uc811 \uac15\ud654\ud569\ub2c8\ub2e4. \ub2e4\ub9cc \uc8fc\uac00\uac00 \uc774\ubbf8 \ub192\uc740 \uae30\ub300\ub97c \ubc18\uc601\ud558\uace0 \uc788\uc5b4, \ud5c8\uac00 \uc77c\uc815\u00b7\uacbd\uc7c1 \uc2ec\ud654\u00b7\uac70\uc2dc \uae08\ub9ac \ubcc0\uc218\uc5d0 \ub530\ub978 \ubcc0\ub3d9\uc131\uc740 \uc720\uc758\ud574\uc57c \ud569\ub2c8\ub2e4. \uacf5\uc2dc \uc81c\uacf5\ucc98\uac00 \ubbf8\uac00\uc6a9\uc774\ubbc0\ub85c \ucd5c\uadfc \uacf5\uc2dd \uacf5\uc2dc \uae30\ubc18 \uc774\ubca4\ud2b8\ub294 \ud655\uc778\ub418\uc9c0 \uc54a\uc558\uc2b5\ub2c8\ub2e4.\n\n| \uad6c\ubd84 | \ub0a0\uc9dc | \ucd9c\ucc98 | \ud575\uc2ec \ub0b4\uc6a9 | \ud22c\uc790 \uc2dc\uc0ac\uc810 | \uc2e0\ub8b0\ub3c4 |\n|---|---:|---|---|---|---|\n| \ud68c\uc0ac \ub274\uc2a4 | 2026-04-16 | USA Today | Foundayo\uac00 \uc2ec\ud608\uad00 \uc0ac\uac74 \ubc0f \uc0ac\ub9dd \uc704\ud5d8 \uac1c\uc120, \ub2f9\ub1e8 \uc801\uc751\uc99d \uc2b9\uc778 \uc2e0\uccad \uacc4\ud68d | \ud575\uc2ec \ud504\ub79c\ucc28\uc774\uc988 \uc131\uc7a5 \uae30\ub300 \uac15\ud654 | \ub192\uc74c |\n| \ud68c\uc0ac \ub274\uc2a4 | 2026-04-15 | MSN | LLY\uc758 Centessa Pharmaceuticals $7.8B \uc778\uc218 \ubcf4\ub3c4 | \uc2e0\uacbd\uacfc\ud559 \ud30c\uc774\ud504\ub77c\uc778 \ubcf4\uac15 | \uc911\uac04 |\n| \ud68c\uc0ac \ub274\uc2a4 | 2026-04-16 | The Globe and Mail | BMO Capital \ub9e4\uc218 \uc758\uacac \ubc0f \ubaa9\ud45c\uac00 $1300.00 \uc720\uc9c0 | \uc2dc\uc7a5 \uae30\ub300\uc640 \ud504\ub9ac\ubbf8\uc5c4 \ubc38\ub958\uc5d0\uc774\uc158 \uc9c0\uc9c0 | \ub192\uc74c |\n| \ud68c\uc0ac \ub274\uc2a4 | 2026-04-16 | Fox 59 | Indiana\uc640 \uc6d0\uc790\ub825 \uc5d0\ub108\uc9c0 \ud611\ub825 \uc758\ud5a5\uc11c \uccb4\uacb0 | \uc7a5\uae30 \uc804\ub825 \uc548\uc815\uc131 \ubc0f \uc9c0\uc18d\uac00\ub2a5\uc131 \uac00\ub2a5\uc131 | \uc911\uac04 |\n| \uac70\uc2dc \ub274\uc2a4 | 2026-04-16 | UBS, WisdomTree, inkl | \ucc44\uad8c \uc120\ud638, \uc911\ub3d9 \ub9ac\uc2a4\ud06c, \uc881\uc740 \uc8fc\uc2dd \ub7a0\ub9ac \uacbd\uacc4 | \uace0\uc131\uc7a5 \ub300\ud615 \ud5ec\uc2a4\ucf00\uc5b4\uc758 \ubc29\uc5b4\uc131\uacfc \ubc38\ub958\uc5d0\uc774\uc158 \ub9ac\uc2a4\ud06c \uacf5\uc874 | \uc911\uac04 |\n| \uacf5\uc2dc | 2026-04-10~2026-04-17 | \uc81c\uacf5\ucc98 \ubbf8\uac00\uc6a9 | \ud655\uc778\ub41c \uacf5\uc2dc \uc5c6\uc74c | \uacf5\uc2dd \uc774\ubca4\ud2b8 \ud655\uc778 \uc81c\ud55c | \ub0ae\uc74c |",
    "fundamentals_report": "**LLY \uae30\ubcf8\uc801 \ubd84\uc11d \ubcf4\uace0\uc11c**\n\nLLY\ub294 \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \uc911\uc2ec\uc758 \uc131\uc7a5\uc131\uc774 \uc5ec\uc804\ud788 \ud575\uc2ec \ud22c\uc790 \ub17c\ub9ac\uc785\ub2c8\ub2e4. 2026-04-16 \uae30\uc900\uc73c\ub85c \ud655\uc778\ub41c \ucd5c\uc2e0 \uc790\ub8cc\uc5d0\uc11c \uc2dc\uac00\ucd1d\uc561\uc740 809087991808, \ub9e4\ucd9c 65179000832, \uc21c\uc774\uc775 20640000000, \uc601\uc5c5\uc774\uc775\ub960 0.44896, \uc21c\uc774\uc775\ub960 0.31667\ub85c \ub300\ud615 \uc81c\uc57d\uc0ac \uc911\uc5d0\uc11c\ub3c4 \ub9e4\uc6b0 \ub192\uc740 \uc218\uc775\uc131\uc744 \ubcf4\uc785\ub2c8\ub2e4. \uc8fc\uac00 \uc9c0\ud45c\ub294 PE Ratio 39.372387, Forward PE 21.472843, PEG Ratio 0.9769\ub85c, \ud604\uc7ac \uc774\uc775 \ub300\ube44 \ubc38\ub958\uc5d0\uc774\uc158\uc740 \ub192\uc9c0\ub9cc \ud5a5\ud6c4 \uc774\uc775 \uc131\uc7a5 \uae30\ub300\uac00 \uc0c1\ub2f9 \ubd80\ubd84 \uc774\ub97c \uc815\ub2f9\ud654\ud558\ub294 \uad6c\uc870\uc785\ub2c8\ub2e4.\n\n**\ucd5c\uadfc \uc2e4\uc801\uacfc \uc218\uc775\uc131**\n\n2025-12-31 \ubd84\uae30 \ub9e4\ucd9c\uc740 19292000000\uc73c\ub85c 2025-09-30\uc758 17600800000, 2025-06-30\uc758 15557700000, 2025-03-31\uc758 12728500000\uc5d0\uc11c \uc5f0\uc18d \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4. \ub9e4\ucd9c\ucd1d\uc774\uc775\ub3c4 15920300000\uc73c\ub85c \ud655\ub300\ub410\uace0, \uc601\uc5c5\uc774\uc775\uc740 8987400000\uae4c\uc9c0 \uc0c1\uc2b9\ud588\uc2b5\ub2c8\ub2e4. \ubd84\uae30 \ud76c\uc11d EPS\ub294 7.39\ub85c \uc9c1\uc804 \ubd84\uae30 6.21, \uc804\ub144 \ub9d0 \ubd84\uae30 4.88\ubcf4\ub2e4 \uac1c\uc120\ub418\uc5c8\uc2b5\ub2c8\ub2e4.\n\n\ub2e4\ub9cc \uc774\uc775\uc758 \uc9c8\uc744 \ubcfc \ub54c \uc77c\ud68c\uc131 \ube44\uc6a9\uacfc \uad6c\uc870\uc870\uc815\u00b7\uc778\uc218\ud569\ubcd1 \uad00\ub828 \ube44\uc6a9\uc774 \uacc4\uc18d \uad00\ucc30\ub429\ub2c8\ub2e4. 2025-12-31 \ubd84\uae30 Total Unusual Items\ub294 -627000000, 2025-09-30\uc740 -973700000, 2025-03-31\uc740 -1753400000\uc774\uc5c8\uc2b5\ub2c8\ub2e4. \ubcf4\uace0 \uc21c\uc774\uc775\uc740 \uac15\ud558\uc9c0\ub9cc, \uc870\uc815 \uc804\ud6c4 \ucc28\uc774\uac00 \ubc18\ubcf5\ub418\ub294 \ub9cc\ud07c \uc784\uc0c1\u00b7\uc778\uc218\u00b7\uc0dd\uc0b0\ub2a5\ub825 \ud655\uc7a5 \uacfc\uc815\uc5d0\uc11c \ube44\uc6a9 \ubcc0\ub3d9\uc131\uc774 \uacc4\uc18d \ub0a8\uc544 \uc788\uc2b5\ub2c8\ub2e4.\n\n**\ud604\uae08\ud750\ub984\uacfc \ud22c\uc790 \ubd80\ub2f4**\n\n\uc601\uc5c5\ud604\uae08\ud750\ub984\uc740 2025-12-31 \ubd84\uae30 3224600000\uc73c\ub85c \ud50c\ub7ec\uc2a4\uc600\uc9c0\ub9cc, 2025-09-30\uc758 8835900000 \ub300\ube44 \ud06c\uac8c \ub0ae\uc544\uc84c\uc2b5\ub2c8\ub2e4. \uac19\uc740 \ubd84\uae30 Free Cash Flow\ub294 254200000\uc5d0 \uadf8\ucce4\uc2b5\ub2c8\ub2e4. \ud575\uc2ec \uc6d0\uc778\uc740 \ub300\uaddc\ubaa8 \uc124\ube44\ud22c\uc790\uc785\ub2c8\ub2e4. 2025-12-31 \ubd84\uae30 Capital Expenditure\ub294 -2970400000, 2025-09-30\uc740 -2808200000, 2025-03-31\uc740 -3266500000\uc73c\ub85c \ub192\uc740 \uc218\uc900\uc774 \uc774\uc5b4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4.\n\n\uc774\ub294 \ubd80\uc815\uc801\uc774\uae30\ub9cc \ud55c \uc2e0\ud638\ub294 \uc544\ub2d9\ub2c8\ub2e4. \uc218\uc694 \ub300\uc751\uc744 \uc704\ud55c \uc0dd\uc0b0\ub2a5\ub825 \ud655\uc7a5\uc73c\ub85c \ud574\uc11d\ud560 \uc218 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc911\uae30 \ud2b8\ub808\uc774\ub354 \uc785\uc7a5\uc5d0\uc11c\ub294 \ub9e4\ucd9c \uc131\uc7a5\uc774 \ud604\uae08\ud750\ub984\uc73c\ub85c \uc5bc\ub9c8\ub098 \ube60\ub974\uac8c \uc804\ud658\ub418\ub294\uc9c0, \uc124\ube44\ud22c\uc790 \ubd80\ub2f4\uc774 \ud53c\ud06c\ub97c \uc9c0\ub098\ub294\uc9c0, \uc7ac\uace0\uc640 \ub9e4\ucd9c\ucc44\uad8c \uc99d\uac00\uac00 \uc6b4\uc804\uc790\ubcf8\uc744 \uc5bc\ub9c8\ub098 \uc7a0\uc2dd\ud558\ub294\uc9c0\uac00 \ud575\uc2ec \uac10\uc2dc \ud3ec\uc778\ud2b8\uc785\ub2c8\ub2e4.\n\n**\uc7ac\ubb34\uc0c1\ud0dc\uc640 \uc790\ubcf8\uad6c\uc870**\n\n\ucd1d\uc790\uc0b0\uc740 2025-12-31 \uae30\uc900 112476000000, \ucd1d\ubd80\ucc44\ub294 85941000000, \ubcf4\ud1b5\uc8fc \uc790\ubcf8\uc740 26535000000\uc785\ub2c8\ub2e4. Total Debt\ub294 42503000000, Net Debt\ub294 35235000000\uc73c\ub85c \uc804\ub144 \ub9d0 2024-12-31\uc758 Total Debt 33644000000, Net Debt 30376000000\ubcf4\ub2e4 \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4. Debt to Equity\ub294 165.31\ub85c \ub808\ubc84\ub9ac\uc9c0\uac00 \ub0ae\ub2e4\uace0 \ubcf4\uae30\ub294 \uc5b4\ub835\uc2b5\ub2c8\ub2e4.\n\n\uae0d\uc815\uc801\uc778 \uc810\uc740 \uc720\ub3d9\uc131\uc785\ub2c8\ub2e4. Current Ratio\ub294 1.579\uc774\uace0, \ud604\uae08 \ubc0f \ud604\uae08\uc131 \uc790\uc0b0\uc740 2025-12-31 \uae30\uc900 7268000000\uc785\ub2c8\ub2e4. \uc6b4\uc804\uc790\ubcf8\ub3c4 20401000000\uc73c\ub85c \uc804\ub144 \ub9d0 4364000000 \ub300\ube44 \ud06c\uac8c \uac1c\uc120\ub410\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc7ac\uace0\uac00 13744000000, \ub9e4\ucd9c\ucc44\uad8c\uc774 20155000000\uc73c\ub85c \uc99d\uac00\ud574 \uace0\uc131\uc7a5 \uae30\uc5c5 \ud2b9\uc720\uc758 \uc6b4\uc804\uc790\ubcf8 \ud655\ub300\uac00 \uacc4\uc18d\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.\n\n**\uc8fc\uc8fc\ud658\uc6d0\uacfc \ub0b4\ubd80\uc790 \uac70\ub798**\n\n2025-12-31 \ubd84\uae30 \ubc30\ub2f9 \uc9c0\uae09\uc740 -1345500000, \uc790\uc0ac\uc8fc \ub9e4\uc785\uc740 -1507700000\uc785\ub2c8\ub2e4. \uc131\uc7a5 \ud22c\uc790\uac00 \ud070 \uad6d\uba74\uc5d0\uc11c\ub3c4 \ubc30\ub2f9\uacfc \ub9e4\uc785\uc744 \ubcd1\ud589\ud558\uace0 \uc788\uc73c\ub098, Free Cash Flow\uac00 \ub0ae\uc740 \ubd84\uae30\uc5d0\ub294 \uc8fc\uc8fc\ud658\uc6d0\uc774 \uc7ac\ubb34 \uc720\uc5f0\uc131\uc744 \uc77c\ubd80 \uc555\ubc15\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n\ub0b4\ubd80\uc790 \uac70\ub798\uc5d0\uc11c\ub294 2026-02-09\uc5d0 CEO RICKS DAVID A\uac00 38913\uc8fc\uc758 Stock Award\ub97c \ubc1b\ub294 \ub4f1 \uc784\uc6d0 \ubcf4\uc0c1\uc131 \uc8fc\uc2dd \ubd80\uc5ec\uac00 \ub2e4\uc218 \ud655\uc778\ub429\ub2c8\ub2e4. \ub354 \ub208\uc5d0 \ub744\ub294 \uac83\uc740 LILLY ENDOWMENT, INC.\uc758 \ubc18\ubcf5\uc801 \ub300\uaddc\ubaa8 \ub9e4\ub3c4\uc785\ub2c8\ub2e4. 2026-01-07\uc5d0\ub294 292148\uc8fc, 322380730 \uaddc\ubaa8\uc758 \ub9e4\ub3c4\uac00 \uc788\uc5c8\uace0, 2025\ub144 10\uc6d4\ubd80\ud130 2026\ub144 1\uc6d4\uae4c\uc9c0 \uc5ec\ub7ec \ucc28\ub840 \ub300\uaddc\ubaa8 \ub9e4\ub3c4\uac00 \uc774\uc5b4\uc84c\uc2b5\ub2c8\ub2e4. \uc774\ub294 10% \uc774\uc0c1 \ubcf4\uc720\uc790\uc758 \uc9c0\ubd84 \uad00\ub9ac \uc131\uaca9\uc77c \uac00\ub2a5\uc131\uc774 \ud06c\uc9c0\ub9cc, \uc218\uae09\uc0c1 \uc624\ubc84\ud589\uc73c\ub85c\ub294 \uacc4\uc18d \uccb4\ud06c\ud574\uc57c \ud569\ub2c8\ub2e4. \ubc18\ub300\ub85c 2025-08\uc5d0\ub294 CEO, CFO, \uc774\uc0ac \ub4f1 \uc77c\ubd80 \ub0b4\ubd80\uc790\uc758 \ub9e4\uc218\ub3c4 \ud655\uc778\ub418\uc5b4 \uacbd\uc601\uc9c4 \uc2e0\ub8b0 \uc2e0\ud638\ub294 \ud63c\uc7ac\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4.\n\n**\uc911\uae30 \ud310\ub2e8**\n\nLLY\uc758 \ud380\ub354\uba58\ud138\uc740 \ub9e4\ucd9c \uc131\uc7a5, \ub9c8\uc9c4, \uc774\uc775 \ud655\ub300 \uce21\uba74\uc5d0\uc11c \ub9e4\uc6b0 \uac15\ud569\ub2c8\ub2e4. \ud2b9\ud788 2025\ub144 \ub0b4\ub0b4 \ubd84\uae30 \ub9e4\ucd9c\uacfc \uc601\uc5c5\uc774\uc775\uc774 \ube60\ub974\uac8c \uc99d\uac00\ud588\uace0, Forward EPS 42.09922 \ubc0f Forward PE 21.472843\ub294 \uc2dc\uc7a5\uc774 \ub192\uc740 \uc774\uc775 \uc131\uc7a5\uc744 \uc608\uc0c1\ud558\uace0 \uc788\uc74c\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ub2e4\ub9cc \uc774\ubbf8 \ub192\uc740 \ubc38\ub958\uc5d0\uc774\uc158, \uc99d\uac00\ud55c \uc21c\ubd80\ucc44, \ub300\uaddc\ubaa8 \uc124\ube44\ud22c\uc790, \uc77c\ud68c\uc131 \ube44\uc6a9, \ub300\uc8fc\uc8fc \ubc18\ubcf5 \ub9e4\ub3c4\ub294 \ub2e8\uae30 \ubcc0\ub3d9\uc131\uc744 \ud0a4\uc6b8 \uc218 \uc788\ub294 \uc694\uc778\uc785\ub2c8\ub2e4.\n\n\ub530\ub77c\uc11c LLY\ub294 \uae30\ubcf8\uc801\uc73c\ub85c \uace0\ud488\uc9c8 \uc131\uc7a5\uc8fc\ub85c \ubcf4\ub418, \ud2b8\ub808\uc774\ub529 \uad00\uc810\uc5d0\uc11c\ub294 \uc2e4\uc801 \ubc1c\ud45c \ub54c \ub9e4\ucd9c \uc131\uc7a5\ub960\ubcf4\ub2e4 \uc601\uc5c5\ud604\uae08\ud750\ub984, Free Cash Flow, \uc7ac\uace0 \uc99d\uac00\uc728, \uc124\ube44\ud22c\uc790 \ud53c\ud06c\uc544\uc6c3 \uc5ec\ubd80, \uadf8\ub9ac\uace0 \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \uacf5\uae09\ub2a5\ub825 \uad00\ub828 \uac00\uc774\ub358\uc2a4 \ubcc0\ud654\uac00 \uc8fc\uac00 \ubc18\uc751\uc744 \uc88c\uc6b0\ud560 \uac00\ub2a5\uc131\uc774 \ud07d\ub2c8\ub2e4.\n\n| \uad6c\ubd84 | \ud575\uc2ec \ub0b4\uc6a9 | \uac70\ub798 \uad00\uc810 |\n|---|---|---|\n| \uac15\uc810 | 2025-12-31 \ubd84\uae30 \ub9e4\ucd9c 19292000000, \uc601\uc5c5\uc774\uc775 8987400000, \ud76c\uc11d EPS 7.39\ub85c \uac15\ud55c \uc131\uc7a5 | \uc2e4\uc801 \ubaa8\uba58\ud140\uc740 \uc6b0\ud638\uc801 |\n| \uac15\uc810 | \uc601\uc5c5\uc774\uc775\ub960 0.44896, \uc21c\uc774\uc775\ub960 0.31667, ROE 1.01159 | \uace0\ub9c8\uc9c4 \uc131\uc7a5\uc8fc \ud504\ub9ac\ubbf8\uc5c4 \uc720\uc9c0 \uc694\uc778 |\n| \uac15\uc810 | Forward PE 21.472843, PEG Ratio 0.9769 | \ub192\uc740 \ud604\uc7ac PE\ub97c \uc131\uc7a5 \uae30\ub300\uac00 \uc77c\ubd80 \uc0c1\uc1c4 |\n| \uc57d\uc810 | Total Debt 42503000000, Net Debt 35235000000, Debt to Equity 165.31 | \uae08\ub9ac\u00b7\ucc28\ud658\u00b7\ud22c\uc790 \ubd80\ub2f4\uc5d0 \ubbfc\uac10 |\n| \uc57d\uc810 | 2025-12-31 \ubd84\uae30 Free Cash Flow 254200000, \uc124\ube44\ud22c\uc790 -2970400000 | \uc774\uc775 \ub300\ube44 \ud604\uae08 \uc804\ud658\uc728 \ud655\uc778 \ud544\uc694 |\n| \uc57d\uc810 | \ubc18\ubcf5\uc801\uc778 \uad6c\uc870\uc870\uc815\u00b7\uc778\uc218\ud569\ubcd1 \uad00\ub828 \ube44\uc6a9\uacfc Total Unusual Items | \ubcf4\uace0 \uc774\uc775\uc758 \uc9c8 \ubcc0\ub3d9\uc131 |\n| \uad00\ucc30 \ud56d\ubaa9 | \uc7ac\uace0 13744000000, \ub9e4\ucd9c\ucc44\uad8c 20155000000 | \uc131\uc7a5 \uc9c0\uc18d\uc131\uacfc \uc6b4\uc804\uc790\ubcf8 \ubd80\ub2f4 \uc810\uac80 |\n| \uad00\ucc30 \ud56d\ubaa9 | LILLY ENDOWMENT, INC.\uc758 \ub300\uaddc\ubaa8 \ubc18\ubcf5 \ub9e4\ub3c4 | \uc218\uae09 \uc624\ubc84\ud589 \uac00\ub2a5\uc131 |\n| \uad00\ucc30 \ud56d\ubaa9 | \uc0dd\uc0b0\ub2a5\ub825 \ud655\uc7a5, \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \uc218\uc694, \ub2e4\uc74c \uac00\uc774\ub358\uc2a4 | \uc8fc\uac00 \uc7ac\ud3c9\uac00\uc758 \ud575\uc2ec \ucd09\ub9e4 |",
    "investment_debate_state": {
        "bull_history": "\nBull Analyst: \uc800\ub294 LLY\uc5d0 \ub300\ud574 \uc5ec\uc804\ud788 \uac15\ud55c Bull \uad00\uc810\uc744 \uc720\uc9c0\ud569\ub2c8\ub2e4. \ub2e8\uae30 \ucc28\ud2b8\uac00 \uc57d\ud558\ub2e4\ub294 \uc810\uc740 \uc778\uc815\ud569\ub2c8\ub2e4. 2026-04-15 \uc885\uac00 905.03\ub2ec\ub7ec\uac00 10\uc77c EMA 927.51, 50\uc77c SMA 978.66 \uc544\ub798\uc5d0 \uc788\uace0 200\uc77c SMA 901.99 \uadfc\ucc98\uae4c\uc9c0 \ubc00\ub9b0 \uac83\uc740 \ubd84\uba85\ud788 \uc870\uc2ec\ud574\uc57c \ud560 \uc2e0\ud638\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc774\uac83\uc744 \u201c\ud22c\uc790 \ub17c\ub9ac \ud6fc\uc190\u201d\uc73c\ub85c \ud574\uc11d\ud558\ub294 \uac83\uc740 \ub108\ubb34 \uac00\uaca9 \uc911\uc2ec\uc801\uc778 \ud310\ub2e8\uc785\ub2c8\ub2e4. \uc9c0\uae08 LLY\uc758 \ud575\uc2ec\uc740 \ub2e8\uae30 \uc774\ub3d9\ud3c9\uade0\uc774 \uc544\ub2c8\ub77c, \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \ud504\ub79c\ucc28\uc774\uc988\uac00 \uc774\uc775 \uc131\uc7a5\uacfc \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5\uc744 \ub3d9\uc2dc\uc5d0 \ub04c\uace0 \uc788\ub2e4\ub294 \uc810\uc785\ub2c8\ub2e4.\n\nBear \ucabd\uc774 \uac00\uc7a5 \uba3c\uc800 \uc9c0\uc801\ud560 \ubd80\ubd84\uc740 \uc544\ub9c8\ub3c4 \uae30\uc220\uc801 \uc57d\uc138\uc77c \uac81\ub2c8\ub2e4. \ub9de\uc2b5\ub2c8\ub2e4. 50\uc77c\uc120\uc740 \ud558\ub77d \uc911\uc774\uace0 MACD\ub3c4 -14.38\ub85c \uc544\uc9c1 \uc57d\uc138\uad8c\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc911\uc694\ud55c \uac74 \ud558\ub77d \ubaa8\uba58\ud140\uc774 \uc774\ubbf8 \uc644\ud654\ub418\uace0 \uc788\ub2e4\ub294 \uc810\uc785\ub2c8\ub2e4. MACD\ub294 2026-03-30\uc758 -35.49\uc5d0\uc11c -14.38\uae4c\uc9c0 \uac1c\uc120\ub410\uace0, RSI\ub3c4 2026-03-27\uc758 29.19\uc5d0\uc11c 39.85\ub85c \ud68c\ubcf5\ub410\uc2b5\ub2c8\ub2e4. \uc989, \uc8fc\uac00\uac00 \uc544\uc9c1 \uac15\uc138 \uc804\ud658\uc744 \ud655\uc815\ud55c \uac83\uc740 \uc544\ub2c8\uc9c0\ub9cc \uae09\ub77d \uad6d\uba74\uc758 \uc555\ub825\uc740 \uc904\uc5b4\ub4e4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub354\uad6c\ub098 \uc8fc\uac00\ub294 \uc0c1\uc2b9 \uc911\uc778 200\uc77c\uc120 \ubd80\uadfc\uc5d0\uc11c \ubc29\uc5b4\ub97c \uc2dc\ud5d8\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc7a5\uae30 \uc0c1\uc2b9 \ucd94\uc138\uac00 \uc544\uc9c1 \uc644\uc804\ud788 \uae68\uc9c4 \uac83\uc774 \uc544\ub2c8\ub77c, \uace0\uc131\uc7a5 \ub300\ud615\uc8fc\uac00 \ud575\uc2ec \uc9c0\uc9c0\uc120\uc5d0\uc11c \uc7ac\ud3c9\uac00\ub97c \ubc1b\ub294 \uad6c\uac04\uc73c\ub85c \ubcf4\ub294 \ud3b8\uc774 \ub354 \ud569\ub9ac\uc801\uc785\ub2c8\ub2e4.\n\n\ud380\ub354\uba58\ud138\uc740 \ub2e8\uae30 \ucc28\ud2b8\ubcf4\ub2e4 \ud6e8\uc52c \uac15\ud569\ub2c8\ub2e4. LLY\uc758 \ucd5c\uadfc \ud655\uc778 \ub9e4\ucd9c\uc740 651.79\uc5b5 \ub2ec\ub7ec, \uc21c\uc774\uc775\uc740 206.4\uc5b5 \ub2ec\ub7ec\uc774\uba70 \uc601\uc5c5\uc774\uc775\ub960\uc740 44.9%, \uc21c\uc774\uc775\ub960\uc740 31.7%\uc785\ub2c8\ub2e4. \ub300\ud615 \uc81c\uc57d\uc0ac\uc5d0\uc11c \uc774 \uc815\ub3c4 \uc131\uc7a5\uc131\uacfc \uc218\uc775\uc131\uc744 \ub3d9\uc2dc\uc5d0 \ubcf4\uc5ec\uc8fc\ub294 \uae30\uc5c5\uc740 \ud754\ud558\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. 2025\ub144 \ubd84\uae30 \ub9e4\ucd9c\ub3c4 127.29\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 155.58\uc5b5 \ub2ec\ub7ec, 176.01\uc5b5 \ub2ec\ub7ec, 192.92\uc5b5 \ub2ec\ub7ec\ub85c \uc5f0\uc18d \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4. \ud76c\uc11d EPS \uc5ed\uc2dc 2025-12-31 \ubd84\uae30 7.39\ub85c \uc9c1\uc804 \ubd84\uae30 6.21, \uc804\ub144 \ub9d0 4.88\ubcf4\ub2e4 \ub69c\ub837\ud558\uac8c \uac1c\uc120\ub410\uc2b5\ub2c8\ub2e4. \uc774\uac74 \ub2e8\uc21c\ud55c \uc2a4\ud1a0\ub9ac \uc8fc\uc2dd\uc774 \uc544\ub2c8\ub77c \uc2e4\uc81c \ub9e4\ucd9c\uacfc \uc774\uc775\uc774 \ube60\ub974\uac8c \ub530\ub77c\uc624\ub294 \uc131\uc7a5\uc8fc\uc785\ub2c8\ub2e4.\n\n\ubc38\ub958\uc5d0\uc774\uc158 \uc6b0\ub824\ub3c4 \uc815\uba74\uc73c\ub85c \ubcf4\uaca0\uc2b5\ub2c8\ub2e4. \ud604\uc7ac PE 39.37\uc740 \ub0ae\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. Bear\ub294 \u201c\uc774\ubbf8 \ube44\uc2f8\ub2e4\u201d\uace0 \ub9d0\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ud558\uc9c0\ub9cc Forward PE\ub294 21.47\uc774\uace0 PEG Ratio\ub294 0.9769\uc785\ub2c8\ub2e4. \uc131\uc7a5\ub960\uc744 \ubc18\uc601\ud558\uba74 \ubc38\ub958\uc5d0\uc774\uc158\uc774 \uacfc\ub3c4\ud558\uac8c \ubd80\ud480\uc5c8\ub2e4\uae30\ubcf4\ub2e4\ub294, \uc2dc\uc7a5\uc774 \ud5a5\ud6c4 \uc774\uc775 \uc131\uc7a5\uc744 \uc0c1\ub2f9\ud788 \uc2e0\ub8b0\ud558\uace0 \uc788\ub2e4\ub294 \ub73b\uc5d0 \uac00\uae5d\uc2b5\ub2c8\ub2e4. \uace0\ub9c8\uc9c4, \uace0\uc131\uc7a5, \uae00\ub85c\ubc8c \uc218\uc694\uac00 \ud655\uc778\ub418\ub294 \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \ub9ac\ub354\uc5d0\uac8c 20\ubc30 \ucd08\ubc18\uc758 \uc120\ud589 \uc774\uc775 \ubc30\uc218\ub294 \uc624\ud788\ub824 \ubc29\uc5b4 \uac00\ub2a5\ud55c \uc218\uc900\uc785\ub2c8\ub2e4.\n\n\uac00\uc7a5 \uac15\ub825\ud55c Bull \ucd09\ub9e4\ub294 Foundayo\uc785\ub2c8\ub2e4. 2026-04-16 \ubcf4\ub3c4\uc5d0\uc11c Foundayo\uac00 \uc81c2\ud615 \ub2f9\ub1e8 \ubc0f \ube44\ub9cc \ud658\uc790\uad70\uc5d0\uc11c \uc8fc\uc694 \uc2ec\ud608\uad00 \uc0ac\uac74 \uc704\ud5d8\uc744 \uc7a5\uae30 \uc9c0\uc18d\ud615 \uc778\uc290\ub9b0 \ub300\ube44 \ube44\uc5f4\ub4f1\ud558\uac8c \ub0ae\ucdc4\uace0, \uc804\uccb4 \uc0ac\ub9dd \uc704\ud5d8\uc744 57% \ub0ae\ucdc4\ub2e4\ub294 \uc810\uc774 \ubc18\ubcf5\uc801\uc73c\ub85c \ubd80\uac01\ub410\uc2b5\ub2c8\ub2e4. \uac04 \uc548\uc804\uc131 \uc2e0\ud638\uac00 \uc5c6\uc5c8\ub2e4\ub294 \uc810\ub3c4 \uc911\uc694\ud569\ub2c8\ub2e4. \ube44\ub9cc \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\uc11c \ub2e8\uc21c \uccb4\uc911 \uac10\ub7c9 \ud6a8\ub2a5\ub9cc\ud07c \uc911\uc694\ud55c \uac83\uc774 \uc2ec\ud608\uad00 \uc548\uc804\uc131\uacfc \uc7a5\uae30 \ucc98\ubc29 \uc2e0\ub8b0\ub3c4\uc778\ub370, \uc774\ubc88 \ub370\uc774\ud130\ub294 \uc758\uc0ac \ucc98\ubc29, \ubcf4\ud5d8 \ub4f1\uc7ac, \uc801\uc751\uc99d \ud655\ub300 \uce21\uba74\uc5d0\uc11c \ubaa8\ub450 \uae0d\uc815\uc801\uc785\ub2c8\ub2e4. \ud68c\uc0ac\uac00 2\ubd84\uae30 \ub9d0\uae4c\uc9c0 \uc81c2\ud615 \ub2f9\ub1e8 \uc801\uc751\uc99d \ubbf8\uad6d \uc2b9\uc778 \uc2e0\uccad\uc744 \uacc4\ud68d\ud55c\ub2e4\ub294 \uc810\ub3c4 \ub9e4\ucd9c \ucd94\uc815\uce58 \uc0c1\ud5a5\uc758 \uc9c1\uc811\uc801 \uadfc\uac70\uac00 \ub429\ub2c8\ub2e4.\n\nBear\uac00 FDA\uc758 \uc2dc\ud310 \ud6c4 \uc2dc\ud5d8 \uc694\uad6c\ub97c \ub4e4\uace0 \ub098\uc62c \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc774\uac83\uc740 \uc989\uac01\uc801\uc778 \ubd80\uc815 \uacb0\ub860\uc774 \uc544\ub2c8\ub77c \uc0ac\ud6c4 \ubaa8\ub2c8\ud130\ub9c1\uc758 \uc131\uaca9\uc73c\ub85c \ubcf4\ub294 \uac83\uc774 \ub9de\uc2b5\ub2c8\ub2e4. \uc624\ud788\ub824 \ud575\uc2ec \uc784\uc0c1 \ub370\uc774\ud130\uac00 \uae0d\uc815\uc801\uc774\uace0 \uac04 \uc548\uc804\uc131 \uc2e0\ud638\uac00 \uc5c6\uc5c8\ub2e4\ub294 \uc810\uc774 \ud604\uc7ac\uae4c\uc9c0\uc758 \uc704\ud5d8 \uade0\ud615\uc744 Bull \ucabd\uc73c\ub85c \uae30\uc6b8\uac8c \ud569\ub2c8\ub2e4. \uc81c\uc57d\uc8fc\uc5d0\uc11c \uaddc\uc81c \ub9ac\uc2a4\ud06c\ub294 \ud56d\uc0c1 \uc874\uc7ac\ud558\uc9c0\ub9cc, LLY\ub294 \uc774\ubbf8 \ub300\ud615 \uc0c1\uc5c5\ud654 \uc5ed\ub7c9\uacfc \uaddc\uc81c \ub300\uc751 \uacbd\ud5d8\uc744 \uac00\uc9c4 \ud68c\uc0ac\uc785\ub2c8\ub2e4. \uc791\uc740 \ubc14\uc774\uc624\ud14d\uc774 \ub2e8\uc77c \uc784\uc0c1 \uacb0\uacfc\uc5d0 \uc758\uc874\ud558\ub294 \uad6c\uc870\uc640\ub294 \ub2e4\ub985\ub2c8\ub2e4.\n\n\uacbd\uc7c1 \uc2ec\ud654 \uc6b0\ub824\ub3c4 \uacfc\uc7a5\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4. Novo Nordisk, Viking Therapeutics, Kailera \ub4f1 \uacbd\uc7c1\uc790\uac00 \ubd80\uac01\ub418\ub294 \uac83\uc740 \ub9de\uc2b5\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uacbd\uc7c1\uc790\uac00 \ub9ce\ub2e4\ub294 \uc0ac\uc2e4\uc740 \uc2dc\uc7a5\uc774 \ud06c\ub2e4\ub294 \uc99d\uac70\uc774\uae30\ub3c4 \ud569\ub2c8\ub2e4. \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc2b9\uc790\ub3c5\uc2dd\uc774\ub77c\uae30\ubcf4\ub2e4 \uacf5\uae09, \uc801\uc751\uc99d, \uc548\uc804\uc131, \ucc98\ubc29 \ud3b8\uc758\uc131, \ubcf4\ud5d8 \uc811\uadfc\uc131\uc5d0 \ub530\ub77c \ubcf5\uc218\uc758 \ub300\ud615 \uc2b9\uc790\uac00 \ub098\uc62c \uc218 \uc788\ub294 \uad6c\uc870\uc785\ub2c8\ub2e4. LLY\ub294 \uc774\ubbf8 \ube0c\ub79c\ub4dc, \uc784\uc0c1 \ub370\uc774\ud130, \uc81c\uc870 \ud655\uc7a5, \uc0c1\uc5c5\ud654 \ub124\ud2b8\uc6cc\ud06c\uc5d0\uc11c \uc120\ub3c4\uad8c\uc744 \uac16\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud6c4\ubc1c \ud6c4\ubcf4\uc758 \uc874\uc7ac\ub9cc\uc73c\ub85c LLY\uc758 \ub9ac\ub354\uc2ed\uc744 \ud560\uc778\ud558\ub294 \uac83\uc740 \uc131\uae09\ud569\ub2c8\ub2e4.\n\n\ud604\uae08\ud750\ub984\uacfc \ubd80\ucc44\uc5d0 \ub300\ud55c \uc6b0\ub824\ub3c4 \uc778\uc815\ud569\ub2c8\ub2e4. 2025-12-31 \ubd84\uae30 Free Cash Flow\uac00 2.54\uc5b5 \ub2ec\ub7ec\uc5d0 \uadf8\ucce4\uace0 Capex\uac00 -29.7\uc5b5 \ub2ec\ub7ec\uc600\ub2e4\ub294 \uc810\uc740 \ub2e8\uae30\uc801\uc73c\ub85c \ubd80\ub2f4\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc774 \uc124\ube44\ud22c\uc790\ub294 \uc218\uc694 \ubd80\uc9c4 \ub54c\ubb38\uc774 \uc544\ub2c8\ub77c \uc218\uc694 \ub300\uc751\uc744 \uc704\ud55c \uc0dd\uc0b0\ub2a5\ub825 \ud655\uc7a5\uc73c\ub85c \ud574\uc11d\ud574\uc57c \ud569\ub2c8\ub2e4. \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \ud070 \ubcd1\ubaa9 \uc911 \ud558\ub098\ub294 \uacf5\uae09\uc785\ub2c8\ub2e4. LLY\uac00 \uc9c0\uae08 \uc0dd\uc0b0\ub2a5\ub825\uc5d0 \ud22c\uc790\ud558\ub294 \uac83\uc740 \ubbf8\ub798 \ub9e4\ucd9c\uc744 \ud604\uc2e4 \ub9e4\ucd9c\ub85c \ubc14\uafb8\uae30 \uc704\ud55c \uc804\ub7b5\uc801 \uc9c0\ucd9c\uc785\ub2c8\ub2e4. \ub192\uc740 ROE 101.2%, \uac15\ud55c \uc601\uc5c5\uc774\uc775\ub960, 72.68\uc5b5 \ub2ec\ub7ec\uc758 \ud604\uae08, Current Ratio 1.579\ub97c \uace0\ub824\ud558\uba74 \uc7ac\ubb34 \uc720\uc5f0\uc131\uc774 \ud6fc\uc190\ub410\ub2e4\uace0 \ubcf4\uae30\ub294 \uc5b4\ub835\uc2b5\ub2c8\ub2e4.\n\nCentessa Pharmaceuticals \uc778\uc218 \ubcf4\ub3c4\ub3c4 Bull \ub17c\ub9ac\uc5d0 \ud798\uc744 \ubcf4\ud0ed\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 LLY\ub97c \ube44\ub9cc\u00b7\ub2f9\ub1e8 \ud558\ub098\uc758 \ud14c\ub9c8\ub85c\ub9cc \ubcf4\ub294 \uacbd\ud5a5\uc774 \uc788\uc9c0\ub9cc, 78\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc2e0\uacbd\uacfc\ud559 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5 \uac00\ub2a5\uc131\uc740 \uc131\uc7a5 \ub3d9\ub825 \ub2e4\ubcc0\ud654 \uc2e0\ud638\uc785\ub2c8\ub2e4. \ubb3c\ub860 \uc778\uc218 \uac00\uaca9\uacfc \ud1b5\ud569 \ub9ac\uc2a4\ud06c\ub294 \uccb4\ud06c\ud574\uc57c \ud569\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \ub300\ud615 \uc81c\uc57d\uc0ac\uc758 \uc7a5\uae30 \uac00\uce58\ub294 \ub2e8\uc77c \ube14\ub85d\ubc84\uc2a4\ud130\uac00 \uc544\ub2c8\ub77c \uc9c0\uc18d\uc801\uc778 \ud30c\uc774\ud504\ub77c\uc778 \uc7ac\ud22c\uc790 \ub2a5\ub825\uc5d0\uc11c \ub098\uc635\ub2c8\ub2e4. LLY\ub294 \ud604\uc7ac \ud575\uc2ec \ud504\ub79c\ucc28\uc774\uc988\uc5d0\uc11c \ucc3d\ucd9c\ub418\ub294 \uc774\uc775\uc744 \ub2e4\uc74c \uc131\uc7a5\ucd95\uc73c\ub85c \uc7ac\ubc30\uce58\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.\n\n\ub2e8\uae30 \ub9e4\ub9e4 \uad00\uc810\uc5d0\uc11c\ub3c4 Bull\uc774 \ubb34\uc870\uac74 \ucd94\uaca9 \ub9e4\uc218\ub97c \uc8fc\uc7a5\ud560 \ud544\uc694\ub294 \uc5c6\uc2b5\ub2c8\ub2e4. \uc800\ub294 902~903\ub2ec\ub7ec\uc758 200\uc77c\uc120 \ubc29\uc5b4\uac00 \ud575\uc2ec\uc774\ub77c\uace0 \ubd05\ub2c8\ub2e4. \uc774 \uad6c\uac04\uc744 \uc9c0\ud0a4\uace0 923~925\ub2ec\ub7ec\uc758 10\uc77c EMA\u00b7VWMA \uad6c\uac04\uc744 \ud68c\ubcf5\ud558\uba74 \ub2e8\uae30 \ubc18\ub4f1 \uc2e0\ub8b0\ub3c4\ub294 \ud06c\uac8c \uc62c\ub77c\uac11\ub2c8\ub2e4. \uc774\ud6c4 939~955\ub2ec\ub7ec, \uadf8\ub9ac\uace0 976~979\ub2ec\ub7ec\uc758 50\uc77c\uc120 \ud68c\ubcf5\uc774 \ub2e4\uc74c \ud655\uc778 \uc9c0\uc810\uc785\ub2c8\ub2e4. \uc989, \uae30\uc220\uc801\uc73c\ub85c\ub294 \uc870\uac74\ubd80 \uc811\uadfc\uc774 \ub9de\uc9c0\ub9cc, \ud380\ub354\uba58\ud138 \uad00\uc810\uc5d0\uc11c\ub294 \uc9c0\uae08\uc758 \uc870\uc815\uc774 \uc7a5\uae30 \uc131\uc7a5\uc8fc\uc5d0 \ub300\ud55c \uc9c4\uc785 \uae30\ud68c\ub97c \ub9cc\ub4e4\uace0 \uc788\uc2b5\ub2c8\ub2e4.\n\n\uacfc\uac70 \ube44\uc2b7\ud55c \uc0c1\ud669\uc5d0\uc11c\uc758 \uad50\ud6c8\ub3c4 \ubc18\uc601\ud574\uc57c \ud569\ub2c8\ub2e4. \uace0\uc131\uc7a5 \uc81c\uc57d\uc8fc\ub294 \ub2e8\uae30 \uc870\uc815 \uc911\uc5d0 \ubc38\ub958\uc5d0\uc774\uc158\uacfc \ucc28\ud2b8\ub9cc \ubcf4\uace0 \uc131\uae09\ud558\uac8c \uc57d\uc138 \uacb0\ub860\uc744 \ub0b4\ub9ac\uba74, \uc784\uc0c1\u00b7\ud5c8\uac00\u00b7\uc2e4\uc801 \ucd09\ub9e4\uac00 \ub098\uc624\ub294 \uc21c\uac04 \ube60\ub974\uac8c \uc7ac\ud3c9\uac00\ub418\ub294 \uacbd\uc6b0\uac00 \ub9ce\uc558\uc2b5\ub2c8\ub2e4. \ubc18\ub300\ub85c Bull\ub3c4 \ubb34\uc870\uac74 \ud638\uc7ac\ub9cc \ubcf4\uace0 \uc9c4\uc785 \uac00\uaca9\uc744 \ubb34\uc2dc\ud558\uba74 \ubcc0\ub3d9\uc131\uc5d0 \ud754\ub4e4\ub9b4 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub798\uc11c \uc774\ubc88\uc5d0\ub294 \ub450 \uac00\uc9c0\ub97c \ub3d9\uc2dc\uc5d0 \ubd10\uc57c \ud569\ub2c8\ub2e4. \ud22c\uc790 \ub17c\ub9ac\ub294 \uac15\ud558\uac8c \uc720\uc9c0\ud558\ub418, \uc9c4\uc785\uc740 200\uc77c\uc120 \ubc29\uc5b4\uc640 923~925\ub2ec\ub7ec \ud68c\ubcf5\uc744 \ud655\uc778\ud558\ub294 \ubc29\uc2dd\uc774 \ub354 \uc6b0\uc218\ud569\ub2c8\ub2e4.\n\n\uacb0\ub860\uc801\uc73c\ub85c LLY\uc758 \ub2e8\uae30 \uac00\uaca9 \ud750\ub984\uc740 \ubd88\ud3b8\ud558\uc9c0\ub9cc, \uae30\uc5c5\uc758 \uc7a5\uae30 \ud22c\uc790 \ub9e4\ub825\uc740 \ud6fc\uc190\ub418\uc9c0 \uc54a\uc558\uc2b5\ub2c8\ub2e4. \ub9e4\ucd9c\uacfc EPS\ub294 \ube60\ub974\uac8c \uc99d\uac00\ud558\uace0 \uc788\uace0, \ub9c8\uc9c4\uc740 \ub300\ud615 \uc81c\uc57d\uc0ac \uc911 \ucd5c\uc0c1\uc704\uad8c\uc774\uba70, Forward PE\uc640 PEG\ub294 \uc131\uc7a5\uc131\uc744 \uac10\uc548\ud558\uba74 \ud569\ub9ac\uc801\uc785\ub2c8\ub2e4. Foundayo\uc758 \uc2ec\ud608\uad00\u00b7\uc0ac\ub9dd \uc704\ud5d8 \ub370\uc774\ud130\uc640 \ub2f9\ub1e8 \uc801\uc751\uc99d \uc2e0\uccad \uacc4\ud68d\uc740 \ud575\uc2ec \ud504\ub79c\ucc28\uc774\uc988\uc758 \uc131\uc7a5 \uac00\uc2dc\uc131\uc744 \ub192\uc785\ub2c8\ub2e4. Bear\uac00 \ub9d0\ud558\ub294 \ubcc0\ub3d9\uc131, \ubc38\ub958\uc5d0\uc774\uc158, \uaddc\uc81c, \uacbd\uc7c1 \uc6b0\ub824\ub294 \ubaa8\ub450 \uccb4\ud06c\ud574\uc57c \ud560 \ub9ac\uc2a4\ud06c\uc9c0\ub9cc, \ud604\uc7ac \uc81c\uacf5\ub41c \ub370\uc774\ud130\ub9cc \ub193\uace0 \ubcf4\uba74 \uadf8\uac83\ub4e4\uc740 \ud22c\uc790 \ub17c\ub9ac\ub97c \ubb34\ub108\ub728\ub9ac\ub294 \uc694\uc778\uc774 \uc544\ub2c8\ub77c \uac15\ud55c \uc131\uc7a5\uc8fc\uac00 \uc870\uc815 \uc911\uc5d0 \uc18c\ud654\ud574\uc57c \ud560 \uc815\uc0c1\uc801\uc778 \ubd80\ub2f4\uc5d0 \uac00\uae5d\uc2b5\ub2c8\ub2e4. \uc800\ub294 LLY\ub97c \ub2e8\uae30\uc801\uc73c\ub85c\ub294 \ud655\uc778 \ub9e4\uc218, \uc911\uc7a5\uae30\uc801\uc73c\ub85c\ub294 \uace0\ud488\uc9c8 \uc131\uc7a5 \ud504\ub9ac\ubbf8\uc5c4\uc744 \ubc1b\uc744 \uc218 \uc788\ub294 \uc6b0\ub7c9 Bull \ud6c4\ubcf4\ub85c \ubd05\ub2c8\ub2e4.",
        "bear_history": "\nBear Analyst: Bull \uad00\uc810\uc774 \uc65c \ub9e4\ub825\uc801\uc73c\ub85c \ub4e4\ub9ac\ub294\uc9c0\ub294 \uc778\uc815\ud569\ub2c8\ub2e4. LLY\ub294 \uc88b\uc740 \ud68c\uc0ac\uc774\uace0, \ub9e4\ucd9c \uc131\uc7a5\uacfc \ub9c8\uc9c4\uc740 \uac15\ud569\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc5ec\uae30\uc11c Bear\uac00 \ubd10\uc57c \ud560 \ud575\uc2ec\uc740 \u201c\uc88b\uc740 \ud68c\uc0ac\uc778\uac00?\u201d\uac00 \uc544\ub2c8\ub77c \u201c\ud604\uc7ac \uac00\uaca9\uacfc \uae30\ub300\uce58\uc5d0\uc11c \uc704\ud5d8 \ub300\ube44 \ubcf4\uc0c1\uc774 \ucda9\ubd84\ud55c\uac00?\u201d\uc785\ub2c8\ub2e4. \uc81c \ub2f5\uc740 \uc544\ub2c8\uc624\uc5d0 \uac00\uae5d\uc2b5\ub2c8\ub2e4.\n\n\uc6b0\uc120 Bull\uc740 \uae30\uc220\uc801 \uc57d\uc138\ub97c \u201c\ub2e8\uae30 \uac00\uaca9 \uc911\uc2ec \ud310\ub2e8\u201d\uc73c\ub85c \ub0ae\ucdb0 \ubcf4\uc9c0\ub9cc, \uc9c0\uae08 \ucc28\ud2b8\ub294 \ub2e8\uc21c\ud55c \ub178\uc774\uc988\uac00 \uc544\ub2d9\ub2c8\ub2e4. 2026-04-15 \uc885\uac00 905.03\ub2ec\ub7ec\ub294 10\uc77c EMA 927.51, 50\uc77c SMA 978.66, VWMA 924.83 \uc544\ub798\uc5d0 \uc788\uace0, 200\uc77c SMA 902.63 \ubc14\ub85c \uc704\uc5d0 \uaca8\uc6b0 \ubd99\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. \uc911\uae30 \ucd94\uc138\uc120\uc778 50\uc77c\uc120\uc740 2026-03-17\uc758 1033.18\uc5d0\uc11c 2026-04-16\uc758 976.71\uae4c\uc9c0 \uacc4\uc18d \ud558\ub77d\ud588\uc2b5\ub2c8\ub2e4. \uc774\uac74 \uc2dc\uc7a5\uc774 \uc77c\uc2dc\uc801\uc73c\ub85c \ud754\ub4e4\ub9b0 \uc815\ub3c4\uac00 \uc544\ub2c8\ub77c, \uace0\uc131\uc7a5 \ud504\ub9ac\ubbf8\uc5c4\uc744 \uc7ac\uac00\uaca9\ud654\ud558\uace0 \uc788\ub2e4\ub294 \uc2e0\ud638\uc785\ub2c8\ub2e4.\n\nBull\uc740 MACD\uac00 -35.49\uc5d0\uc11c -14.38\ub85c \uac1c\uc120\ub410\uace0 RSI\uac00 29.19\uc5d0\uc11c 39.85\ub85c \ud68c\ubcf5\ub410\ub2e4\uace0 \ub9d0\ud569\ub2c8\ub2e4. \ub9de\uc2b5\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc774\uac74 \u201c\uae09\ub77d \uc18d\ub3c4\uac00 \ub454\ud654\ub410\ub2e4\u201d\ub294 \ub73b\uc774\uc9c0 \u201c\uc0c1\uc2b9 \uc804\ud658\uc774 \uc2dc\uc791\ub410\ub2e4\u201d\ub294 \ub73b\uc774 \uc544\ub2d9\ub2c8\ub2e4. MACD\ub294 \uc5ec\uc804\ud788 \uc74c\uc218\uc774\uace0, MACD \ud788\uc2a4\ud1a0\uadf8\ub7a8\uc740 8.42\uc5d0\uc11c 1.75\ub85c \uc57d\ud574\uc84c\uc73c\uba70, RSI\ub294 50\uc744 \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud588\uc2b5\ub2c8\ub2e4. \ubc18\ub4f1 \ubaa8\uba58\ud140\uc774 \uc0b4\uc544\ub098\ub294 \uad6c\uac04\uc774\ub77c\uba74 923~925\ub2ec\ub7ec\uc758 10\uc77c EMA\u00b7VWMA\ub97c \ud68c\ubcf5\ud574\uc57c \ud558\ub294\ub370, \ud604\uc7ac \uac00\uaca9\uc740 \uadf8 \uc544\ub798\uc785\ub2c8\ub2e4. \uc989 Bull\uc774 \ub9d0\ud558\ub294 \ubc18\ub4f1 \uc870\uac74\uc740 \uc544\uc9c1 \ucda9\uc871\ub418\uc9c0 \uc54a\uc558\uc2b5\ub2c8\ub2e4.\n\n200\uc77c\uc120 \ubc29\uc5b4\ub3c4 Bull \ub17c\ub9ac\uc758 \ud575\uc2ec\uc778\ub370, \ubc14\ub85c \uadf8 \uc810\uc774 \uc704\ud5d8\ud569\ub2c8\ub2e4. \uc885\uac00 905.03\ub2ec\ub7ec\uc640 200\uc77c\uc120 902.63\ub2ec\ub7ec\uc758 \ucc28\uc774\ub294 \uc57d 2.40\ub2ec\ub7ec\ubfd0\uc785\ub2c8\ub2e4. ATR\uc774 28.13\ub2ec\ub7ec, \uc885\uac00 \ub300\ube44 \uc57d 3.1%\ub77c\ub294 \uc810\uc744 \uac10\uc548\ud558\uba74 \ud558\ub8e8 \ubcc0\ub3d9\uc131 \uc548\uc5d0\uc11c \uc7a5\uae30 \uc9c0\uc9c0\uc120 \uc774\ud0c8\uc774 \ucda9\ubd84\ud788 \ubc1c\uc0dd\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. 2026-04-15\uc5d0\ub294 \uac70\ub798\ub7c9\uc774 4,233,400\uc73c\ub85c \uc804\uc77c 2,360,200\ubcf4\ub2e4 \ud06c\uac8c \ub298\uc5c8\uace0 \uc800\uac00\ub294 888.03\uae4c\uc9c0 \ubc00\ub838\uc2b5\ub2c8\ub2e4. \uac70\ub798\ub7c9\uc774 \uc2e4\ub9b0 \ud558\ub77d \uc555\ub825\uc740 \u201c\uc88b\uc740 \ud68c\uc0ac\uac00 \uc2f8\uc84c\ub2e4\u201d\ubcf4\ub2e4 \u201c\ud575\uc2ec \uc9c0\uc9c0\uc120\uc5d0\uc11c \ub9e4\ub3c4\uc790\uac00 \uac15\ud558\ub2e4\u201d\ub85c \uc77d\ub294 \ud3b8\uc774 \ub354 \ubcf4\uc218\uc801\uc785\ub2c8\ub2e4.\n\n\ud380\ub354\uba58\ud138\ub3c4 Bull\uc774 \ub9d0\ud558\ub294 \uac83\ub9cc\ud07c \uc77c\ubc29\uc801\uc73c\ub85c \uae68\ub057\ud558\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \ub9e4\ucd9c 651.79\uc5b5 \ub2ec\ub7ec, \uc21c\uc774\uc775 206.4\uc5b5 \ub2ec\ub7ec, \uc601\uc5c5\uc774\uc775\ub960 44.9%\ub294 \ud6cc\ub96d\ud569\ub2c8\ub2e4. \uadf8\ub7f0\ub370 \uc8fc\uac00\ub294 \uc774\ubbf8 \uadf8 \ud6cc\ub96d\ud568\uc744 \uc0c1\ub2f9 \ubd80\ubd84 \ubc18\uc601\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud604\uc7ac PE 39.37\uc740 \ub300\ud615 \uc81c\uc57d\uc8fc\ub85c \ub0ae\uc9c0 \uc54a\uace0, Forward PE 21.47\uacfc PEG 0.9769\ub294 \u201c\ud5a5\ud6c4 \uc131\uc7a5\uc774 \uac70\uc758 \uacc4\ud68d\ub300\ub85c \uc628\ub2e4\u201d\ub294 \uc804\uc81c\ub97c \uae54\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774 \uc804\uc81c\uac00 \ud754\ub4e4\ub9ac\uba74 \uba40\ud2f0\ud50c \ubc29\uc5b4 \ub17c\ub9ac\ub294 \ube60\ub974\uac8c \ubb34\ub108\uc9c8 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ub192\uc740 \uae30\ub300\uce58\uac00 \ubd99\uc740 \uc8fc\uc2dd\uc740 \uc88b\uc740 \ub274\uc2a4\uac00 \ub098\uc640\ub3c4 \ub35c \uc624\ub974\uace0, \uc791\uc740 \uc9c0\uc5f0\uc774\ub098 \ub77c\ubca8 \uc81c\ud55c\uc5d0\ub3c4 \ud06c\uac8c \ube60\uc9c8 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n\ud604\uae08\ud750\ub984\uc740 \ud2b9\ud788 \ubd88\ud3b8\ud569\ub2c8\ub2e4. 2025-12-31 \ubd84\uae30 \uc601\uc5c5\ud604\uae08\ud750\ub984\uc740 32.25\uc5b5 \ub2ec\ub7ec\ub85c \ud50c\ub7ec\uc2a4\uc600\uc9c0\ub9cc \uc9c1\uc804 \ubd84\uae30 88.36\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c \ud06c\uac8c \uc904\uc5c8\uace0, Free Cash Flow\ub294 2.54\uc5b5 \ub2ec\ub7ec\uc5d0 \ubd88\uacfc\ud588\uc2b5\ub2c8\ub2e4. \uac19\uc740 \ubd84\uae30 Capex\ub294 -29.70\uc5b5 \ub2ec\ub7ec\uc600\uc2b5\ub2c8\ub2e4. Bull\uc740 \uc774\uac83\uc744 \uc218\uc694 \ub300\uc751\uc744 \uc704\ud55c \uc804\ub7b5\uc801 \ud22c\uc790\ub77c\uace0 \ub9d0\ud558\uc9c0\ub9cc, Bear \uc785\uc7a5\uc5d0\uc11c\ub294 \ubc14\ub85c \uadf8\uac8c \ubb38\uc81c\uc785\ub2c8\ub2e4. \uc131\uc7a5 \uc2a4\ud1a0\ub9ac\ub97c \ud604\uc2e4 \ub9e4\ucd9c\ub85c \ubc14\uafb8\ub824\uba74 \uacc4\uc18d \ub9c9\ub300\ud55c \uc124\ube44\ud22c\uc790\uac00 \ud544\uc694\ud558\uace0, \uadf8 \uc0ac\uc774 \uc774\uc775\uc740 \uc88b\uc544 \ubcf4\uc5ec\ub3c4 \ud604\uae08 \uc804\ud658\uc740 \uc57d\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uace0\ub9c8\uc9c4 \uc190\uc775\uacc4\uc0b0\uc11c\uc640 \ub0ae\uc740 FCF\uac00 \ud568\uaed8 \ub098\ud0c0\ub098\uba74, \uc2dc\uc7a5\uc740 \uc5b8\uc820\uac00 \u201c\uc131\uc7a5\u201d\ubcf4\ub2e4 \u201c\ud604\uae08 \ucc3d\ucd9c\ub825\u201d\uc744 \uc694\uad6c\ud569\ub2c8\ub2e4.\n\n\ubd80\ucc44\ub3c4 \ubb34\uc2dc\ud558\uae30 \uc5b4\ub835\uc2b5\ub2c8\ub2e4. Total Debt\ub294 425.03\uc5b5 \ub2ec\ub7ec, Net Debt\ub294 352.35\uc5b5 \ub2ec\ub7ec\uc774\uace0 Debt to Equity\ub294 165.31\uc785\ub2c8\ub2e4. \ud604\uae08 72.68\uc5b5 \ub2ec\ub7ec\uc640 Current Ratio 1.579\uac00 \uc644\ucda9 \uc5ed\ud560\uc744 \ud558\ub294 \uac83\uc740 \ub9de\uc9c0\ub9cc, \ub3d9\uc2dc\uc5d0 \uc124\ube44\ud22c\uc790, \ubc30\ub2f9, \uc790\uc0ac\uc8fc \ub9e4\uc785, \uc778\uc218 \uac00\ub2a5\uc131\uae4c\uc9c0 \ubcd1\ud589\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2025-12-31 \ubd84\uae30\uc5d0\ub294 \ubc30\ub2f9 -13.46\uc5b5 \ub2ec\ub7ec\uc640 \uc790\uc0ac\uc8fc \ub9e4\uc785 -15.08\uc5b5 \ub2ec\ub7ec\ub3c4 \uc788\uc5c8\uc2b5\ub2c8\ub2e4. FCF\uac00 2.54\uc5b5 \ub2ec\ub7ec\uc778 \ubd84\uae30\uc5d0 \uc774\ub7f0 \uc8fc\uc8fc\ud658\uc6d0\uc744 \uc720\uc9c0\ud55c\ub2e4\uba74 \uc7ac\ubb34 \uc720\uc5f0\uc131\uc740 Bull\uc774 \ub9d0\ud558\ub294 \uac83\ubcf4\ub2e4 \ub35c \ub109\ub109\ud569\ub2c8\ub2e4.\n\nFoundayo\uc5d0 \ub300\ud55c Bull\uc758 \ub099\uad00\ub3c4 \uacfc\ub3c4\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc2ec\ud608\uad00 \uc0ac\uac74\uacfc \uc0ac\ub9dd \uc704\ud5d8 \ub370\uc774\ud130, \uac04 \uc548\uc804\uc131 \uc2e0\ud638 \ubd80\uc7ac\ub294 \uae0d\uc815\uc801\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc2dc\uc7a5\uc740 \uc774\ubbf8 \uc774 \ub274\uc2a4\ub97c \uac15\ud558\uac8c \uc18c\ube44\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ucd5c\uadfc \ub274\uc2a4 \uae30\ubc18 \uac10\uc131\uc774 \uae0d\uc815 \ucabd\uc73c\ub85c \uc9d1\uc911\ub410\uace0, \ubaa9\ud45c\uac00 1300\ub2ec\ub7ec \ubc0f \ud3c9\uade0 \ubaa9\ud45c\uac00 1224.59\ub2ec\ub7ec \uac19\uc740 \ub192\uc740 \uae30\ub300\uac00 \uc5b8\uae09\ub429\ub2c8\ub2e4. \ubb38\uc81c\ub294 \ub0b4\ub7ec\ud2f0\ube0c \uc9d1\uc911\ub3c4\uac00 \ub108\ubb34 \ub192\ub2e4\ub294 \uac81\ub2c8\ub2e4. \ud22c\uc790 \uc2ec\ub9ac\uac00 Foundayo, GLP-1, \ube44\ub9cc\u00b7\ub2f9\ub1e8 \ud504\ub79c\ucc28\uc774\uc988\uc5d0 \uc9c0\ub098\uce58\uac8c \ubab0\ub824 \uc788\uc73c\uba74, FDA\uc758 \uc2dc\ud310 \ud6c4 \uc2dc\ud5d8 \uc694\uad6c \uac19\uc740 \uc791\uc740 \uaddc\uc81c \ubd80\ub2f4\ub3c4 \u201c\uc0ac\uc18c\ud55c \ubaa8\ub2c8\ud130\ub9c1\u201d\uc774 \uc544\ub2c8\ub77c \u201c\uae30\ub300\uce58 \uc7ac\uc870\uc815\u201d\uc758 \uacc4\uae30\uac00 \ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\nBull\uc740 FDA \uc2dc\ud310 \ud6c4 \uc2dc\ud5d8 \uc694\uad6c\ub97c \ub2e8\uc21c \uc0ac\ud6c4 \ubaa8\ub2c8\ud130\ub9c1\uc73c\ub85c \ubd05\ub2c8\ub2e4. \ud558\uc9c0\ub9cc Bear\ub294 \uadf8\ub807\uac8c \uac00\ubccd\uac8c \ubcf4\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \u201cunexpected serious\u201d \uc704\ud5d8 \ud3c9\uac00\uac00 \uc5b8\uae09\ub410\ub2e4\ub294 \uc0ac\uc2e4 \uc790\uccb4\uac00 \uc548\uc804\uc131 \ucd94\uc801 \ubd80\ub2f4\uc774 \ub0a8\uc544 \uc788\ub2e4\ub294 \ub73b\uc785\ub2c8\ub2e4. \ub300\ud615 \uc81c\uc57d\uc0ac\ub77c\uc11c \uaddc\uc81c \ub300\uc751 \uacbd\ud5d8\uc774 \uc788\ub2e4\ub294 \ub9d0\uc740 \ub9de\uc9c0\ub9cc, \ub300\ud615 \uc81c\uc57d\uc0ac\ub3c4 \ub77c\ubca8 \uc81c\ud55c, \uc2b9\uc778 \uc9c0\uc5f0, \ucd94\uac00 \ub370\uc774\ud130 \uc694\uad6c, \ubcf4\ud5d8 \ub4f1\uc7ac \uc18d\ub3c4 \uc800\ud558\uc5d0\uc11c \uc790\uc720\ub86d\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \ud604\uc7ac \ubc38\ub958\uc5d0\uc774\uc158\uc740 \ud5c8\uac00 \ud655\uc7a5\uacfc \uc0c1\uc5c5\ud654 \uc131\uacf5\uc744 \uc0c1\ub2f9\ud788 \uc120\ubc18\uc601\ud558\uace0 \uc788\uae30 \ub54c\ubb38\uc5d0, \uacb0\uacfc\uac00 \u201c\ub098\uc058\uc9c0 \uc54a\ub2e4\u201d \uc815\ub3c4\ub85c\ub294 \ubd80\uc871\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n\uacbd\uc7c1 \uad6c\ub3c4\uc5d0 \ub300\ud574\uc11c\ub3c4 Bull\uc740 \u201c\uc2dc\uc7a5\uc774 \ud06c\ub2e4\ub294 \uc99d\uac70\u201d\ub77c\uace0 \ub9d0\ud569\ub2c8\ub2e4. \uadf8 \uc5ed\uc2dc \uc808\ubc18\ub9cc \ub9de\ub294 \uc8fc\uc7a5\uc785\ub2c8\ub2e4. Novo Nordisk, Viking Therapeutics, Kailera \ub4f1 \uacbd\uc7c1\uc790\uac00 \ubd80\uac01\ub418\ub294 \uc2dc\uc7a5\uc740 \ud655\uc2e4\ud788 \ud07d\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc2dc\uc7a5\uc774 \ud06c\ub2e4\uace0 \ud574\uc11c \ub9c8\uc9c4\uacfc \uc810\uc720\uc728\uc774 \uc790\ub3d9\uc73c\ub85c \uc720\uc9c0\ub418\ub294 \uac83\uc740 \uc544\ub2d9\ub2c8\ub2e4. \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uc2dc\uc7a5\uc740 \ud6a8\ub2a5, \ubd80\uc791\uc6a9, \ud22c\uc57d \ud3b8\uc758\uc131, \uac00\uaca9, \ubcf4\ud5d8 \uc811\uadfc\uc131, \uacf5\uae09 \ub2a5\ub825\uc774 \ubaa8\ub450 \uc911\uc694\ud569\ub2c8\ub2e4. \ud6c4\ubc1c \ud6c4\ubcf4\uac00 \ub354 \ud3b8\ub9ac\ud558\uac70\ub098 \ub354 \uc800\ub834\ud558\uac70\ub098 \ud2b9\uc815 \ud658\uc790\uad70\uc5d0\uc11c \uac15\ud55c \ub370\uc774\ud130\ub97c \ubcf4\uc774\uba74, LLY\uc758 \ud504\ub9ac\ubbf8\uc5c4\uc740 \uc555\ubc15\ubc1b\uc744 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \u201c\ubcf5\uc218 \uc2b9\uc790 \uc2dc\uc7a5\u201d\uc774\ub77c\ub294 \ub9d0\uc740 \uace7 LLY\uac00 \ub3c5\uc810\uc801 \uc774\uc775\uc744 \ub204\ub9ac\uae30 \uc5b4\ub835\ub2e4\ub294 \ub9d0\uc774\uae30\ub3c4 \ud569\ub2c8\ub2e4.\n\nCentessa \uc778\uc218 \ubcf4\ub3c4\ub3c4 Bear\uc5d0\uac8c\ub294 \uc591\ub0a0\uc758 \uac80\uc785\ub2c8\ub2e4. 78\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc2e0\uacbd\uacfc\ud559 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5\uc740 \ub2e4\ubcc0\ud654\ucc98\ub7fc \ubcf4\uc774\uc9c0\ub9cc, \ub3d9\uc2dc\uc5d0 \ud575\uc2ec \ube44\ub9cc\u00b7\ub2f9\ub1e8 \ud504\ub79c\ucc28\uc774\uc988 \uc758\uc874\ub3c4\ub97c \ub0ae\ucd94\uae30 \uc704\ud574 \ube44\uc2fc \uc678\ubd80 \uc131\uc7a5 \uc635\uc158\uc744 \uc0ac\uc57c \ud55c\ub2e4\ub294 \uc2e0\ud638\uc77c \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc778\uc218 \uac00\uaca9, \ud1b5\ud569 \ub9ac\uc2a4\ud06c, \uc784\uc0c1 \uc2e4\ud328 \uac00\ub2a5\uc131\uc740 \ubaa8\ub450 \ud604\uc2e4\uc801\uc778 \ubd80\ub2f4\uc785\ub2c8\ub2e4. \ud2b9\ud788 \uc774\ubbf8 Net Debt\uac00 352.35\uc5b5 \ub2ec\ub7ec\uc774\uace0 Capex \ubd80\ub2f4\uc774 \ud070 \uc0c1\ud669\uc5d0\uc11c \ub300\ud615 \uc778\uc218\ub294 \u201c\uc131\uc7a5 \uc7ac\ud22c\uc790\u201d\ub77c\uae30\ubcf4\ub2e4 \uc790\ubcf8 \ubc30\ubd84 \ub9ac\uc2a4\ud06c\ub85c \ubcfc \uc5ec\uc9c0\ub3c4 \ud07d\ub2c8\ub2e4.\n\n\ub610 \ud558\ub098 Bull\uc774 \uacfc\uc18c\ud3c9\uac00\ud558\ub294 \ubd80\ubd84\uc740 \uc218\uae09\uc785\ub2c8\ub2e4. LILLY ENDOWMENT, INC.\uac00 2026-01-07\uc5d0\ub9cc 292,148\uc8fc, 3.2238\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\ub97c \ub9e4\ub3c4\ud588\uace0, 2025\ub144 10\uc6d4\ubd80\ud130 2026\ub144 1\uc6d4\uae4c\uc9c0 \ubc18\ubcf5\uc801\uc778 \ub300\uaddc\ubaa8 \ub9e4\ub3c4\uac00 \uc788\uc5c8\uc2b5\ub2c8\ub2e4. \ubb3c\ub860 \uc9c0\ubd84 \uad00\ub9ac \uc131\uaca9\uc77c \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc8fc\uac00\uac00 \uc7a5\uae30 \uc9c0\uc9c0\uc120\uc744 \uc2dc\ud5d8\ud558\ub294 \uad6c\uac04\uc5d0\uc11c \uc774\ub7f0 \ub300\uc8fc\uc8fc \ub9e4\ub3c4 \uc774\ub825\uc740 \uc624\ubc84\ud589\uc73c\ub85c \uc791\uc6a9\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ub0b4\ubd80\uc790 \ub9e4\uc218\uac00 \uc77c\ubd80 \uc788\uc5c8\ub2e4\uace0 \ud574\ub3c4, \ud604\uc7ac \uc8fc\uac00 \ud750\ub984\uacfc \ub300\uaddc\ubaa8 \ub9e4\ub3c4 \uc774\ub825\uc744 \ud568\uaed8 \ubcf4\uba74 \uc218\uae09\uc774 \uc644\uc804\ud788 \uc6b0\ud638\uc801\uc774\ub77c\uace0 \ub9d0\ud558\uae30 \uc5b4\ub835\uc2b5\ub2c8\ub2e4.\n\n\uac70\uc2dc \ud658\uacbd\ub3c4 Bear\uc5d0\uac8c \uc720\ub9ac\ud569\ub2c8\ub2e4. \ucd5c\uadfc \ubbf8\uad6d \uc2dc\uc7a5\uc5d0\uc11c\ub294 \ub7a0\ub9ac \ud3ed\uc774 \uc881\ub2e4\ub294 \uacbd\uacc4, \uc911\ub3d9 \uc804\uc7c1\uc5d0 \ub530\ub978 \uc5d0\ub108\uc9c0\u00b7\uc778\ud50c\ub808\uc774\uc158 \ub9ac\uc2a4\ud06c, \ud488\uc9c8 \ucc44\uad8c \uc120\ud638 \ud655\ub300\uac00 \ud568\uaed8 \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. LLY\uac00 \ubc29\uc5b4\uc801 \ud5ec\uc2a4\ucf00\uc5b4 \uc131\uaca9\uc744 \uac16\ub294 \uac83\uc740 \ub9de\uc9c0\ub9cc, \ub3d9\uc2dc\uc5d0 \uace0\uc131\uc7a5 \uace0\ubc38\ub958\uc5d0\uc774\uc158 \uc8fc\uc2dd\uc785\ub2c8\ub2e4. \uae08\ub9ac \uae30\ub300\uac00 \ud754\ub4e4\ub9ac\uace0 \uc704\ud5d8\uc790\uc0b0 \uc120\ud638\uac00 \uc57d\ud574\uc9c0\uba74, \uc2dc\uc7a5\uc740 \u201c\uc88b\uc740 \uae30\uc5c5\u201d\ub3c4 \ub192\uc740 \uba40\ud2f0\ud50c\ubd80\ud130 \uae4e\uc2b5\ub2c8\ub2e4. PE 39\ubc30 \uc8fc\uc2dd\uc740 \uc774\ub7f0 \ud658\uacbd\uc5d0\uc11c \ubc29\uc5b4\uc8fc\ucc98\ub7fc\ub9cc \uc6c0\uc9c1\uc774\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4.\n\n\uacfc\uac70 \uc720\uc0ac \uc0c1\ud669\uc5d0\uc11c\uc758 \uad50\ud6c8\ub3c4 \uc5ec\uae30\uc11c \uc911\uc694\ud569\ub2c8\ub2e4. \uc81c\uac00 Bear\ub85c\uc11c \uacbd\uacc4\ud574\uc57c \ud560 \uc2e4\uc218\ub294 \ud6cc\ub96d\ud55c \uae30\uc5c5\uc758 \uc7a5\uae30 \uc131\uc7a5\uc131\uc744 \ub108\ubb34 \uc27d\uac8c \ubb34\uc2dc\ud558\ub294 \uac83\uc785\ub2c8\ub2e4. LLY\uc758 \uc81c\ud488\ub825\uacfc \uc2e4\uc801 \ubaa8\uba58\ud140\uc740 \ubd84\uba85 \uac15\ud569\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \ubc18\ub300\ub85c Bull\uc774 \ud754\ud788 \uc800\uc9c0\ub974\ub294 \uc2e4\uc218\ub294 \uac15\ud55c \ud380\ub354\uba58\ud138\uc744 \uc774\uc720\ub85c \uac00\uaca9, \ud604\uae08\ud750\ub984, \ub808\ubc84\ub9ac\uc9c0, \uaddc\uc81c \ub9ac\uc2a4\ud06c\ub97c \u201c\uc77c\uc2dc\uc801 \ubd80\ub2f4\u201d\uc73c\ub85c\ub9cc \uce58\ubd80\ud558\ub294 \uac83\uc785\ub2c8\ub2e4. \uace0\uc131\uc7a5 \uc81c\uc57d\uc8fc\ub294 \uc784\uc0c1 \ud638\uc7ac\uac00 \uc7ac\ud3c9\uac00\ub97c \ub9cc\ub4e4 \uc218 \uc788\uc9c0\ub9cc, \uae30\ub300\uac00 \ub108\ubb34 \ub192\uc544\uc9c4 \uc0c1\ud0dc\uc5d0\uc11c\ub294 \ud638\uc7ac\uac00 \uc774\ubbf8 \uac00\uaca9\uc5d0 \ub4e4\uc5b4\uac00 \uc788\uace0 \uc545\uc7ac\ub9cc \ud06c\uac8c \ubc18\uc601\ub418\ub294 \uad6c\uac04\uc774 \uc790\uc8fc \ub098\uc635\ub2c8\ub2e4.\n\n\uadf8\ub798\uc11c \uc81c \uacb0\ub860\uc740 \ub2e8\uc21c\ud55c \u201cLLY\ub294 \ub098\uc05c \ud68c\uc0ac\u201d\uac00 \uc544\ub2d9\ub2c8\ub2e4. LLY\ub294 \uc88b\uc740 \ud68c\uc0ac\uc9c0\ub9cc, \uc9c0\uae08\uc740 \uc88b\uc740 \uc8fc\uc2dd\uc774\ub77c\uace0 \ubcf4\uae30 \uc5b4\ub835\uc2b5\ub2c8\ub2e4. \uae30\uc220\uc801\uc73c\ub85c\ub294 902~903\ub2ec\ub7ec 200\uc77c\uc120\uc774 \uc704\ud0dc\ub86d\uace0, 888.03\ub2ec\ub7ec \uc774\ud0c8 \uc2dc 878.24\ub2ec\ub7ec \uc7ac\uc2dc\ud5d8 \uac00\ub2a5\uc131\uc774 \ucee4\uc9d1\ub2c8\ub2e4. 923~925\ub2ec\ub7ec\ub97c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud558\uba74 \ubc18\ub4f1\uc740 \uc2e4\ud328\ud55c \ub418\ub3cc\ub9bc\uc73c\ub85c \ub0a8\uc744 \uc218 \uc788\uace0, 976~979\ub2ec\ub7ec\uc758 50\uc77c\uc120 \ud68c\ubcf5 \uc804\uc5d0\ub294 \uc911\uae30 \ucd94\uc138 \uc804\ud658\uc744 \ub9d0\ud558\uae30 \uc5b4\ub835\uc2b5\ub2c8\ub2e4.\n\nBull\uc774 \ub9d0\ud55c \ud655\uc778 \ub9e4\uc218 \uc870\uac74 \uc790\uccb4\uac00 \uc0ac\uc2e4\uc0c1 Bear \ub17c\ub9ac\ub97c \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4. \uc544\uc9c1 923~925\ub2ec\ub7ec\ub97c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud588\uace0, 200\uc77c\uc120\uc740 \uac70\uc758 \ub2ff\uc544 \uc788\uc73c\uba70, \uac70\ub798\ub7c9\uc740 \ud558\ub77d\uc77c\uc5d0 \ucee4\uc84c\uace0, MACD\uc640 RSI\ub294 \uc5ec\uc804\ud788 \uc57d\uc138\uad8c\uc785\ub2c8\ub2e4. \ud380\ub354\uba58\ud138\uc740 \uac15\ud558\uc9c0\ub9cc FCF, \ubd80\ucc44, Capex, \uc778\uc218 \ub9ac\uc2a4\ud06c, FDA \uc0ac\ud6c4 \uc694\uad6c, \uacbd\uc7c1 \uc2ec\ud654, \ub300\uc8fc\uc8fc \ub9e4\ub3c4\ub77c\ub294 \ubd80\ub2f4\uc774 \uc313\uc5ec \uc788\uc2b5\ub2c8\ub2e4. \uc774 \uc815\ub3c4 \uae30\ub300\uce58\uc640 \ubc38\ub958\uc5d0\uc774\uc158\uc5d0\uc11c\ub294 \u201c\uc131\uc7a5 \uc2a4\ud1a0\ub9ac\uac00 \uc720\uc9c0\ub41c\ub2e4\u201d\ub9cc\uc73c\ub85c\ub294 \ubd80\uc871\ud569\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \uc774\uc81c LLY\uc5d0\uac8c \uc644\ubcbd\uc5d0 \uac00\uae4c\uc6b4 \uc2e4\ud589\uc744 \uc694\uad6c\ud558\uace0 \uc788\uace0, \uadf8\ub7f0 \uc8fc\uc2dd\uc740 \uc791\uc740 \uade0\uc5f4\uc5d0\ub3c4 \ud06c\uac8c \ud754\ub4e4\ub9bd\ub2c8\ub2e4.",
        "history": "\nBull Analyst: \uc800\ub294 LLY\uc5d0 \ub300\ud574 \uc5ec\uc804\ud788 \uac15\ud55c Bull \uad00\uc810\uc744 \uc720\uc9c0\ud569\ub2c8\ub2e4. \ub2e8\uae30 \ucc28\ud2b8\uac00 \uc57d\ud558\ub2e4\ub294 \uc810\uc740 \uc778\uc815\ud569\ub2c8\ub2e4. 2026-04-15 \uc885\uac00 905.03\ub2ec\ub7ec\uac00 10\uc77c EMA 927.51, 50\uc77c SMA 978.66 \uc544\ub798\uc5d0 \uc788\uace0 200\uc77c SMA 901.99 \uadfc\ucc98\uae4c\uc9c0 \ubc00\ub9b0 \uac83\uc740 \ubd84\uba85\ud788 \uc870\uc2ec\ud574\uc57c \ud560 \uc2e0\ud638\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc774\uac83\uc744 \u201c\ud22c\uc790 \ub17c\ub9ac \ud6fc\uc190\u201d\uc73c\ub85c \ud574\uc11d\ud558\ub294 \uac83\uc740 \ub108\ubb34 \uac00\uaca9 \uc911\uc2ec\uc801\uc778 \ud310\ub2e8\uc785\ub2c8\ub2e4. \uc9c0\uae08 LLY\uc758 \ud575\uc2ec\uc740 \ub2e8\uae30 \uc774\ub3d9\ud3c9\uade0\uc774 \uc544\ub2c8\ub77c, \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \ud504\ub79c\ucc28\uc774\uc988\uac00 \uc774\uc775 \uc131\uc7a5\uacfc \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5\uc744 \ub3d9\uc2dc\uc5d0 \ub04c\uace0 \uc788\ub2e4\ub294 \uc810\uc785\ub2c8\ub2e4.\n\nBear \ucabd\uc774 \uac00\uc7a5 \uba3c\uc800 \uc9c0\uc801\ud560 \ubd80\ubd84\uc740 \uc544\ub9c8\ub3c4 \uae30\uc220\uc801 \uc57d\uc138\uc77c \uac81\ub2c8\ub2e4. \ub9de\uc2b5\ub2c8\ub2e4. 50\uc77c\uc120\uc740 \ud558\ub77d \uc911\uc774\uace0 MACD\ub3c4 -14.38\ub85c \uc544\uc9c1 \uc57d\uc138\uad8c\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc911\uc694\ud55c \uac74 \ud558\ub77d \ubaa8\uba58\ud140\uc774 \uc774\ubbf8 \uc644\ud654\ub418\uace0 \uc788\ub2e4\ub294 \uc810\uc785\ub2c8\ub2e4. MACD\ub294 2026-03-30\uc758 -35.49\uc5d0\uc11c -14.38\uae4c\uc9c0 \uac1c\uc120\ub410\uace0, RSI\ub3c4 2026-03-27\uc758 29.19\uc5d0\uc11c 39.85\ub85c \ud68c\ubcf5\ub410\uc2b5\ub2c8\ub2e4. \uc989, \uc8fc\uac00\uac00 \uc544\uc9c1 \uac15\uc138 \uc804\ud658\uc744 \ud655\uc815\ud55c \uac83\uc740 \uc544\ub2c8\uc9c0\ub9cc \uae09\ub77d \uad6d\uba74\uc758 \uc555\ub825\uc740 \uc904\uc5b4\ub4e4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub354\uad6c\ub098 \uc8fc\uac00\ub294 \uc0c1\uc2b9 \uc911\uc778 200\uc77c\uc120 \ubd80\uadfc\uc5d0\uc11c \ubc29\uc5b4\ub97c \uc2dc\ud5d8\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc7a5\uae30 \uc0c1\uc2b9 \ucd94\uc138\uac00 \uc544\uc9c1 \uc644\uc804\ud788 \uae68\uc9c4 \uac83\uc774 \uc544\ub2c8\ub77c, \uace0\uc131\uc7a5 \ub300\ud615\uc8fc\uac00 \ud575\uc2ec \uc9c0\uc9c0\uc120\uc5d0\uc11c \uc7ac\ud3c9\uac00\ub97c \ubc1b\ub294 \uad6c\uac04\uc73c\ub85c \ubcf4\ub294 \ud3b8\uc774 \ub354 \ud569\ub9ac\uc801\uc785\ub2c8\ub2e4.\n\n\ud380\ub354\uba58\ud138\uc740 \ub2e8\uae30 \ucc28\ud2b8\ubcf4\ub2e4 \ud6e8\uc52c \uac15\ud569\ub2c8\ub2e4. LLY\uc758 \ucd5c\uadfc \ud655\uc778 \ub9e4\ucd9c\uc740 651.79\uc5b5 \ub2ec\ub7ec, \uc21c\uc774\uc775\uc740 206.4\uc5b5 \ub2ec\ub7ec\uc774\uba70 \uc601\uc5c5\uc774\uc775\ub960\uc740 44.9%, \uc21c\uc774\uc775\ub960\uc740 31.7%\uc785\ub2c8\ub2e4. \ub300\ud615 \uc81c\uc57d\uc0ac\uc5d0\uc11c \uc774 \uc815\ub3c4 \uc131\uc7a5\uc131\uacfc \uc218\uc775\uc131\uc744 \ub3d9\uc2dc\uc5d0 \ubcf4\uc5ec\uc8fc\ub294 \uae30\uc5c5\uc740 \ud754\ud558\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. 2025\ub144 \ubd84\uae30 \ub9e4\ucd9c\ub3c4 127.29\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 155.58\uc5b5 \ub2ec\ub7ec, 176.01\uc5b5 \ub2ec\ub7ec, 192.92\uc5b5 \ub2ec\ub7ec\ub85c \uc5f0\uc18d \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4. \ud76c\uc11d EPS \uc5ed\uc2dc 2025-12-31 \ubd84\uae30 7.39\ub85c \uc9c1\uc804 \ubd84\uae30 6.21, \uc804\ub144 \ub9d0 4.88\ubcf4\ub2e4 \ub69c\ub837\ud558\uac8c \uac1c\uc120\ub410\uc2b5\ub2c8\ub2e4. \uc774\uac74 \ub2e8\uc21c\ud55c \uc2a4\ud1a0\ub9ac \uc8fc\uc2dd\uc774 \uc544\ub2c8\ub77c \uc2e4\uc81c \ub9e4\ucd9c\uacfc \uc774\uc775\uc774 \ube60\ub974\uac8c \ub530\ub77c\uc624\ub294 \uc131\uc7a5\uc8fc\uc785\ub2c8\ub2e4.\n\n\ubc38\ub958\uc5d0\uc774\uc158 \uc6b0\ub824\ub3c4 \uc815\uba74\uc73c\ub85c \ubcf4\uaca0\uc2b5\ub2c8\ub2e4. \ud604\uc7ac PE 39.37\uc740 \ub0ae\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. Bear\ub294 \u201c\uc774\ubbf8 \ube44\uc2f8\ub2e4\u201d\uace0 \ub9d0\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ud558\uc9c0\ub9cc Forward PE\ub294 21.47\uc774\uace0 PEG Ratio\ub294 0.9769\uc785\ub2c8\ub2e4. \uc131\uc7a5\ub960\uc744 \ubc18\uc601\ud558\uba74 \ubc38\ub958\uc5d0\uc774\uc158\uc774 \uacfc\ub3c4\ud558\uac8c \ubd80\ud480\uc5c8\ub2e4\uae30\ubcf4\ub2e4\ub294, \uc2dc\uc7a5\uc774 \ud5a5\ud6c4 \uc774\uc775 \uc131\uc7a5\uc744 \uc0c1\ub2f9\ud788 \uc2e0\ub8b0\ud558\uace0 \uc788\ub2e4\ub294 \ub73b\uc5d0 \uac00\uae5d\uc2b5\ub2c8\ub2e4. \uace0\ub9c8\uc9c4, \uace0\uc131\uc7a5, \uae00\ub85c\ubc8c \uc218\uc694\uac00 \ud655\uc778\ub418\ub294 \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \ub9ac\ub354\uc5d0\uac8c 20\ubc30 \ucd08\ubc18\uc758 \uc120\ud589 \uc774\uc775 \ubc30\uc218\ub294 \uc624\ud788\ub824 \ubc29\uc5b4 \uac00\ub2a5\ud55c \uc218\uc900\uc785\ub2c8\ub2e4.\n\n\uac00\uc7a5 \uac15\ub825\ud55c Bull \ucd09\ub9e4\ub294 Foundayo\uc785\ub2c8\ub2e4. 2026-04-16 \ubcf4\ub3c4\uc5d0\uc11c Foundayo\uac00 \uc81c2\ud615 \ub2f9\ub1e8 \ubc0f \ube44\ub9cc \ud658\uc790\uad70\uc5d0\uc11c \uc8fc\uc694 \uc2ec\ud608\uad00 \uc0ac\uac74 \uc704\ud5d8\uc744 \uc7a5\uae30 \uc9c0\uc18d\ud615 \uc778\uc290\ub9b0 \ub300\ube44 \ube44\uc5f4\ub4f1\ud558\uac8c \ub0ae\ucdc4\uace0, \uc804\uccb4 \uc0ac\ub9dd \uc704\ud5d8\uc744 57% \ub0ae\ucdc4\ub2e4\ub294 \uc810\uc774 \ubc18\ubcf5\uc801\uc73c\ub85c \ubd80\uac01\ub410\uc2b5\ub2c8\ub2e4. \uac04 \uc548\uc804\uc131 \uc2e0\ud638\uac00 \uc5c6\uc5c8\ub2e4\ub294 \uc810\ub3c4 \uc911\uc694\ud569\ub2c8\ub2e4. \ube44\ub9cc \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\uc11c \ub2e8\uc21c \uccb4\uc911 \uac10\ub7c9 \ud6a8\ub2a5\ub9cc\ud07c \uc911\uc694\ud55c \uac83\uc774 \uc2ec\ud608\uad00 \uc548\uc804\uc131\uacfc \uc7a5\uae30 \ucc98\ubc29 \uc2e0\ub8b0\ub3c4\uc778\ub370, \uc774\ubc88 \ub370\uc774\ud130\ub294 \uc758\uc0ac \ucc98\ubc29, \ubcf4\ud5d8 \ub4f1\uc7ac, \uc801\uc751\uc99d \ud655\ub300 \uce21\uba74\uc5d0\uc11c \ubaa8\ub450 \uae0d\uc815\uc801\uc785\ub2c8\ub2e4. \ud68c\uc0ac\uac00 2\ubd84\uae30 \ub9d0\uae4c\uc9c0 \uc81c2\ud615 \ub2f9\ub1e8 \uc801\uc751\uc99d \ubbf8\uad6d \uc2b9\uc778 \uc2e0\uccad\uc744 \uacc4\ud68d\ud55c\ub2e4\ub294 \uc810\ub3c4 \ub9e4\ucd9c \ucd94\uc815\uce58 \uc0c1\ud5a5\uc758 \uc9c1\uc811\uc801 \uadfc\uac70\uac00 \ub429\ub2c8\ub2e4.\n\nBear\uac00 FDA\uc758 \uc2dc\ud310 \ud6c4 \uc2dc\ud5d8 \uc694\uad6c\ub97c \ub4e4\uace0 \ub098\uc62c \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc774\uac83\uc740 \uc989\uac01\uc801\uc778 \ubd80\uc815 \uacb0\ub860\uc774 \uc544\ub2c8\ub77c \uc0ac\ud6c4 \ubaa8\ub2c8\ud130\ub9c1\uc758 \uc131\uaca9\uc73c\ub85c \ubcf4\ub294 \uac83\uc774 \ub9de\uc2b5\ub2c8\ub2e4. \uc624\ud788\ub824 \ud575\uc2ec \uc784\uc0c1 \ub370\uc774\ud130\uac00 \uae0d\uc815\uc801\uc774\uace0 \uac04 \uc548\uc804\uc131 \uc2e0\ud638\uac00 \uc5c6\uc5c8\ub2e4\ub294 \uc810\uc774 \ud604\uc7ac\uae4c\uc9c0\uc758 \uc704\ud5d8 \uade0\ud615\uc744 Bull \ucabd\uc73c\ub85c \uae30\uc6b8\uac8c \ud569\ub2c8\ub2e4. \uc81c\uc57d\uc8fc\uc5d0\uc11c \uaddc\uc81c \ub9ac\uc2a4\ud06c\ub294 \ud56d\uc0c1 \uc874\uc7ac\ud558\uc9c0\ub9cc, LLY\ub294 \uc774\ubbf8 \ub300\ud615 \uc0c1\uc5c5\ud654 \uc5ed\ub7c9\uacfc \uaddc\uc81c \ub300\uc751 \uacbd\ud5d8\uc744 \uac00\uc9c4 \ud68c\uc0ac\uc785\ub2c8\ub2e4. \uc791\uc740 \ubc14\uc774\uc624\ud14d\uc774 \ub2e8\uc77c \uc784\uc0c1 \uacb0\uacfc\uc5d0 \uc758\uc874\ud558\ub294 \uad6c\uc870\uc640\ub294 \ub2e4\ub985\ub2c8\ub2e4.\n\n\uacbd\uc7c1 \uc2ec\ud654 \uc6b0\ub824\ub3c4 \uacfc\uc7a5\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4. Novo Nordisk, Viking Therapeutics, Kailera \ub4f1 \uacbd\uc7c1\uc790\uac00 \ubd80\uac01\ub418\ub294 \uac83\uc740 \ub9de\uc2b5\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uacbd\uc7c1\uc790\uac00 \ub9ce\ub2e4\ub294 \uc0ac\uc2e4\uc740 \uc2dc\uc7a5\uc774 \ud06c\ub2e4\ub294 \uc99d\uac70\uc774\uae30\ub3c4 \ud569\ub2c8\ub2e4. \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc2b9\uc790\ub3c5\uc2dd\uc774\ub77c\uae30\ubcf4\ub2e4 \uacf5\uae09, \uc801\uc751\uc99d, \uc548\uc804\uc131, \ucc98\ubc29 \ud3b8\uc758\uc131, \ubcf4\ud5d8 \uc811\uadfc\uc131\uc5d0 \ub530\ub77c \ubcf5\uc218\uc758 \ub300\ud615 \uc2b9\uc790\uac00 \ub098\uc62c \uc218 \uc788\ub294 \uad6c\uc870\uc785\ub2c8\ub2e4. LLY\ub294 \uc774\ubbf8 \ube0c\ub79c\ub4dc, \uc784\uc0c1 \ub370\uc774\ud130, \uc81c\uc870 \ud655\uc7a5, \uc0c1\uc5c5\ud654 \ub124\ud2b8\uc6cc\ud06c\uc5d0\uc11c \uc120\ub3c4\uad8c\uc744 \uac16\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud6c4\ubc1c \ud6c4\ubcf4\uc758 \uc874\uc7ac\ub9cc\uc73c\ub85c LLY\uc758 \ub9ac\ub354\uc2ed\uc744 \ud560\uc778\ud558\ub294 \uac83\uc740 \uc131\uae09\ud569\ub2c8\ub2e4.\n\n\ud604\uae08\ud750\ub984\uacfc \ubd80\ucc44\uc5d0 \ub300\ud55c \uc6b0\ub824\ub3c4 \uc778\uc815\ud569\ub2c8\ub2e4. 2025-12-31 \ubd84\uae30 Free Cash Flow\uac00 2.54\uc5b5 \ub2ec\ub7ec\uc5d0 \uadf8\ucce4\uace0 Capex\uac00 -29.7\uc5b5 \ub2ec\ub7ec\uc600\ub2e4\ub294 \uc810\uc740 \ub2e8\uae30\uc801\uc73c\ub85c \ubd80\ub2f4\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc774 \uc124\ube44\ud22c\uc790\ub294 \uc218\uc694 \ubd80\uc9c4 \ub54c\ubb38\uc774 \uc544\ub2c8\ub77c \uc218\uc694 \ub300\uc751\uc744 \uc704\ud55c \uc0dd\uc0b0\ub2a5\ub825 \ud655\uc7a5\uc73c\ub85c \ud574\uc11d\ud574\uc57c \ud569\ub2c8\ub2e4. \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \ud070 \ubcd1\ubaa9 \uc911 \ud558\ub098\ub294 \uacf5\uae09\uc785\ub2c8\ub2e4. LLY\uac00 \uc9c0\uae08 \uc0dd\uc0b0\ub2a5\ub825\uc5d0 \ud22c\uc790\ud558\ub294 \uac83\uc740 \ubbf8\ub798 \ub9e4\ucd9c\uc744 \ud604\uc2e4 \ub9e4\ucd9c\ub85c \ubc14\uafb8\uae30 \uc704\ud55c \uc804\ub7b5\uc801 \uc9c0\ucd9c\uc785\ub2c8\ub2e4. \ub192\uc740 ROE 101.2%, \uac15\ud55c \uc601\uc5c5\uc774\uc775\ub960, 72.68\uc5b5 \ub2ec\ub7ec\uc758 \ud604\uae08, Current Ratio 1.579\ub97c \uace0\ub824\ud558\uba74 \uc7ac\ubb34 \uc720\uc5f0\uc131\uc774 \ud6fc\uc190\ub410\ub2e4\uace0 \ubcf4\uae30\ub294 \uc5b4\ub835\uc2b5\ub2c8\ub2e4.\n\nCentessa Pharmaceuticals \uc778\uc218 \ubcf4\ub3c4\ub3c4 Bull \ub17c\ub9ac\uc5d0 \ud798\uc744 \ubcf4\ud0ed\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 LLY\ub97c \ube44\ub9cc\u00b7\ub2f9\ub1e8 \ud558\ub098\uc758 \ud14c\ub9c8\ub85c\ub9cc \ubcf4\ub294 \uacbd\ud5a5\uc774 \uc788\uc9c0\ub9cc, 78\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc2e0\uacbd\uacfc\ud559 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5 \uac00\ub2a5\uc131\uc740 \uc131\uc7a5 \ub3d9\ub825 \ub2e4\ubcc0\ud654 \uc2e0\ud638\uc785\ub2c8\ub2e4. \ubb3c\ub860 \uc778\uc218 \uac00\uaca9\uacfc \ud1b5\ud569 \ub9ac\uc2a4\ud06c\ub294 \uccb4\ud06c\ud574\uc57c \ud569\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \ub300\ud615 \uc81c\uc57d\uc0ac\uc758 \uc7a5\uae30 \uac00\uce58\ub294 \ub2e8\uc77c \ube14\ub85d\ubc84\uc2a4\ud130\uac00 \uc544\ub2c8\ub77c \uc9c0\uc18d\uc801\uc778 \ud30c\uc774\ud504\ub77c\uc778 \uc7ac\ud22c\uc790 \ub2a5\ub825\uc5d0\uc11c \ub098\uc635\ub2c8\ub2e4. LLY\ub294 \ud604\uc7ac \ud575\uc2ec \ud504\ub79c\ucc28\uc774\uc988\uc5d0\uc11c \ucc3d\ucd9c\ub418\ub294 \uc774\uc775\uc744 \ub2e4\uc74c \uc131\uc7a5\ucd95\uc73c\ub85c \uc7ac\ubc30\uce58\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.\n\n\ub2e8\uae30 \ub9e4\ub9e4 \uad00\uc810\uc5d0\uc11c\ub3c4 Bull\uc774 \ubb34\uc870\uac74 \ucd94\uaca9 \ub9e4\uc218\ub97c \uc8fc\uc7a5\ud560 \ud544\uc694\ub294 \uc5c6\uc2b5\ub2c8\ub2e4. \uc800\ub294 902~903\ub2ec\ub7ec\uc758 200\uc77c\uc120 \ubc29\uc5b4\uac00 \ud575\uc2ec\uc774\ub77c\uace0 \ubd05\ub2c8\ub2e4. \uc774 \uad6c\uac04\uc744 \uc9c0\ud0a4\uace0 923~925\ub2ec\ub7ec\uc758 10\uc77c EMA\u00b7VWMA \uad6c\uac04\uc744 \ud68c\ubcf5\ud558\uba74 \ub2e8\uae30 \ubc18\ub4f1 \uc2e0\ub8b0\ub3c4\ub294 \ud06c\uac8c \uc62c\ub77c\uac11\ub2c8\ub2e4. \uc774\ud6c4 939~955\ub2ec\ub7ec, \uadf8\ub9ac\uace0 976~979\ub2ec\ub7ec\uc758 50\uc77c\uc120 \ud68c\ubcf5\uc774 \ub2e4\uc74c \ud655\uc778 \uc9c0\uc810\uc785\ub2c8\ub2e4. \uc989, \uae30\uc220\uc801\uc73c\ub85c\ub294 \uc870\uac74\ubd80 \uc811\uadfc\uc774 \ub9de\uc9c0\ub9cc, \ud380\ub354\uba58\ud138 \uad00\uc810\uc5d0\uc11c\ub294 \uc9c0\uae08\uc758 \uc870\uc815\uc774 \uc7a5\uae30 \uc131\uc7a5\uc8fc\uc5d0 \ub300\ud55c \uc9c4\uc785 \uae30\ud68c\ub97c \ub9cc\ub4e4\uace0 \uc788\uc2b5\ub2c8\ub2e4.\n\n\uacfc\uac70 \ube44\uc2b7\ud55c \uc0c1\ud669\uc5d0\uc11c\uc758 \uad50\ud6c8\ub3c4 \ubc18\uc601\ud574\uc57c \ud569\ub2c8\ub2e4. \uace0\uc131\uc7a5 \uc81c\uc57d\uc8fc\ub294 \ub2e8\uae30 \uc870\uc815 \uc911\uc5d0 \ubc38\ub958\uc5d0\uc774\uc158\uacfc \ucc28\ud2b8\ub9cc \ubcf4\uace0 \uc131\uae09\ud558\uac8c \uc57d\uc138 \uacb0\ub860\uc744 \ub0b4\ub9ac\uba74, \uc784\uc0c1\u00b7\ud5c8\uac00\u00b7\uc2e4\uc801 \ucd09\ub9e4\uac00 \ub098\uc624\ub294 \uc21c\uac04 \ube60\ub974\uac8c \uc7ac\ud3c9\uac00\ub418\ub294 \uacbd\uc6b0\uac00 \ub9ce\uc558\uc2b5\ub2c8\ub2e4. \ubc18\ub300\ub85c Bull\ub3c4 \ubb34\uc870\uac74 \ud638\uc7ac\ub9cc \ubcf4\uace0 \uc9c4\uc785 \uac00\uaca9\uc744 \ubb34\uc2dc\ud558\uba74 \ubcc0\ub3d9\uc131\uc5d0 \ud754\ub4e4\ub9b4 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub798\uc11c \uc774\ubc88\uc5d0\ub294 \ub450 \uac00\uc9c0\ub97c \ub3d9\uc2dc\uc5d0 \ubd10\uc57c \ud569\ub2c8\ub2e4. \ud22c\uc790 \ub17c\ub9ac\ub294 \uac15\ud558\uac8c \uc720\uc9c0\ud558\ub418, \uc9c4\uc785\uc740 200\uc77c\uc120 \ubc29\uc5b4\uc640 923~925\ub2ec\ub7ec \ud68c\ubcf5\uc744 \ud655\uc778\ud558\ub294 \ubc29\uc2dd\uc774 \ub354 \uc6b0\uc218\ud569\ub2c8\ub2e4.\n\n\uacb0\ub860\uc801\uc73c\ub85c LLY\uc758 \ub2e8\uae30 \uac00\uaca9 \ud750\ub984\uc740 \ubd88\ud3b8\ud558\uc9c0\ub9cc, \uae30\uc5c5\uc758 \uc7a5\uae30 \ud22c\uc790 \ub9e4\ub825\uc740 \ud6fc\uc190\ub418\uc9c0 \uc54a\uc558\uc2b5\ub2c8\ub2e4. \ub9e4\ucd9c\uacfc EPS\ub294 \ube60\ub974\uac8c \uc99d\uac00\ud558\uace0 \uc788\uace0, \ub9c8\uc9c4\uc740 \ub300\ud615 \uc81c\uc57d\uc0ac \uc911 \ucd5c\uc0c1\uc704\uad8c\uc774\uba70, Forward PE\uc640 PEG\ub294 \uc131\uc7a5\uc131\uc744 \uac10\uc548\ud558\uba74 \ud569\ub9ac\uc801\uc785\ub2c8\ub2e4. Foundayo\uc758 \uc2ec\ud608\uad00\u00b7\uc0ac\ub9dd \uc704\ud5d8 \ub370\uc774\ud130\uc640 \ub2f9\ub1e8 \uc801\uc751\uc99d \uc2e0\uccad \uacc4\ud68d\uc740 \ud575\uc2ec \ud504\ub79c\ucc28\uc774\uc988\uc758 \uc131\uc7a5 \uac00\uc2dc\uc131\uc744 \ub192\uc785\ub2c8\ub2e4. Bear\uac00 \ub9d0\ud558\ub294 \ubcc0\ub3d9\uc131, \ubc38\ub958\uc5d0\uc774\uc158, \uaddc\uc81c, \uacbd\uc7c1 \uc6b0\ub824\ub294 \ubaa8\ub450 \uccb4\ud06c\ud574\uc57c \ud560 \ub9ac\uc2a4\ud06c\uc9c0\ub9cc, \ud604\uc7ac \uc81c\uacf5\ub41c \ub370\uc774\ud130\ub9cc \ub193\uace0 \ubcf4\uba74 \uadf8\uac83\ub4e4\uc740 \ud22c\uc790 \ub17c\ub9ac\ub97c \ubb34\ub108\ub728\ub9ac\ub294 \uc694\uc778\uc774 \uc544\ub2c8\ub77c \uac15\ud55c \uc131\uc7a5\uc8fc\uac00 \uc870\uc815 \uc911\uc5d0 \uc18c\ud654\ud574\uc57c \ud560 \uc815\uc0c1\uc801\uc778 \ubd80\ub2f4\uc5d0 \uac00\uae5d\uc2b5\ub2c8\ub2e4. \uc800\ub294 LLY\ub97c \ub2e8\uae30\uc801\uc73c\ub85c\ub294 \ud655\uc778 \ub9e4\uc218, \uc911\uc7a5\uae30\uc801\uc73c\ub85c\ub294 \uace0\ud488\uc9c8 \uc131\uc7a5 \ud504\ub9ac\ubbf8\uc5c4\uc744 \ubc1b\uc744 \uc218 \uc788\ub294 \uc6b0\ub7c9 Bull \ud6c4\ubcf4\ub85c \ubd05\ub2c8\ub2e4.\nBear Analyst: Bull \uad00\uc810\uc774 \uc65c \ub9e4\ub825\uc801\uc73c\ub85c \ub4e4\ub9ac\ub294\uc9c0\ub294 \uc778\uc815\ud569\ub2c8\ub2e4. LLY\ub294 \uc88b\uc740 \ud68c\uc0ac\uc774\uace0, \ub9e4\ucd9c \uc131\uc7a5\uacfc \ub9c8\uc9c4\uc740 \uac15\ud569\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc5ec\uae30\uc11c Bear\uac00 \ubd10\uc57c \ud560 \ud575\uc2ec\uc740 \u201c\uc88b\uc740 \ud68c\uc0ac\uc778\uac00?\u201d\uac00 \uc544\ub2c8\ub77c \u201c\ud604\uc7ac \uac00\uaca9\uacfc \uae30\ub300\uce58\uc5d0\uc11c \uc704\ud5d8 \ub300\ube44 \ubcf4\uc0c1\uc774 \ucda9\ubd84\ud55c\uac00?\u201d\uc785\ub2c8\ub2e4. \uc81c \ub2f5\uc740 \uc544\ub2c8\uc624\uc5d0 \uac00\uae5d\uc2b5\ub2c8\ub2e4.\n\n\uc6b0\uc120 Bull\uc740 \uae30\uc220\uc801 \uc57d\uc138\ub97c \u201c\ub2e8\uae30 \uac00\uaca9 \uc911\uc2ec \ud310\ub2e8\u201d\uc73c\ub85c \ub0ae\ucdb0 \ubcf4\uc9c0\ub9cc, \uc9c0\uae08 \ucc28\ud2b8\ub294 \ub2e8\uc21c\ud55c \ub178\uc774\uc988\uac00 \uc544\ub2d9\ub2c8\ub2e4. 2026-04-15 \uc885\uac00 905.03\ub2ec\ub7ec\ub294 10\uc77c EMA 927.51, 50\uc77c SMA 978.66, VWMA 924.83 \uc544\ub798\uc5d0 \uc788\uace0, 200\uc77c SMA 902.63 \ubc14\ub85c \uc704\uc5d0 \uaca8\uc6b0 \ubd99\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. \uc911\uae30 \ucd94\uc138\uc120\uc778 50\uc77c\uc120\uc740 2026-03-17\uc758 1033.18\uc5d0\uc11c 2026-04-16\uc758 976.71\uae4c\uc9c0 \uacc4\uc18d \ud558\ub77d\ud588\uc2b5\ub2c8\ub2e4. \uc774\uac74 \uc2dc\uc7a5\uc774 \uc77c\uc2dc\uc801\uc73c\ub85c \ud754\ub4e4\ub9b0 \uc815\ub3c4\uac00 \uc544\ub2c8\ub77c, \uace0\uc131\uc7a5 \ud504\ub9ac\ubbf8\uc5c4\uc744 \uc7ac\uac00\uaca9\ud654\ud558\uace0 \uc788\ub2e4\ub294 \uc2e0\ud638\uc785\ub2c8\ub2e4.\n\nBull\uc740 MACD\uac00 -35.49\uc5d0\uc11c -14.38\ub85c \uac1c\uc120\ub410\uace0 RSI\uac00 29.19\uc5d0\uc11c 39.85\ub85c \ud68c\ubcf5\ub410\ub2e4\uace0 \ub9d0\ud569\ub2c8\ub2e4. \ub9de\uc2b5\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc774\uac74 \u201c\uae09\ub77d \uc18d\ub3c4\uac00 \ub454\ud654\ub410\ub2e4\u201d\ub294 \ub73b\uc774\uc9c0 \u201c\uc0c1\uc2b9 \uc804\ud658\uc774 \uc2dc\uc791\ub410\ub2e4\u201d\ub294 \ub73b\uc774 \uc544\ub2d9\ub2c8\ub2e4. MACD\ub294 \uc5ec\uc804\ud788 \uc74c\uc218\uc774\uace0, MACD \ud788\uc2a4\ud1a0\uadf8\ub7a8\uc740 8.42\uc5d0\uc11c 1.75\ub85c \uc57d\ud574\uc84c\uc73c\uba70, RSI\ub294 50\uc744 \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud588\uc2b5\ub2c8\ub2e4. \ubc18\ub4f1 \ubaa8\uba58\ud140\uc774 \uc0b4\uc544\ub098\ub294 \uad6c\uac04\uc774\ub77c\uba74 923~925\ub2ec\ub7ec\uc758 10\uc77c EMA\u00b7VWMA\ub97c \ud68c\ubcf5\ud574\uc57c \ud558\ub294\ub370, \ud604\uc7ac \uac00\uaca9\uc740 \uadf8 \uc544\ub798\uc785\ub2c8\ub2e4. \uc989 Bull\uc774 \ub9d0\ud558\ub294 \ubc18\ub4f1 \uc870\uac74\uc740 \uc544\uc9c1 \ucda9\uc871\ub418\uc9c0 \uc54a\uc558\uc2b5\ub2c8\ub2e4.\n\n200\uc77c\uc120 \ubc29\uc5b4\ub3c4 Bull \ub17c\ub9ac\uc758 \ud575\uc2ec\uc778\ub370, \ubc14\ub85c \uadf8 \uc810\uc774 \uc704\ud5d8\ud569\ub2c8\ub2e4. \uc885\uac00 905.03\ub2ec\ub7ec\uc640 200\uc77c\uc120 902.63\ub2ec\ub7ec\uc758 \ucc28\uc774\ub294 \uc57d 2.40\ub2ec\ub7ec\ubfd0\uc785\ub2c8\ub2e4. ATR\uc774 28.13\ub2ec\ub7ec, \uc885\uac00 \ub300\ube44 \uc57d 3.1%\ub77c\ub294 \uc810\uc744 \uac10\uc548\ud558\uba74 \ud558\ub8e8 \ubcc0\ub3d9\uc131 \uc548\uc5d0\uc11c \uc7a5\uae30 \uc9c0\uc9c0\uc120 \uc774\ud0c8\uc774 \ucda9\ubd84\ud788 \ubc1c\uc0dd\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. 2026-04-15\uc5d0\ub294 \uac70\ub798\ub7c9\uc774 4,233,400\uc73c\ub85c \uc804\uc77c 2,360,200\ubcf4\ub2e4 \ud06c\uac8c \ub298\uc5c8\uace0 \uc800\uac00\ub294 888.03\uae4c\uc9c0 \ubc00\ub838\uc2b5\ub2c8\ub2e4. \uac70\ub798\ub7c9\uc774 \uc2e4\ub9b0 \ud558\ub77d \uc555\ub825\uc740 \u201c\uc88b\uc740 \ud68c\uc0ac\uac00 \uc2f8\uc84c\ub2e4\u201d\ubcf4\ub2e4 \u201c\ud575\uc2ec \uc9c0\uc9c0\uc120\uc5d0\uc11c \ub9e4\ub3c4\uc790\uac00 \uac15\ud558\ub2e4\u201d\ub85c \uc77d\ub294 \ud3b8\uc774 \ub354 \ubcf4\uc218\uc801\uc785\ub2c8\ub2e4.\n\n\ud380\ub354\uba58\ud138\ub3c4 Bull\uc774 \ub9d0\ud558\ub294 \uac83\ub9cc\ud07c \uc77c\ubc29\uc801\uc73c\ub85c \uae68\ub057\ud558\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \ub9e4\ucd9c 651.79\uc5b5 \ub2ec\ub7ec, \uc21c\uc774\uc775 206.4\uc5b5 \ub2ec\ub7ec, \uc601\uc5c5\uc774\uc775\ub960 44.9%\ub294 \ud6cc\ub96d\ud569\ub2c8\ub2e4. \uadf8\ub7f0\ub370 \uc8fc\uac00\ub294 \uc774\ubbf8 \uadf8 \ud6cc\ub96d\ud568\uc744 \uc0c1\ub2f9 \ubd80\ubd84 \ubc18\uc601\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud604\uc7ac PE 39.37\uc740 \ub300\ud615 \uc81c\uc57d\uc8fc\ub85c \ub0ae\uc9c0 \uc54a\uace0, Forward PE 21.47\uacfc PEG 0.9769\ub294 \u201c\ud5a5\ud6c4 \uc131\uc7a5\uc774 \uac70\uc758 \uacc4\ud68d\ub300\ub85c \uc628\ub2e4\u201d\ub294 \uc804\uc81c\ub97c \uae54\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774 \uc804\uc81c\uac00 \ud754\ub4e4\ub9ac\uba74 \uba40\ud2f0\ud50c \ubc29\uc5b4 \ub17c\ub9ac\ub294 \ube60\ub974\uac8c \ubb34\ub108\uc9c8 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ub192\uc740 \uae30\ub300\uce58\uac00 \ubd99\uc740 \uc8fc\uc2dd\uc740 \uc88b\uc740 \ub274\uc2a4\uac00 \ub098\uc640\ub3c4 \ub35c \uc624\ub974\uace0, \uc791\uc740 \uc9c0\uc5f0\uc774\ub098 \ub77c\ubca8 \uc81c\ud55c\uc5d0\ub3c4 \ud06c\uac8c \ube60\uc9c8 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n\ud604\uae08\ud750\ub984\uc740 \ud2b9\ud788 \ubd88\ud3b8\ud569\ub2c8\ub2e4. 2025-12-31 \ubd84\uae30 \uc601\uc5c5\ud604\uae08\ud750\ub984\uc740 32.25\uc5b5 \ub2ec\ub7ec\ub85c \ud50c\ub7ec\uc2a4\uc600\uc9c0\ub9cc \uc9c1\uc804 \ubd84\uae30 88.36\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c \ud06c\uac8c \uc904\uc5c8\uace0, Free Cash Flow\ub294 2.54\uc5b5 \ub2ec\ub7ec\uc5d0 \ubd88\uacfc\ud588\uc2b5\ub2c8\ub2e4. \uac19\uc740 \ubd84\uae30 Capex\ub294 -29.70\uc5b5 \ub2ec\ub7ec\uc600\uc2b5\ub2c8\ub2e4. Bull\uc740 \uc774\uac83\uc744 \uc218\uc694 \ub300\uc751\uc744 \uc704\ud55c \uc804\ub7b5\uc801 \ud22c\uc790\ub77c\uace0 \ub9d0\ud558\uc9c0\ub9cc, Bear \uc785\uc7a5\uc5d0\uc11c\ub294 \ubc14\ub85c \uadf8\uac8c \ubb38\uc81c\uc785\ub2c8\ub2e4. \uc131\uc7a5 \uc2a4\ud1a0\ub9ac\ub97c \ud604\uc2e4 \ub9e4\ucd9c\ub85c \ubc14\uafb8\ub824\uba74 \uacc4\uc18d \ub9c9\ub300\ud55c \uc124\ube44\ud22c\uc790\uac00 \ud544\uc694\ud558\uace0, \uadf8 \uc0ac\uc774 \uc774\uc775\uc740 \uc88b\uc544 \ubcf4\uc5ec\ub3c4 \ud604\uae08 \uc804\ud658\uc740 \uc57d\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uace0\ub9c8\uc9c4 \uc190\uc775\uacc4\uc0b0\uc11c\uc640 \ub0ae\uc740 FCF\uac00 \ud568\uaed8 \ub098\ud0c0\ub098\uba74, \uc2dc\uc7a5\uc740 \uc5b8\uc820\uac00 \u201c\uc131\uc7a5\u201d\ubcf4\ub2e4 \u201c\ud604\uae08 \ucc3d\ucd9c\ub825\u201d\uc744 \uc694\uad6c\ud569\ub2c8\ub2e4.\n\n\ubd80\ucc44\ub3c4 \ubb34\uc2dc\ud558\uae30 \uc5b4\ub835\uc2b5\ub2c8\ub2e4. Total Debt\ub294 425.03\uc5b5 \ub2ec\ub7ec, Net Debt\ub294 352.35\uc5b5 \ub2ec\ub7ec\uc774\uace0 Debt to Equity\ub294 165.31\uc785\ub2c8\ub2e4. \ud604\uae08 72.68\uc5b5 \ub2ec\ub7ec\uc640 Current Ratio 1.579\uac00 \uc644\ucda9 \uc5ed\ud560\uc744 \ud558\ub294 \uac83\uc740 \ub9de\uc9c0\ub9cc, \ub3d9\uc2dc\uc5d0 \uc124\ube44\ud22c\uc790, \ubc30\ub2f9, \uc790\uc0ac\uc8fc \ub9e4\uc785, \uc778\uc218 \uac00\ub2a5\uc131\uae4c\uc9c0 \ubcd1\ud589\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2025-12-31 \ubd84\uae30\uc5d0\ub294 \ubc30\ub2f9 -13.46\uc5b5 \ub2ec\ub7ec\uc640 \uc790\uc0ac\uc8fc \ub9e4\uc785 -15.08\uc5b5 \ub2ec\ub7ec\ub3c4 \uc788\uc5c8\uc2b5\ub2c8\ub2e4. FCF\uac00 2.54\uc5b5 \ub2ec\ub7ec\uc778 \ubd84\uae30\uc5d0 \uc774\ub7f0 \uc8fc\uc8fc\ud658\uc6d0\uc744 \uc720\uc9c0\ud55c\ub2e4\uba74 \uc7ac\ubb34 \uc720\uc5f0\uc131\uc740 Bull\uc774 \ub9d0\ud558\ub294 \uac83\ubcf4\ub2e4 \ub35c \ub109\ub109\ud569\ub2c8\ub2e4.\n\nFoundayo\uc5d0 \ub300\ud55c Bull\uc758 \ub099\uad00\ub3c4 \uacfc\ub3c4\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc2ec\ud608\uad00 \uc0ac\uac74\uacfc \uc0ac\ub9dd \uc704\ud5d8 \ub370\uc774\ud130, \uac04 \uc548\uc804\uc131 \uc2e0\ud638 \ubd80\uc7ac\ub294 \uae0d\uc815\uc801\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc2dc\uc7a5\uc740 \uc774\ubbf8 \uc774 \ub274\uc2a4\ub97c \uac15\ud558\uac8c \uc18c\ube44\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ucd5c\uadfc \ub274\uc2a4 \uae30\ubc18 \uac10\uc131\uc774 \uae0d\uc815 \ucabd\uc73c\ub85c \uc9d1\uc911\ub410\uace0, \ubaa9\ud45c\uac00 1300\ub2ec\ub7ec \ubc0f \ud3c9\uade0 \ubaa9\ud45c\uac00 1224.59\ub2ec\ub7ec \uac19\uc740 \ub192\uc740 \uae30\ub300\uac00 \uc5b8\uae09\ub429\ub2c8\ub2e4. \ubb38\uc81c\ub294 \ub0b4\ub7ec\ud2f0\ube0c \uc9d1\uc911\ub3c4\uac00 \ub108\ubb34 \ub192\ub2e4\ub294 \uac81\ub2c8\ub2e4. \ud22c\uc790 \uc2ec\ub9ac\uac00 Foundayo, GLP-1, \ube44\ub9cc\u00b7\ub2f9\ub1e8 \ud504\ub79c\ucc28\uc774\uc988\uc5d0 \uc9c0\ub098\uce58\uac8c \ubab0\ub824 \uc788\uc73c\uba74, FDA\uc758 \uc2dc\ud310 \ud6c4 \uc2dc\ud5d8 \uc694\uad6c \uac19\uc740 \uc791\uc740 \uaddc\uc81c \ubd80\ub2f4\ub3c4 \u201c\uc0ac\uc18c\ud55c \ubaa8\ub2c8\ud130\ub9c1\u201d\uc774 \uc544\ub2c8\ub77c \u201c\uae30\ub300\uce58 \uc7ac\uc870\uc815\u201d\uc758 \uacc4\uae30\uac00 \ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\nBull\uc740 FDA \uc2dc\ud310 \ud6c4 \uc2dc\ud5d8 \uc694\uad6c\ub97c \ub2e8\uc21c \uc0ac\ud6c4 \ubaa8\ub2c8\ud130\ub9c1\uc73c\ub85c \ubd05\ub2c8\ub2e4. \ud558\uc9c0\ub9cc Bear\ub294 \uadf8\ub807\uac8c \uac00\ubccd\uac8c \ubcf4\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \u201cunexpected serious\u201d \uc704\ud5d8 \ud3c9\uac00\uac00 \uc5b8\uae09\ub410\ub2e4\ub294 \uc0ac\uc2e4 \uc790\uccb4\uac00 \uc548\uc804\uc131 \ucd94\uc801 \ubd80\ub2f4\uc774 \ub0a8\uc544 \uc788\ub2e4\ub294 \ub73b\uc785\ub2c8\ub2e4. \ub300\ud615 \uc81c\uc57d\uc0ac\ub77c\uc11c \uaddc\uc81c \ub300\uc751 \uacbd\ud5d8\uc774 \uc788\ub2e4\ub294 \ub9d0\uc740 \ub9de\uc9c0\ub9cc, \ub300\ud615 \uc81c\uc57d\uc0ac\ub3c4 \ub77c\ubca8 \uc81c\ud55c, \uc2b9\uc778 \uc9c0\uc5f0, \ucd94\uac00 \ub370\uc774\ud130 \uc694\uad6c, \ubcf4\ud5d8 \ub4f1\uc7ac \uc18d\ub3c4 \uc800\ud558\uc5d0\uc11c \uc790\uc720\ub86d\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \ud604\uc7ac \ubc38\ub958\uc5d0\uc774\uc158\uc740 \ud5c8\uac00 \ud655\uc7a5\uacfc \uc0c1\uc5c5\ud654 \uc131\uacf5\uc744 \uc0c1\ub2f9\ud788 \uc120\ubc18\uc601\ud558\uace0 \uc788\uae30 \ub54c\ubb38\uc5d0, \uacb0\uacfc\uac00 \u201c\ub098\uc058\uc9c0 \uc54a\ub2e4\u201d \uc815\ub3c4\ub85c\ub294 \ubd80\uc871\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n\uacbd\uc7c1 \uad6c\ub3c4\uc5d0 \ub300\ud574\uc11c\ub3c4 Bull\uc740 \u201c\uc2dc\uc7a5\uc774 \ud06c\ub2e4\ub294 \uc99d\uac70\u201d\ub77c\uace0 \ub9d0\ud569\ub2c8\ub2e4. \uadf8 \uc5ed\uc2dc \uc808\ubc18\ub9cc \ub9de\ub294 \uc8fc\uc7a5\uc785\ub2c8\ub2e4. Novo Nordisk, Viking Therapeutics, Kailera \ub4f1 \uacbd\uc7c1\uc790\uac00 \ubd80\uac01\ub418\ub294 \uc2dc\uc7a5\uc740 \ud655\uc2e4\ud788 \ud07d\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc2dc\uc7a5\uc774 \ud06c\ub2e4\uace0 \ud574\uc11c \ub9c8\uc9c4\uacfc \uc810\uc720\uc728\uc774 \uc790\ub3d9\uc73c\ub85c \uc720\uc9c0\ub418\ub294 \uac83\uc740 \uc544\ub2d9\ub2c8\ub2e4. \ube44\ub9cc\u00b7\ub2f9\ub1e8 \uc2dc\uc7a5\uc740 \ud6a8\ub2a5, \ubd80\uc791\uc6a9, \ud22c\uc57d \ud3b8\uc758\uc131, \uac00\uaca9, \ubcf4\ud5d8 \uc811\uadfc\uc131, \uacf5\uae09 \ub2a5\ub825\uc774 \ubaa8\ub450 \uc911\uc694\ud569\ub2c8\ub2e4. \ud6c4\ubc1c \ud6c4\ubcf4\uac00 \ub354 \ud3b8\ub9ac\ud558\uac70\ub098 \ub354 \uc800\ub834\ud558\uac70\ub098 \ud2b9\uc815 \ud658\uc790\uad70\uc5d0\uc11c \uac15\ud55c \ub370\uc774\ud130\ub97c \ubcf4\uc774\uba74, LLY\uc758 \ud504\ub9ac\ubbf8\uc5c4\uc740 \uc555\ubc15\ubc1b\uc744 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \u201c\ubcf5\uc218 \uc2b9\uc790 \uc2dc\uc7a5\u201d\uc774\ub77c\ub294 \ub9d0\uc740 \uace7 LLY\uac00 \ub3c5\uc810\uc801 \uc774\uc775\uc744 \ub204\ub9ac\uae30 \uc5b4\ub835\ub2e4\ub294 \ub9d0\uc774\uae30\ub3c4 \ud569\ub2c8\ub2e4.\n\nCentessa \uc778\uc218 \ubcf4\ub3c4\ub3c4 Bear\uc5d0\uac8c\ub294 \uc591\ub0a0\uc758 \uac80\uc785\ub2c8\ub2e4. 78\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc2e0\uacbd\uacfc\ud559 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5\uc740 \ub2e4\ubcc0\ud654\ucc98\ub7fc \ubcf4\uc774\uc9c0\ub9cc, \ub3d9\uc2dc\uc5d0 \ud575\uc2ec \ube44\ub9cc\u00b7\ub2f9\ub1e8 \ud504\ub79c\ucc28\uc774\uc988 \uc758\uc874\ub3c4\ub97c \ub0ae\ucd94\uae30 \uc704\ud574 \ube44\uc2fc \uc678\ubd80 \uc131\uc7a5 \uc635\uc158\uc744 \uc0ac\uc57c \ud55c\ub2e4\ub294 \uc2e0\ud638\uc77c \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc778\uc218 \uac00\uaca9, \ud1b5\ud569 \ub9ac\uc2a4\ud06c, \uc784\uc0c1 \uc2e4\ud328 \uac00\ub2a5\uc131\uc740 \ubaa8\ub450 \ud604\uc2e4\uc801\uc778 \ubd80\ub2f4\uc785\ub2c8\ub2e4. \ud2b9\ud788 \uc774\ubbf8 Net Debt\uac00 352.35\uc5b5 \ub2ec\ub7ec\uc774\uace0 Capex \ubd80\ub2f4\uc774 \ud070 \uc0c1\ud669\uc5d0\uc11c \ub300\ud615 \uc778\uc218\ub294 \u201c\uc131\uc7a5 \uc7ac\ud22c\uc790\u201d\ub77c\uae30\ubcf4\ub2e4 \uc790\ubcf8 \ubc30\ubd84 \ub9ac\uc2a4\ud06c\ub85c \ubcfc \uc5ec\uc9c0\ub3c4 \ud07d\ub2c8\ub2e4.\n\n\ub610 \ud558\ub098 Bull\uc774 \uacfc\uc18c\ud3c9\uac00\ud558\ub294 \ubd80\ubd84\uc740 \uc218\uae09\uc785\ub2c8\ub2e4. LILLY ENDOWMENT, INC.\uac00 2026-01-07\uc5d0\ub9cc 292,148\uc8fc, 3.2238\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\ub97c \ub9e4\ub3c4\ud588\uace0, 2025\ub144 10\uc6d4\ubd80\ud130 2026\ub144 1\uc6d4\uae4c\uc9c0 \ubc18\ubcf5\uc801\uc778 \ub300\uaddc\ubaa8 \ub9e4\ub3c4\uac00 \uc788\uc5c8\uc2b5\ub2c8\ub2e4. \ubb3c\ub860 \uc9c0\ubd84 \uad00\ub9ac \uc131\uaca9\uc77c \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc8fc\uac00\uac00 \uc7a5\uae30 \uc9c0\uc9c0\uc120\uc744 \uc2dc\ud5d8\ud558\ub294 \uad6c\uac04\uc5d0\uc11c \uc774\ub7f0 \ub300\uc8fc\uc8fc \ub9e4\ub3c4 \uc774\ub825\uc740 \uc624\ubc84\ud589\uc73c\ub85c \uc791\uc6a9\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ub0b4\ubd80\uc790 \ub9e4\uc218\uac00 \uc77c\ubd80 \uc788\uc5c8\ub2e4\uace0 \ud574\ub3c4, \ud604\uc7ac \uc8fc\uac00 \ud750\ub984\uacfc \ub300\uaddc\ubaa8 \ub9e4\ub3c4 \uc774\ub825\uc744 \ud568\uaed8 \ubcf4\uba74 \uc218\uae09\uc774 \uc644\uc804\ud788 \uc6b0\ud638\uc801\uc774\ub77c\uace0 \ub9d0\ud558\uae30 \uc5b4\ub835\uc2b5\ub2c8\ub2e4.\n\n\uac70\uc2dc \ud658\uacbd\ub3c4 Bear\uc5d0\uac8c \uc720\ub9ac\ud569\ub2c8\ub2e4. \ucd5c\uadfc \ubbf8\uad6d \uc2dc\uc7a5\uc5d0\uc11c\ub294 \ub7a0\ub9ac \ud3ed\uc774 \uc881\ub2e4\ub294 \uacbd\uacc4, \uc911\ub3d9 \uc804\uc7c1\uc5d0 \ub530\ub978 \uc5d0\ub108\uc9c0\u00b7\uc778\ud50c\ub808\uc774\uc158 \ub9ac\uc2a4\ud06c, \ud488\uc9c8 \ucc44\uad8c \uc120\ud638 \ud655\ub300\uac00 \ud568\uaed8 \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. LLY\uac00 \ubc29\uc5b4\uc801 \ud5ec\uc2a4\ucf00\uc5b4 \uc131\uaca9\uc744 \uac16\ub294 \uac83\uc740 \ub9de\uc9c0\ub9cc, \ub3d9\uc2dc\uc5d0 \uace0\uc131\uc7a5 \uace0\ubc38\ub958\uc5d0\uc774\uc158 \uc8fc\uc2dd\uc785\ub2c8\ub2e4. \uae08\ub9ac \uae30\ub300\uac00 \ud754\ub4e4\ub9ac\uace0 \uc704\ud5d8\uc790\uc0b0 \uc120\ud638\uac00 \uc57d\ud574\uc9c0\uba74, \uc2dc\uc7a5\uc740 \u201c\uc88b\uc740 \uae30\uc5c5\u201d\ub3c4 \ub192\uc740 \uba40\ud2f0\ud50c\ubd80\ud130 \uae4e\uc2b5\ub2c8\ub2e4. PE 39\ubc30 \uc8fc\uc2dd\uc740 \uc774\ub7f0 \ud658\uacbd\uc5d0\uc11c \ubc29\uc5b4\uc8fc\ucc98\ub7fc\ub9cc \uc6c0\uc9c1\uc774\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4.\n\n\uacfc\uac70 \uc720\uc0ac \uc0c1\ud669\uc5d0\uc11c\uc758 \uad50\ud6c8\ub3c4 \uc5ec\uae30\uc11c \uc911\uc694\ud569\ub2c8\ub2e4. \uc81c\uac00 Bear\ub85c\uc11c \uacbd\uacc4\ud574\uc57c \ud560 \uc2e4\uc218\ub294 \ud6cc\ub96d\ud55c \uae30\uc5c5\uc758 \uc7a5\uae30 \uc131\uc7a5\uc131\uc744 \ub108\ubb34 \uc27d\uac8c \ubb34\uc2dc\ud558\ub294 \uac83\uc785\ub2c8\ub2e4. LLY\uc758 \uc81c\ud488\ub825\uacfc \uc2e4\uc801 \ubaa8\uba58\ud140\uc740 \ubd84\uba85 \uac15\ud569\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \ubc18\ub300\ub85c Bull\uc774 \ud754\ud788 \uc800\uc9c0\ub974\ub294 \uc2e4\uc218\ub294 \uac15\ud55c \ud380\ub354\uba58\ud138\uc744 \uc774\uc720\ub85c \uac00\uaca9, \ud604\uae08\ud750\ub984, \ub808\ubc84\ub9ac\uc9c0, \uaddc\uc81c \ub9ac\uc2a4\ud06c\ub97c \u201c\uc77c\uc2dc\uc801 \ubd80\ub2f4\u201d\uc73c\ub85c\ub9cc \uce58\ubd80\ud558\ub294 \uac83\uc785\ub2c8\ub2e4. \uace0\uc131\uc7a5 \uc81c\uc57d\uc8fc\ub294 \uc784\uc0c1 \ud638\uc7ac\uac00 \uc7ac\ud3c9\uac00\ub97c \ub9cc\ub4e4 \uc218 \uc788\uc9c0\ub9cc, \uae30\ub300\uac00 \ub108\ubb34 \ub192\uc544\uc9c4 \uc0c1\ud0dc\uc5d0\uc11c\ub294 \ud638\uc7ac\uac00 \uc774\ubbf8 \uac00\uaca9\uc5d0 \ub4e4\uc5b4\uac00 \uc788\uace0 \uc545\uc7ac\ub9cc \ud06c\uac8c \ubc18\uc601\ub418\ub294 \uad6c\uac04\uc774 \uc790\uc8fc \ub098\uc635\ub2c8\ub2e4.\n\n\uadf8\ub798\uc11c \uc81c \uacb0\ub860\uc740 \ub2e8\uc21c\ud55c \u201cLLY\ub294 \ub098\uc05c \ud68c\uc0ac\u201d\uac00 \uc544\ub2d9\ub2c8\ub2e4. LLY\ub294 \uc88b\uc740 \ud68c\uc0ac\uc9c0\ub9cc, \uc9c0\uae08\uc740 \uc88b\uc740 \uc8fc\uc2dd\uc774\ub77c\uace0 \ubcf4\uae30 \uc5b4\ub835\uc2b5\ub2c8\ub2e4. \uae30\uc220\uc801\uc73c\ub85c\ub294 902~903\ub2ec\ub7ec 200\uc77c\uc120\uc774 \uc704\ud0dc\ub86d\uace0, 888.03\ub2ec\ub7ec \uc774\ud0c8 \uc2dc 878.24\ub2ec\ub7ec \uc7ac\uc2dc\ud5d8 \uac00\ub2a5\uc131\uc774 \ucee4\uc9d1\ub2c8\ub2e4. 923~925\ub2ec\ub7ec\ub97c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud558\uba74 \ubc18\ub4f1\uc740 \uc2e4\ud328\ud55c \ub418\ub3cc\ub9bc\uc73c\ub85c \ub0a8\uc744 \uc218 \uc788\uace0, 976~979\ub2ec\ub7ec\uc758 50\uc77c\uc120 \ud68c\ubcf5 \uc804\uc5d0\ub294 \uc911\uae30 \ucd94\uc138 \uc804\ud658\uc744 \ub9d0\ud558\uae30 \uc5b4\ub835\uc2b5\ub2c8\ub2e4.\n\nBull\uc774 \ub9d0\ud55c \ud655\uc778 \ub9e4\uc218 \uc870\uac74 \uc790\uccb4\uac00 \uc0ac\uc2e4\uc0c1 Bear \ub17c\ub9ac\ub97c \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4. \uc544\uc9c1 923~925\ub2ec\ub7ec\ub97c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud588\uace0, 200\uc77c\uc120\uc740 \uac70\uc758 \ub2ff\uc544 \uc788\uc73c\uba70, \uac70\ub798\ub7c9\uc740 \ud558\ub77d\uc77c\uc5d0 \ucee4\uc84c\uace0, MACD\uc640 RSI\ub294 \uc5ec\uc804\ud788 \uc57d\uc138\uad8c\uc785\ub2c8\ub2e4. \ud380\ub354\uba58\ud138\uc740 \uac15\ud558\uc9c0\ub9cc FCF, \ubd80\ucc44, Capex, \uc778\uc218 \ub9ac\uc2a4\ud06c, FDA \uc0ac\ud6c4 \uc694\uad6c, \uacbd\uc7c1 \uc2ec\ud654, \ub300\uc8fc\uc8fc \ub9e4\ub3c4\ub77c\ub294 \ubd80\ub2f4\uc774 \uc313\uc5ec \uc788\uc2b5\ub2c8\ub2e4. \uc774 \uc815\ub3c4 \uae30\ub300\uce58\uc640 \ubc38\ub958\uc5d0\uc774\uc158\uc5d0\uc11c\ub294 \u201c\uc131\uc7a5 \uc2a4\ud1a0\ub9ac\uac00 \uc720\uc9c0\ub41c\ub2e4\u201d\ub9cc\uc73c\ub85c\ub294 \ubd80\uc871\ud569\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \uc774\uc81c LLY\uc5d0\uac8c \uc644\ubcbd\uc5d0 \uac00\uae4c\uc6b4 \uc2e4\ud589\uc744 \uc694\uad6c\ud558\uace0 \uc788\uace0, \uadf8\ub7f0 \uc8fc\uc2dd\uc740 \uc791\uc740 \uade0\uc5f4\uc5d0\ub3c4 \ud06c\uac8c \ud754\ub4e4\ub9bd\ub2c8\ub2e4.",
        "current_response": "{\n  \"rating\": \"OVERWEIGHT\",\n  \"portfolio_stance\": \"BULLISH\",\n  \"entry_action\": \"WAIT\",\n  \"setup_quality\": \"DEVELOPING\",\n  \"confidence\": 0.68,\n  \"time_horizon\": \"medium\",\n  \"entry_logic\": \"LLY remains investable on strong fundamentals, high margins, accelerating 2025 revenue/EPS, constructive Foundayo cardiovascular and mortality data, and supportive analyst sentiment. However, immediate entry is not confirmed because price is below the 10-day EMA/VWMA area near 923-925 and the 50-day SMA near 976-979, while it is testing the 200-day SMA near 902-903 with elevated ATR. Wait for a daily close back above 923-925 with volume confirmation, or a successful hold of 902-903 followed by higher lows, before initiating or adding exposure.\",\n  \"exit_logic\": \"Reduce or avoid new exposure if LLY closes below the 200-day SMA near 902-903 and fails to reclaim it quickly. Exit tactical exposure on a decisive break below 888, especially if volume expands, because that would raise the probability of a retest of 878.24 and confirm failed long-term support. Reassess the medium-term overweight thesis if Foundayo approval timing slips materially, safety labeling becomes restrictive, or free cash flow remains weak despite continued earnings growth.\",\n  \"position_sizing\": \"Use partial sizing until technical confirmation improves. For new money, start no more than a half-sized position only after the 923-925 reclaim is confirmed; otherwise maintain watchlist status or hold existing strategic exposure. Size stops using at least one ATR, about 28 points, to avoid being shaken out by normal volatility.\",\n  \"risk_limits\": \"Do not chase below 923-925 without confirmed support. Keep risk per trade modest because ATR is about 3.1% of price and event risk is high. Use 888 as the key tactical failure level and 902-903 as the long-term trend defense level. Monitor leverage, capex, free cash flow conversion, FDA post-marketing requirements, and competitive GLP-1 data as thesis risks.\",\n  \"catalysts\": [\n    \"Foundayo cardiovascular and mortality data supporting diabetes and obesity franchise expansion\",\n    \"Planned US approval submission for the type 2 diabetes indication by the end of Q2\",\n    \"Potential upward estimate revisions if Foundayo label and uptake expectations improve\",\n    \"Continued high revenue growth, strong operating margin, and EPS expansion\",\n    \"Centessa acquisition report suggesting longer-term pipeline diversification\",\n    \"Recovery of 923-925 followed by 939-955 and 976-979 technical resistance zones\"\n  ],\n  \"invalidators\": [\n    \"Daily close below 902-903 followed by failure to reclaim the 200-day SMA\",\n    \"Break below 888 with expanding volume, increasing risk of a retest of 878.24\",\n    \"FDA delay, restrictive label, or more serious safety concern tied to Foundayo post-marketing requirements\",\n    \"Evidence that competition from Novo Nordisk, Viking Therapeutics, Kailera, or others is pressuring pricing, share, or prescribing expectations\",\n    \"Free cash flow remains weak while capex, debt, buybacks, dividends, and acquisition spending continue to rise\",\n    \"Forward growth expectations are revised lower enough to make PE and PEG support less credible\"\n  ],\n  \"watchlist_triggers\": [\n    \"Close above 923-925 with volume above recent average\",\n    \"Successful retest of 923-925 as support after reclaiming it\",\n    \"RSI recovery above 50 and MACD improvement toward the zero line\",\n    \"Close above 939-955 to confirm stronger rebound momentum\",\n    \"Close above 976-979 to indicate medium-term trend repair\",\n    \"Close below 902-903 or intraday pressure through 888 as downside warning\",\n    \"Updates on Foundayo approval filing, FDA post-marketing study scope, and label language\",\n    \"Next earnings details on free cash flow, capex, inventory, receivables, and supply capacity guidance\"\n  ],\n  \"data_coverage\": {\n    \"company_news_count\": 4,\n    \"disclosures_count\": 0,\n    \"social_source\": \"news_derived\",\n    \"macro_items_count\": 1\n  }\n}",
        "judge_decision": "{\n  \"rating\": \"OVERWEIGHT\",\n  \"portfolio_stance\": \"BULLISH\",\n  \"entry_action\": \"WAIT\",\n  \"setup_quality\": \"DEVELOPING\",\n  \"confidence\": 0.68,\n  \"time_horizon\": \"medium\",\n  \"entry_logic\": \"LLY\ub294 \ud0c4\ud0c4\ud55c \ud380\ub354\uba58\ud138, \ub192\uc740 \ub9c8\uc9c4, 2025\ub144 \ub9e4\ucd9c/EPS \uac00\uc18d\ud654, \uae0d\uc815\uc801\uc778 Foundayo \uc2ec\ud608\uad00 \ubc0f \uc0ac\ub9dd\ub960 \ub370\uc774\ud130, \uc6b0\ud638\uc801\uc778 \uc560\ub110\ub9ac\uc2a4\ud2b8 \uc2ec\ub9ac\uc5d0 \ud798\uc785\uc5b4 \uc5ec\uc804\ud788 \ud22c\uc790 \uac00\ub2a5\ud55c \uc885\ubaa9\uc785\ub2c8\ub2e4. \ub2e4\ub9cc \uc8fc\uac00\uac00 923-925 \ubd80\uadfc\uc758 10\uc77c EMA/VWMA \uad6c\uac04\uacfc 976-979 \ubd80\uadfc\uc758 50\uc77c SMA \uc544\ub798\uc5d0 \uc788\uace0, ATR\uc774 \ub192\uc544\uc9c4 \uc0c1\ud0dc\uc5d0\uc11c 902-903 \ubd80\uadfc\uc758 200\uc77c SMA\ub97c \ud14c\uc2a4\ud2b8\ud558\uace0 \uc788\uc5b4 \uc989\uac01\uc801\uc778 \uc9c4\uc785\uc740 \uc544\uc9c1 \ud655\uc778\ub418\uc9c0 \uc54a\uc558\uc2b5\ub2c8\ub2e4. \uc2e0\uaddc \uc9c4\uc785\ud558\uac70\ub098 \ube44\uc911\uc744 \ud655\ub300\ud558\uae30 \uc804\uc5d0\ub294 \uac70\ub798\ub7c9 \ud655\uc778\uc744 \ub3d9\ubc18\ud55c 923-925 \uc0c1\ud68c \uc77c\ubd09 \uc885\uac00 \ud68c\ubcf5, \ub610\ub294 902-903 \uc9c0\uc9c0\uc5d0 \uc131\uacf5\ud55c \ub4a4 \uc800\uc810\uc744 \ub192\uc5ec\uac00\ub294 \ud750\ub984\uc744 \uae30\ub2e4\ub9ac\ub294 \uac83\uc774 \uc88b\uc2b5\ub2c8\ub2e4.\",\n  \"exit_logic\": \"LLY\uac00 902~903 \ubd80\uadfc\uc758 200\uc77c \ub2e8\uc21c\uc774\ub3d9\ud3c9\uade0(SMA) \uc544\ub798\uc5d0\uc11c \ub9c8\uac10\ud558\uace0 \uc774\ub97c \ube60\ub974\uac8c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud55c\ub2e4\uba74 \uc2e0\uaddc \ub178\ucd9c\uc744 \uc904\uc774\uac70\ub098 \ud53c\ud558\uc138\uc694. \ud2b9\ud788 \uac70\ub798\ub7c9\uc774 \uc99d\uac00\ud55c \uac00\uc6b4\ub370 888 \uc544\ub798\ub85c \ub69c\ub837\ud558\uac8c \uc774\ud0c8\ud558\uba74 \uc804\uc220\uc801 \ub178\ucd9c\uc744 \uccad\uc0b0\ud558\uc138\uc694. \uc774\ub294 878.24 \uc7ac\uc2dc\ud5d8 \uac00\ub2a5\uc131\uc744 \ub192\uc774\uace0 \uc7a5\uae30 \uc9c0\uc9c0\uc120 \uc2e4\ud328\ub97c \ud655\uc778\ud558\ub294 \uc2e0\ud638\uac00 \ub420 \uc218 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. Foundayo \uc2b9\uc778 \uc77c\uc815\uc774 \ud06c\uac8c \uc9c0\uc5f0\ub418\uac70\ub098, \uc548\uc804\uc131 \uad00\ub828 \ub77c\ubca8\uc774 \uc81c\ud55c\uc801\uc73c\ub85c \ubcc0\uacbd\ub418\uac70\ub098, \uc774\uc775 \uc131\uc7a5 \uc9c0\uc18d\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \uc789\uc5ec\ud604\uae08\ud750\ub984\uc774 \uacc4\uc18d \uc57d\ud558\ub2e4\uba74 \uc911\uae30 \ube44\uc911\ud655\ub300 \ud22c\uc790 \ub17c\ub9ac\ub97c \uc7ac\uac80\ud1a0\ud558\uc138\uc694.\",\n  \"position_sizing\": \"\uae30\uc220\uc801 \ud655\uc778\uc774 \uac1c\uc120\ub420 \ub54c\uae4c\uc9c0\ub294 \ubd80\ubd84 \ube44\uc911\ub9cc \ud65c\uc6a9\ud558\uc2ed\uc2dc\uc624. \uc2e0\uaddc \uc790\uae08\uc758 \uacbd\uc6b0 923~925 \uad6c\uac04 \ud68c\ubcf5\uc774 \ud655\uc778\ub41c \ub4a4\uc5d0\ub9cc \ucd5c\ub300 \uc808\ubc18 \uaddc\ubaa8\uc758 \ud3ec\uc9c0\uc158\uc73c\ub85c \uc2dc\uc791\ud558\uc2ed\uc2dc\uc624. \uadf8\ub807\uc9c0 \uc54a\uc73c\uba74 \uad00\ub9dd \uc885\ubaa9\uc73c\ub85c \uc720\uc9c0\ud558\uac70\ub098 \uae30\uc874 \uc804\ub7b5\uc801 \uc775\uc2a4\ud3ec\uc800\ub9cc \ubcf4\uc720\ud558\uc2ed\uc2dc\uc624. \uc815\uc0c1\uc801\uc778 \ubcc0\ub3d9\uc131\uc5d0 \ud754\ub4e4\ub824 \uc774\ud0c8\ud558\uc9c0 \uc54a\ub3c4\ub85d \uc190\uc808 \ud3ed\uc740 \ucd5c\uc18c 1 ATR, \uc57d 28\ud3ec\uc778\ud2b8\ub97c \uae30\uc900\uc73c\ub85c \uc124\uc815\ud558\uc2ed\uc2dc\uc624.\",\n  \"risk_limits\": \"\ud655\uc778\ub41c \uc9c0\uc9c0 \uc5c6\uc774 923~925 \uc544\ub798\ub97c \ucd94\uaca9 \ub9e4\uc218\ud558\uc9c0 \ub9c8\uc2ed\uc2dc\uc624. ATR\uc774 \uc8fc\uac00\uc758 \uc57d 3.1% \uc218\uc900\uc774\uace0 \uc774\ubca4\ud2b8 \ub9ac\uc2a4\ud06c\uac00 \ub192\uc73c\ubbc0\ub85c \uac70\ub798\ub2f9 \uc704\ud5d8\uc740 \ubcf4\uc218\uc801\uc73c\ub85c \uc720\uc9c0\ud558\uc2ed\uc2dc\uc624. 888\uc744 \ud575\uc2ec \uc804\uc220\uc801 \uc2e4\ud328 \uae30\uc900\uc120\uc73c\ub85c, 902~903\uc744 \uc7a5\uae30 \ucd94\uc138 \ubc29\uc5b4\uc120\uc73c\ub85c \ud65c\uc6a9\ud558\uc2ed\uc2dc\uc624. \ud22c\uc790 \uac00\uc815\uc758 \ub9ac\uc2a4\ud06c \uc694\uc778\uc73c\ub85c\ub294 \ub808\ubc84\ub9ac\uc9c0, CAPEX, \uc789\uc5ec\ud604\uae08\ud750\ub984 \uc804\ud658\uc728, FDA \uc2dc\ud310 \ud6c4 \uc694\uad6c\uc0ac\ud56d, \uacbd\uc7c1 GLP-1 \ub370\uc774\ud130 \ub4f1\uc744 \ubaa8\ub2c8\ud130\ub9c1\ud558\uc2ed\uc2dc\uc624.\",\n  \"catalysts\": [\n    \"\uc2ec\ud608\uad00 \ubc0f \uc0ac\ub9dd\ub960 \ub370\uc774\ud130\uac00 \ub2f9\ub1e8\ubcd1\u00b7\ube44\ub9cc \ud504\ub79c\ucc28\uc774\uc988 \ud655\uc7a5\uc744 \ub4b7\ubc1b\uce68\",\n    \"\uc81c2\ud615 \ub2f9\ub1e8\ubcd1 \uc801\uc751\uc99d\uc5d0 \ub300\ud55c \ubbf8\uad6d \uc2b9\uc778 \uc2e0\uccad\uc744 2\ubd84\uae30 \ub9d0\uae4c\uc9c0 \uc81c\ucd9c\ud560 \uacc4\ud68d\",\n    \"Foundayo \ub77c\ubca8 \ubc0f \ucc44\ud0dd \uae30\ub300\uac00 \uac1c\uc120\ub420 \uacbd\uc6b0 \uc2e4\uc801 \ucd94\uc815\uce58\uac00 \uc0c1\ud5a5 \uc870\uc815\ub420 \uac00\ub2a5\uc131\",\n    \"\uc9c0\uc18d\uc801\uc778 \ub192\uc740 \ub9e4\ucd9c \uc131\uc7a5, \uacac\uc870\ud55c \uc601\uc5c5\uc774\uc775\ub960, \uadf8\ub9ac\uace0 EPS \ud655\ub300\",\n    \"Centessa \uc778\uc218 \ubcf4\uace0\uc11c\ub294 \uc7a5\uae30\uc801\uc73c\ub85c \ud30c\uc774\ud504\ub77c\uc778 \ub2e4\uac01\ud654 \uac00\ub2a5\uc131\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.\",\n    \"923~925 \ud68c\ubcf5 \uc774\ud6c4 939~955 \ubc0f 976~979 \uae30\uc220\uc801 \uc800\ud56d \uad6c\uac04\"\n  ],\n  \"invalidators\": [\n    \"\uc77c\uc77c \uc885\uac00\uac00 902~903 \uc544\ub798\ub85c \ub0b4\ub824\uac04 \ub4a4 200\uc77c SMA\ub97c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud558\ub294 \uacbd\uc6b0\",\n    \"\uac70\ub798\ub7c9\uc774 \uc99d\uac00\ud558\ub294 \uac00\uc6b4\ub370 888 \uc544\ub798\ub85c \uc774\ud0c8\ud558\uba74 878.24 \uc7ac\uc2dc\ud5d8 \uc704\ud5d8\uc774 \ucee4\uc9d1\ub2c8\ub2e4.\",\n    \"FDA \uc9c0\uc5f0, \uc81c\ud55c\uc801\uc778 \ud5c8\uac00 \ub77c\ubca8, \ub610\ub294 Foundayo \uc2dc\ud310 \ud6c4 \uc694\uac74\uacfc \uad00\ub828\ub41c \ub354 \uc911\ub300\ud55c \uc548\uc804\uc131 \uc6b0\ub824\",\n    \"Novo Nordisk, Viking Therapeutics, Kailera \ub610\ub294 \uae30\ud0c0 \uacbd\uc7c1\uc0ac\uc640\uc758 \uacbd\uc7c1\uc774 \uac00\uaca9, \uc810\uc720\uc728 \ub610\ub294 \ucc98\ubc29 \uae30\ub300\uce58\uc5d0 \uc555\ubc15\uc744 \uac00\ud558\uace0 \uc788\ub2e4\ub294 \uc99d\uac70\",\n    \"\uc789\uc5ec\ud604\uae08\ud750\ub984\uc740 \uc5ec\uc804\ud788 \uc57d\ud55c \ubc18\uba74, CAPEX, \ubd80\ucc44, \uc790\uc0ac\uc8fc \ub9e4\uc785, \ubc30\ub2f9, \uc778\uc218 \uc9c0\ucd9c\uc740 \uacc4\uc18d \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4\",\n    \"\ud5a5\ud6c4 \uc131\uc7a5 \uae30\ub300\uce58\uac00 \ucda9\ubd84\ud788 \ud558\ud5a5 \uc870\uc815\ub418\uc5b4 PE\uc640 PEG\uc5d0 \uae30\ubc18\ud55c \uc9c0\uc9c0 \ub17c\ub9ac\uac00 \ub35c \uc2e0\ub8b0\ud560 \ub9cc\ud574\uc9d0\"\n  ],\n  \"watchlist_triggers\": [\n    \"\ucd5c\uadfc \ud3c9\uade0\uc744 \uc6c3\ub3c4\ub294 \uac70\ub798\ub7c9\uc744 \ub3d9\ubc18\ud574 923~925\ub97c \uc0c1\ud5a5 \ub3cc\ud30c\ud558\uba70 \ub9c8\uac10\",\n    \"923~925 \uad6c\uac04\uc744 \ub418\ucc3e\uc740 \ub4a4 \uc9c0\uc9c0\uc120\uc73c\ub85c \uc131\uacf5\uc801\uc73c\ub85c \uc7ac\ud655\uc778\",\n    \"RSI\uac00 50\uc744 \ud68c\ubcf5\ud558\uace0 MACD\uac00 0\uc120 \ubc29\ud5a5\uc73c\ub85c \uac1c\uc120\ub418\ub294\uc9c0 \ud655\uc778\",\n    \"939~955 \uc0c1\ub2e8 \ub3cc\ud30c \ubc0f \uc885\uac00 \uc548\ucc29 \uc2dc \ub354 \uac15\ud55c \ubc18\ub4f1 \ubaa8\uba58\ud140 \ud655\uc778\",\n    \"976~979 \uc0c1\ub2e8\uc5d0\uc11c \ub9c8\uac10\ud558\uba74 \uc911\uae30 \ucd94\uc138 \ud68c\ubcf5\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.\",\n    \"902~903 \uc544\ub798\uc5d0\uc11c \uc885\uac00\uac00 \ud615\uc131\ub418\uac70\ub098 \uc7a5\uc911 888\uc744 \ud558\ud5a5 \uc555\ubc15\ud558\uba74 \ud558\ubc29 \uacbd\uace0 \uc2e0\ud638\ub85c \ubd05\ub2c8\ub2e4.\",\n    \"Foundayo \uc2b9\uc778 \uc2e0\uccad \ud604\ud669, FDA \uc2dc\ud310 \ud6c4 \uc5f0\uad6c \ubc94\uc704, \ub77c\ubca8 \ubb38\uad6c \uad00\ub828 \uc5c5\ub370\uc774\ud2b8\",\n    \"\ub2e4\uc74c \uc2e4\uc801 \ubc1c\ud45c\uc5d0\uc11c \uc790\uc720\ud604\uae08\ud750\ub984, CAPEX, \uc7ac\uace0, \ub9e4\ucd9c\ucc44\uad8c, \uacf5\uae09\ub2a5\ub825 \uac00\uc774\ub358\uc2a4\uc758 \uc138\ubd80 \ub0b4\uc6a9\uc744 \ud655\uc778\"\n  ],\n  \"data_coverage\": {\n    \"company_news_count\": 4,\n    \"disclosures_count\": 0,\n    \"social_source\": \"news_derived\",\n    \"macro_items_count\": 1\n  }\n}"
    },
    "trader_investment_decision": "{\n  \"rating\": \"OVERWEIGHT\",\n  \"portfolio_stance\": \"BULLISH\",\n  \"entry_action\": \"WAIT\",\n  \"setup_quality\": \"DEVELOPING\",\n  \"confidence\": 0.68,\n  \"time_horizon\": \"medium\",\n  \"entry_logic\": \"LLY\ub294 \uc911\uae30\uc801\uc73c\ub85c \uac74\uc124\uc801\uc778 \ube44\uc911 \ud655\ub300 \ud6c4\ubcf4\ub85c \uc720\uc9c0\ud558\ub418, \uac00\uaca9\uc774 \uc9c0\uc9c0\uc120 \ub610\ub294 \ubaa8\uba58\ud140\uc744 \ud655\uc778\ud558\uae30 \uc804\uae4c\uc9c0\ub294 \uc2e0\uaddc \uc804\uc220\uc801 \uc775\uc2a4\ud3ec\uc800\ub97c \uc2dc\uc791\ud558\uc9c0 \ub9c8\uc2ed\uc2dc\uc624. \uc120\ud638 \uc9c4\uc785 \uc870\uac74\uc740 \ucd5c\uadfc \ud3c9\uade0\uc744 \uc6c3\ub3c4\ub294 \uac70\ub798\ub7c9\uc744 \ub3d9\ubc18\ud574 923~925 \uc704\uc5d0\uc11c \uc77c\ubd09 \uc885\uac00\uac00 \ud615\uc131\ub418\ub294 \uac83\uc774\uba70, \uc774\ud6c4 939~955\ub97c \ud5a5\ud55c \ucd94\uac00 \uc0c1\uc2b9\uc774 \uc774\uc5b4\uc9c0\uac70\ub098 923~925 \uad6c\uac04\uc744 \uc9c0\uc9c0\uc120\uc73c\ub85c \uc131\uacf5\uc801\uc73c\ub85c \uc7ac\ud655\uc778\ud558\ub294 \ud750\ub984\uc785\ub2c8\ub2e4. \ubcf4\uc870 \uc9c4\uc785 \uc870\uac74\uc740 902~903 \ubd80\uadfc\uc758 200\uc77c \ub2e8\uc21c\uc774\ub3d9\ud3c9\uade0\uc120(SMA) \uc601\uc5ed\uc744 \uc131\uacf5\uc801\uc73c\ub85c \ubc29\uc5b4\ud55c \ub4a4, \uc800\uc810\uc774 \ub192\uc544\uc9c0\uace0 RSI/MACD\uac00 \uac1c\uc120\ub418\ub294 \uac83\uc785\ub2c8\ub2e4.\",\n  \"exit_logic\": \"LLY\uac00 902~903 \uc544\ub798\uc5d0\uc11c \ub9c8\uac10\ud558\uace0 \ud574\ub2f9 \uc7a5\uae30 \uc9c0\uc9c0 \uad6c\uac04\uc744 \ube60\ub974\uac8c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud558\uba74 \ucd94\uac00 \ub9e4\uc218\ub97c \ud53c\ud558\uace0 \uc804\uc220\uc801 \uc775\uc2a4\ud3ec\uc800\ub97c \uc904\uc774\uc2ed\uc2dc\uc624. 888 \uc544\ub798\ub85c \uacb0\uc815\uc801\uc73c\ub85c \uc774\ud0c8\ud560 \uacbd\uc6b0, \ud2b9\ud788 \uac70\ub798\ub7c9\uc774 \ud655\ub300\ub418\uba74 \uc9c0\uc9c0 \uc2e4\ud328\uac00 \ud655\uc778\ub418\uace0 878.24\ub97c \ud5a5\ud55c \ud558\ub77d \uc704\ud5d8\uc774 \ucee4\uc9c0\ubbc0\ub85c \uc804\uc220\uc801 \uc775\uc2a4\ud3ec\uc800\ub97c \uccad\uc0b0\ud558\uc2ed\uc2dc\uc624. Foundayo\uc758 \ucd9c\uc2dc \uc2dc\uc810, \ub77c\ubca8\ub9c1, \uc548\uc804\uc131, \uacbd\uc7c1 \uc555\ub825 \ub610\ub294 \uc789\uc5ec\ud604\uae08\ud750\ub984 \uc804\ud658\uc728\uc774 \uc911\ub300\ud558\uac8c \uc545\ud654\ub418\uba74 \uc911\uae30 \ube44\uc911\ud655\ub300 \ub17c\ub9ac\ub97c \uc7ac\ud3c9\uac00\ud558\uc2ed\uc2dc\uc624.\",\n  \"position_sizing\": \"\uc124\uc815\uc774 \uc544\uc9c1 \ud655\uc778\ub418\uc9c0 \uc54a\uc740 \uc0c1\ud0dc\uc5d0\uc11c\ub294 \uc2e0\uaddc \ud3ec\uc9c0\uc158\uc744 \uc7a1\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. 923-925 \uad6c\uac04\uc744 \uac70\ub798\ub7c9 \ud655\uc778\uacfc \ud568\uaed8 \ud68c\ubcf5\ud558\uba74, \ucd5c\ub300 \uc808\ubc18 \uaddc\ubaa8\uc758 \ud3ec\uc9c0\uc158\uc73c\ub85c \uc2dc\uc791\ud569\ub2c8\ub2e4. \ucd94\uac00 \ub9e4\uc218\ub294 \uac74\uc124\uc801\uc778 \uc7ac\ud14c\uc2a4\ud2b8\uac00 \ub098\uc624\uac70\ub098 939-955 \uad6c\uac04\uc744 \uc885\uac00 \uae30\uc900\uc73c\ub85c \ub3cc\ud30c\ud55c \ub4a4\uc5d0\ub9cc \uace0\ub824\ud569\ub2c8\ub2e4. \uc77c\ubc18\uc801\uc778 \ubcc0\ub3d9\uc131 \uc7a1\uc74c\uc5d0 \uac78\ub824\ub4e4\uc9c0 \uc54a\ub3c4\ub85d ATR\uc744 \ubc18\uc601\ud574 \ud3ec\uc9c0\uc158 \ud06c\uae30\ub97c \uc815\ud558\uace0, \uc190\uc808\uac00\ub294 \uc9c4\uc785\uac00\uc5d0\uc11c \ucd5c\uc18c \uc57d 1 ATR \uc774\uc0c1 \ub5a8\uc5b4\uc9c4 \uacf3\uc5d0 \ub461\ub2c8\ub2e4.\",\n  \"risk_limits\": \"\uac70\ub798\ub2f9 \uc704\ud5d8\uc740 \uc801\uc815 \uc218\uc900\uc73c\ub85c \uc81c\ud55c\ud558\uc138\uc694. ATR\uc774 \uac00\uaca9\uc758 \uc57d 3.1% \uc218\uc900\uc73c\ub85c \ub192\uace0 \uc774\ubca4\ud2b8 \ub9ac\uc2a4\ud06c\ub3c4 \uc5ec\uc804\ud788 \uc758\ubbf8 \uc788\uac8c \ub0a8\uc544 \uc788\uc2b5\ub2c8\ub2e4. 902-903 \uad6c\uac04\uc740 \uc7a5\uae30 \ucd94\uc138 \ubc29\uc5b4 \uad6c\uac04\uc73c\ub85c, 888\uc740 \uc804\uc220\uc801 \uc2e4\ud328 \uc218\uc900\uc73c\ub85c \uac04\uc8fc\ud558\uc138\uc694. \ud655\uc778\ub41c \uc9c0\uc9c0 \uc5c6\uc774 923-925 \uc544\ub798\uc5d0\uc11c \ucd94\uaca9 \ub9e4\uc218\ud558\uc9c0 \ub9c8\uc138\uc694. FDA \uc808\ucc28, \uc2dc\ud310 \ud6c4 \uc694\uad6c\uc0ac\ud56d, GLP-1 \uacbd\uc7c1 \ub370\uc774\ud130, \ub808\ubc84\ub9ac\uc9c0, CAPEX, \uc7ac\uace0, \ub9e4\ucd9c\ucc44\uad8c, \uc789\uc5ec\ud604\uae08\ud750\ub984 \uc804\ud658\uc728\uc744 \ubaa8\ub2c8\ud130\ub9c1\ud558\uc138\uc694.\",\n  \"catalysts\": [\n    \"Foundayo\uc758 \ub2f9\ub1e8\ubcd1 \ubc0f \ube44\ub9cc \ud504\ub79c\ucc28\uc774\uc988 \ud655\uc7a5\uc744 \ub4b7\ubc1b\uce68\ud558\ub294 \uc2ec\ud608\uad00 \ubc0f \uc0ac\ub9dd\ub960 \ub370\uc774\ud130\",\n    \"\uc81c2\ud615 \ub2f9\ub1e8\ubcd1 \uc801\uc751\uc99d\uc5d0 \ub300\ud55c \ubbf8\uad6d \uc2b9\uc778 \uc2e0\uccad\uc744 2\ubd84\uae30 \ub9d0\uae4c\uc9c0 \uc81c\ucd9c\ud560 \uacc4\ud68d\",\n    \"Foundayo \ub77c\ubca8\uacfc \ucc44\ud0dd \uae30\ub300\uce58\uac00 \uac1c\uc120\ub420 \uacbd\uc6b0 \uc2e4\uc801 \ucd94\uc815\uce58\uac00 \uc0c1\ud5a5 \uc870\uc815\ub420 \uac00\ub2a5\uc131\",\n    \"\ub192\uc740 \ub9e4\ucd9c \uc131\uc7a5\uc138 \uc9c0\uc18d, \uacac\uc870\ud55c \uc601\uc5c5\uc774\uc775\ub960, EPS \ud655\ub300\",\n    \"Centessa \uc778\uc218 \ubcf4\uace0\uc11c\ub294 \uc7a5\uae30\uc801\uc778 \ud30c\uc774\ud504\ub77c\uc778 \ub2e4\uac01\ud654 \uac00\ub2a5\uc131\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.\",\n    \"923~925 \ud68c\ubcf5 \uc774\ud6c4\uc5d0\ub294 939~955 \ubc0f 976~979 \uae30\uc220\uc801 \uc800\ud56d \uad6c\uac04\uc774 \uc774\uc5b4\uc9d1\ub2c8\ub2e4.\"\n  ],\n  \"invalidators\": [\n    \"\uc77c\uc77c \uc885\uac00\uac00 902~903 \uc544\ub798\ub85c \ub0b4\ub824\uac04 \ub4a4 200\uc77c \ub2e8\uc21c\uc774\ub3d9\ud3c9\uade0\uc120(SMA)\uc744 \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud558\ub294 \uacbd\uc6b0\",\n    \"\uac70\ub798\ub7c9\uc774 \uc99d\uac00\ud558\ub294 \uac00\uc6b4\ub370 888 \uc544\ub798\ub85c \uc774\ud0c8\ud558\uba74 878.24 \uc7ac\uc2dc\ud5d8 \uc704\ud5d8\uc774 \ucee4\uc9d1\ub2c8\ub2e4.\",\n    \"FDA \uc9c0\uc5f0, \uc81c\ud55c\uc801\uc778 \ub77c\ubca8 \ubd80\uc5ec, \ub610\ub294 Foundayo \uc2dc\ud310 \ud6c4 \uc694\uad6c\uc0ac\ud56d\uacfc \uad00\ub828\ub41c \ub354 \uc911\ub300\ud55c \uc548\uc804\uc131 \uc6b0\ub824\",\n    \"Novo Nordisk, Viking Therapeutics, Kailera \ub610\ub294 \uae30\ud0c0 \uacbd\uc7c1\uc0ac\uc758 \uacbd\uc7c1\uc73c\ub85c \uc778\ud574 \uac00\uaca9, \uc810\uc720\uc728, \ucc98\ubc29 \uae30\ub300\uce58\uc5d0 \uc555\ubc15\uc774 \uac00\ud574\uc9c0\uace0 \uc788\ub2e4\ub294 \uc99d\uac70\",\n    \"\uc789\uc5ec\ud604\uae08\ud750\ub984\uc740 \uc5ec\uc804\ud788 \ubd80\uc9c4\ud55c \ubc18\uba74, CAPEX, \ubd80\ucc44, \uc790\uc0ac\uc8fc \ub9e4\uc785, \ubc30\ub2f9, \uc778\uc218 \uc9c0\ucd9c\uc740 \uacc4\uc18d \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.\",\n    \"\uc120\ud589 \uc131\uc7a5 \uae30\ub300\uce58\uac00 \ucda9\ubd84\ud788 \ud558\ud5a5 \uc870\uc815\ub418\uc5b4 PE\uc640 PEG \uae30\ubc18 \uc9c0\uc9c0 \ub17c\ub9ac\uac00 \ub35c \uc2e0\ub8b0\ud560 \ub9cc\ud574\uc9c0\ub294 \uacbd\uc6b0\"\n  ],\n  \"watchlist_triggers\": [\n    \"\ucd5c\uadfc \ud3c9\uade0\uc744 \uc6c3\ub3c4\ub294 \uac70\ub798\ub7c9\uc744 \ub3d9\ubc18\ud574 923-925 \uc704\uc5d0\uc11c \ub9c8\uac10\",\n    \"923~925 \uad6c\uac04\uc744 \uc7ac\ub3cc\ud30c\ud55c \ub4a4 \uc9c0\uc9c0\uc120\uc73c\ub85c \uc131\uacf5\uc801\uc73c\ub85c \uc7ac\ud655\uc778\",\n    \"RSI\uac00 50 \uc704\ub85c \ud68c\ubcf5\ub418\uace0 MACD\uac00 0\uc120 \ucabd\uc73c\ub85c \uac1c\uc120\ub418\ub294\uc9c0 \ud655\uc778\",\n    \"939-955 \uc704\uc5d0\uc11c \ub9c8\uac10\ud558\uba74 \ub354 \uac15\ud55c \ubc18\ub4f1 \ubaa8\uba58\ud140\uc774 \ud655\uc778\ub429\ub2c8\ub2e4.\",\n    \"976~979\ub97c \uc0c1\ud68c\ud574 \ub9c8\uac10\ud558\uba74 \uc911\uae30 \ucd94\uc138 \ud68c\ubcf5 \uc2e0\ud638\ub85c \ud574\uc11d\",\n    \"902~903 \uc544\ub798\uc5d0\uc11c \uc885\uac00\ub97c \ud615\uc131\ud558\uac70\ub098 \uc7a5\uc911 888\uc744 \ud558\ud5a5 \uc555\ubc15\ud558\uba74 \ud558\ubc29 \uacbd\uace0 \uc2e0\ud638\ub85c \ubd05\ub2c8\ub2e4.\",\n    \"Foundayo \uc2b9\uc778 \uc2e0\uccad, FDA \uc2dc\ud310 \ud6c4 \uc5f0\uad6c \ubc94\uc704 \ubc0f \ub77c\ubca8 \ubb38\uad6c \uad00\ub828 \uc5c5\ub370\uc774\ud2b8\",\n    \"\ub2e4\uc74c \uc2e4\uc801 \ubc1c\ud45c\uc5d0\uc11c \uc790\uc720\ud604\uae08\ud750\ub984, CAPEX, \uc7ac\uace0, \ub9e4\ucd9c\ucc44\uad8c, \uacf5\uae09 \ub2a5\ub825 \uac00\uc774\ub358\uc2a4 \uad00\ub828 \uc138\ubd80 \ub0b4\uc6a9\uc744 \ud655\uc778\ud558\uc138\uc694.\"\n  ],\n  \"data_coverage\": {\n    \"company_news_count\": 4,\n    \"disclosures_count\": 0,\n    \"social_source\": \"news_derived\",\n    \"macro_items_count\": 1\n  }\n}",
    "risk_debate_state": {
        "aggressive_history": "\uacf5\uaca9\uc801 \ubd84\uc11d\uac00: \uc800\ub294 \ud2b8\ub808\uc774\ub354\uc758 **\ube44\uc911\ud655\ub300(\ube44\uc911 \ud655\ub300)** \uc758\uacac\uacfc \uc911\uae30 \uac15\uc138 \uad00\uc810\uc744 \uc9c0\uc9c0\ud558\uba70, \uc5ec\uae30\uc11c \uc9c0\ub098\uce58\uac8c \uc2e0\uc911\ud55c \uac83\uc740 \uc624\ud788\ub824 **\ub300\uae30(WAIT)** \uc790\uc138\ubfd0\uc774\ub77c\uace0 \ubd05\ub2c8\ub2e4. \uad6c\ub3c4\ub294 \uc544\uc9c1 \ud615\uc131 \uc911\uc774\uc9c0\ub9cc, \uc704\ud5d8 \ub300\ube44 \ubcf4\uc0c1\uc740 \uacf5\uaca9\uc801 \uc790\uae08\uc774 \ud65c\uc6a9\ud560 \uc900\ube44\ub97c \ud574\uc57c \ud558\ub294 \ubc14\ub85c \uadf8\ub7f0 \ube44\ub300\uce6d\uc801 \uae30\ud68c\uc785\ub2c8\ub2e4. LLY\ub294 \ud22c\uc790\uc2ec\ub9ac\uc5d0 \uae0d\uc815\uc801\uc778 \uc784\uc0c1 \ucd09\ub9e4 \uc774\ud6c4 902-903 \ubd80\uadfc\uc758 \uc0c1\uc2b9 \uc911\uc778 200\uc77c \uc774\ub3d9\ud3c9\uade0\uc120 \uadfc\ucc98\uc5d0 \uba38\ubb3c\uace0 \uc788\uc73c\uba70, \uc120\ud589 PE\ub294 \uc57d 21.5, PEG\ub294 1.0 \ubbf8\ub9cc\uc785\ub2c8\ub2e4. \uc774\ub294 \uc5ec\uc804\ud788 \ub9e4\ucd9c, \ub9c8\uc9c4, EPS\ub97c \uc608\uc678\uc801\uc778 \uc18d\ub3c4\ub85c \ubcf5\ub9ac \uc131\uc7a5\uc2dc\ud0a4\uace0 \uc788\ub294 \uae30\uc5c5\uc5d0 \ud574\ub2f9\ud569\ub2c8\ub2e4.\n\n\ubcf4\uc218\uc801 \ubd84\uc11d\uac00\uc758 \ubc18\ub860\uc774 \ucc28\ud2b8\uac00 \uc57d\ud558\ub2e4\ub294 \uac83\uc774\ub77c\uba74, \ud45c\uba74\uc801\uc73c\ub85c\ub9cc \ub3d9\uc758\ud569\ub2c8\ub2e4. \ub9de\uc2b5\ub2c8\ub2e4. \uc8fc\uac00\ub294 10\uc77c EMA, 50\uc77c SMA, VWMA \uc544\ub798\uc5d0 \uc788\uace0 MACD\ub3c4 \uc5ec\uc804\ud788 \uc74c\uc218\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \ubc14\ub85c \uadf8\ub807\uae30 \ub54c\ubb38\uc5d0 \uae30\ud68c\uac00 \uc874\uc7ac\ud569\ub2c8\ub2e4. \uae68\ub057\ud558\uace0 \uba85\ud655\ud55c \uc0c1\uc2b9 \ucd94\uc138\ub77c\uba74 \uc774\ub7f0 \uc9c4\uc785 \uad6c\uac04\uc744 \uc81c\uacf5\ud558\uc9c0 \uc54a\uc744 \uac83\uc785\ub2c8\ub2e4. 200\uc77c SMA\ub294 887.62\uc5d0\uc11c 902.63\uc73c\ub85c \uacc4\uc18d \uc0c1\uc2b9\ud588\uace0, \ucd5c\uadfc \uc885\uac00\uac00 905.03 \ubd80\uadfc\uc774\ub77c\ub294 \uac83\uc740 LLY\uac00 \uc7a5\uae30 \ucd94\uc138 \uc9c0\uc9c0\uc120\uc744 \uc2dc\ud5d8\ud558\uace0 \uc788\ub2e4\ub294 \ub73b\uc774\uc9c0, \ud655\uc778\ub41c \ubc29\uc2dd\uc73c\ub85c \ubb34\ub108\uc9c0\uace0 \uc788\ub2e4\ub294 \ub73b\uc740 \uc544\ub2d9\ub2c8\ub2e4. \uc8fc\uc694 \uc784\uc0c1 \ub0b4\ub7ec\ud2f0\ube0c\uac00 \uac1c\uc120\ub41c \ub4a4 \uc7a5\uae30 \uc9c0\uc9c0\uc120\uae4c\uc9c0 \ub418\ub3cc\ub9b0 \uace0\ud488\uc9c8 \uc131\uc7a5\uc8fc\ub294 \uc228\uc744 \uc774\uc720\uac00 \uc544\ub2c8\ub77c, \ub300\uc911\uc774 \ub354 \ub192\uc740 \uac00\uaca9\uc5d0\uc11c \ud655\uc778\uc744 \uc694\uad6c\ud558\uae30 \uc804\uc5d0 \uc900\ube44\ud574\uc57c \ud560 \uc774\uc720\uc785\ub2c8\ub2e4.\n\n\ubcf4\uc218\uc801 \uad00\uc810\uc774 888 \ud558\ubc29 \uc704\ud5d8\uacfc \ub192\uc740 ATR\uc744 \uac15\uc870\ud55c\ub2e4\uba74, \uadf8\uac83\uc740 \uc57d\uc138 \ub17c\ub9ac\uac00 \uc544\ub2c8\ub77c \uc704\ud5d8\uad00\ub9ac \uc9c0\uc810\uc785\ub2c8\ub2e4. ATR\uc774 28.13, \uac00\uaca9\uc758 \uc57d 3.1%\ub77c\ub294 \uac83\uc740 \ud3ec\uc9c0\uc158 \uaddc\ubaa8\ub97c \ud604\uba85\ud558\uac8c \uc815\ud574\uc57c \ud55c\ub2e4\ub294 \ub73b\uc785\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ubcc0\ub3d9\uc131\uc740 \uae09\uaca9\ud55c \ubc18\ub4f1\uc758 \uc5f0\ub8cc\uc774\uae30\ub3c4 \ud569\ub2c8\ub2e4. 905 \ubd80\uadfc\uc5d0\uc11c 923-925\ub97c \ud68c\ubcf5\ud558\uba74 \uc8fc\uac00\ub294 \ube60\ub974\uac8c 10\uc77c EMA\uc640 VWMA \uc704\ub85c \ubcf5\uadc0\ud560 \uc218 \uc788\uace0, 939-955\ub97c \ud5a5\ud55c \uc6c0\uc9c1\uc784\uc774 \uc5f4\ub9bd\ub2c8\ub2e4. \uadf8 \uc774\ud6c4 976-979\ub97c \ud5a5\ud55c \ubcf5\uc6d0\uc740 \uc560\ub110\ub9ac\uc2a4\ud2b8 \ubaa9\ud45c\uac00 \ud504\ub808\uc784\uc6cc\ud06c\ub97c \ub17c\ud558\uae30 \uc804\ubd80\ud130 \uc758\ubbf8 \uc788\ub294 \uc0c1\uc2b9 \uc5ec\ub825\uc744 \ub73b\ud569\ub2c8\ub2e4. BMO \ubaa9\ud45c\uac00 $1300\uc640 \ud3c9\uade0 \ubaa9\ud45c\uac00 \uc57d $1,224.59\ub294 \uc2dc\uc7a5\uc758 \uc815\ubcf4 \uae30\ubc18 \uc0c1\uc2b9 \uc2dc\ub098\ub9ac\uc624\uac00 \ud604\uc7ac \uac00\uaca9\ubcf4\ub2e4 \ud6e8\uc52c \uc704\uc5d0 \uc5ec\uc804\ud788 \uc874\uc7ac\ud55c\ub2e4\ub294 \uc810\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.\n\n\ubcf4\uc218\uc801 \ubd84\uc11d\uac00\uac00 Foundayo FDA \uc2dc\ud310 \ud6c4 \uc694\uac74\uc744 \uc8fc\uc694 \uacbd\uace0 \uc2e0\ud638\ub77c\uace0 \uc8fc\uc7a5\ud55c\ub2e4\uba74, \uc800\ub294 \uadf8\uac83\uc774 \uacfc\uc7a5\ub410\ub2e4\uace0 \ubd05\ub2c8\ub2e4. \uc774\uc6a9 \uac00\ub2a5\ud55c \ud22c\uc790\uc2ec\ub9ac \ub370\uc774\ud130\uc5d0 \ub530\ub974\uba74 \uc9c0\ubc30\uc801\uc778 \uc5c5\ub370\uc774\ud2b8\ub294 \uae0d\uc815\uc801\uc774\uc5c8\uc2b5\ub2c8\ub2e4. Foundayo\ub294 \uc2ec\ud608\uad00 \ud61c\ud0dd \ud2b9\uc131, \uac04 \uc548\uc804\uc131 \uc2e0\ud638 \ubd80\uc7ac, \uadf8\ub9ac\uace0 \uc0ac\ub9dd \uc704\ud5d8 57% \uac10\uc18c\ub97c \ubcf4\uc778 \uac83\uc73c\ub85c \ubcf4\uace0\ub410\uc2b5\ub2c8\ub2e4. \uc2dc\ud310 \ud6c4 \uac10\uc2dc\ub294 \uc548\uc804\uc131 \ud504\ub85c\ud544 \uc2e4\ud328\uc640 \uac19\uc740 \uac83\uc774 \uc544\ub2d9\ub2c8\ub2e4. \uac70\ub300\ud55c \ub2f9\ub1e8\uc640 \ube44\ub9cc \uc2dc\uc7a5\uc5d0\uc11c \uaddc\uc81c\ub2f9\uad6d\uc774 \uc9c0\uc18d\uc801 \ubaa8\ub2c8\ud130\ub9c1\uc744 \uc694\uad6c\ud55c\ub2e4\uace0 \ud574\uc11c \uc0ac\ub9dd\ub960 \ubc0f \uc2ec\ud608\uad00 \ub370\uc774\ud130\uc758 \uc0c1\uc5c5\uc801 \uc758\ubbf8\uac00 \uc0ac\ub77c\uc9c0\ub294 \uac83\uc740 \uc544\ub2d9\ub2c8\ub2e4. \ubcf4\uc218\uc801 \ubd84\uc11d\uc740 \uc885\uc885 \uaddc\uc81c \ubd88\ud655\uc2e4\uc131\uc744 \uc0c1\uc2b9 \uc5ec\ub825\uc744 \uc9c0\ub098\uce58\uac8c \ud560\uc778\ud560 \uc774\uc720\ub85c \ub2e4\ub8f9\ub2c8\ub2e4. \ubc18\uba74 \uacf5\uaca9\uc801 \ubd84\uc11d\uc740 \ub77c\ubca8\ub9c1\uacfc \ucc44\ud0dd\uc774 \ud604\uc2e4\ud654\ub420 \uacbd\uc6b0 \ucd94\uc815\uce58\uac00 \ub0ae\uc544\uc9c0\ub294 \uac83\uc774 \uc544\ub2c8\ub77c \ub192\uc544\uc838\uc57c \ud560 \uc218 \uc788\ub2e4\ub294 \uc810\uc744 \uc778\uc2dd\ud569\ub2c8\ub2e4.\n\n\uc911\ub9bd\uc801 \ubd84\uc11d\uac00\uc758 \uc608\uc0c1 \ub17c\uc810\uc774 \uae30\uc220\uc801 \uc9c0\ud45c\uac00 \ud63c\uc7ac\ub418\uc5b4 \uc788\uc73c\ubbc0\ub85c \ud2b8\ub808\uc774\ub354\uac00 923-925\ub97c \uae30\ub2e4\ub824\uc57c \ud55c\ub2e4\ub294 \uac83\uc774\ub77c\uba74, \uadf8\uac83\uc740 \uc804\uc220\uc801 \ud2c0\ub85c\ub294 \ud0c0\ub2f9\ud569\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uc774 \uae30\ud68c\uc5d0\ub294 \uc9c0\ub098\uce58\uac8c \uade0\ud615\uc801\uc785\ub2c8\ub2e4. \uc911\ub9bd\uc131\uc740 \ubc18\uc804\uc758 \uccab \uad6c\uac04\uc744 \ub193\uce60 \uc218 \uc788\uc2b5\ub2c8\ub2e4. RSI\ub294 \uc774\ubbf8 29.19\uc5d0\uc11c 39.85\ub85c \ud68c\ubcf5\ud588\uace0, MACD\ub294 -35.49\uc5d0\uc11c -14.38\ub85c \uac1c\uc120\ub410\uc73c\uba70, MACD \ud788\uc2a4\ud1a0\uadf8\ub7a8\uc740 \uc2dd\uc5b4\uac00\ub294 \uc911\uc5d0\ub3c4 1.75\ub85c \uc591\uc218\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc9c1 \uc644\uc804\ud55c \uac15\uc138 \uc2e0\ud638\ub294 \uc544\ub2c8\uc9c0\ub9cc, \ud558\ubc29 \ubaa8\uba58\ud140\uc774 \uc774\ubbf8 \uc57d\ud574\uc84c\ub2e4\ub294 \uc99d\uac70\uc785\ub2c8\ub2e4. \ubaa8\ub4e0 \uc9c0\ud45c\uac00 \ud655\uc778\ub420 \ub54c\uae4c\uc9c0 \uae30\ub2e4\ub9b0\ub2e4\ub294 \uac83\uc740 \uac00\uc7a5 \ud655\uc2e0 \uc788\ub294 \ub9e4\uc218\uc790\ub4e4\uc774 \uc774\ubbf8 \ud589\ub3d9\ud55c \ub4a4 \ub354 \ub098\uc05c \uc9c4\uc785\uac00\ub97c \ubc1b\uc544\ub4e4\uc774\uaca0\ub2e4\ub294 \ub73b\uc785\ub2c8\ub2e4.\n\n\ud380\ub354\uba58\ud138 \uce21\uba74\uc5d0\uc11c \uc789\uc5ec\ud604\uae08\ud750\ub984\uacfc \ubd80\ucc44\uc5d0 \ub300\ud55c \uc57d\uc138\uc801 \uacbd\uacc4\ub294 \uc65c \uadf8 \uc218\uce58\ub4e4\uc774 \uc555\ubc15\ubc1b\uc544 \ubcf4\uc774\ub294\uc9c0\ub97c \ubb34\uc2dc\ud569\ub2c8\ub2e4. \uc57d $3B\uc5d0 \ub2ec\ud558\ub294 CAPEX\ub294 \ub0ad\ube44\uac00 \uc544\ub2c8\ub77c \ube44\ub9cc\uacfc \ub2f9\ub1e8 \ubd84\uc57c\uc758 \uc774\ub840\uc801 \uc218\uc694\ub97c \uc704\ud55c \uc0dd\uc0b0\ub2a5\ub825 \ud655\uc7a5\uc785\ub2c8\ub2e4. LLY\uc758 \ucd5c\uadfc \ub9e4\ucd9c \uada4\uc801\uc740 \uac15\ub825\ud569\ub2c8\ub2e4. \ubd84\uae30 \ub9e4\ucd9c\uc740 2025\ub144 \ub3d9\uc548 12.7285B\uc5d0\uc11c 15.5577B, 17.6008B, 19.292B\ub85c \uc99d\uac00\ud588\uace0, \uc601\uc5c5\uc774\uc775\uc740 8.9874B\uc5d0 \ub3c4\ub2ec\ud588\uc73c\uba70 \ud76c\uc11d EPS\ub294 7.39\ub85c \uc0c1\uc2b9\ud588\uc2b5\ub2c8\ub2e4. \uc601\uc5c5\uc774\uc775\ub960 44.896%\uc640 \uc21c\uc774\uc775\ub960 31.667%\ub294 \ucd5c\uc0c1\uc704\uad8c\uc785\ub2c8\ub2e4. \uc774\ub7f0 \ub9c8\uc9c4 \uad6c\uc870\ub97c \uac00\uc9c4 \uae30\uc5c5\uc774 \uc0dd\uc0b0\ub2a5\ub825\uc5d0 \ub300\uaddc\ubaa8 \ud22c\uc790\ud558\ub294 \uac83\uc740 \ub2e8\uc21c\ud788 \ud604\uae08\uc744 \ud0dc\uc6b0\ub294 \uac83\uc774 \uc544\ub2c8\ub77c, \uc2dc\uc7a5\uc774 \uacc4\uc18d \ud504\ub9ac\ubbf8\uc5c4 \uba40\ud2f0\ud50c\ub85c \ubcf4\uc0c1\ud560 \uc218 \uc788\ub294 \ud504\ub79c\ucc28\uc774\uc988\ub97c \ud655\uc7a5\ud558\ub294 \uac83\uc785\ub2c8\ub2e4.\n\n\ubc38\ub958\uc5d0\uc774\uc158 \uc6b0\ub824\uc5d0\ub3c4 \ubc18\ubc15\uc774 \ud544\uc694\ud569\ub2c8\ub2e4. \ud6c4\ud589 PE \uc57d 39\ub294 \ub2e8\ub3c5\uc73c\ub85c \ubcf4\uba74 \ube44\uc2f8 \ubcf4\uc77c \uc218 \uc788\uc9c0\ub9cc, \uc120\ud589 PE 21.47\uacfc PEG 0.9769\ub294 \uacf5\uaca9\uc801 \ud22c\uc790\uc790\ub4e4\uc774 \ubcf4\uace0 \uc2f6\uc5b4 \ud558\ub294 \ubc14\ub85c \uadf8 \uc870\ud569\uc785\ub2c8\ub2e4. \uc774 \uc8fc\uc2dd\uc740 \ud3c9\ubc94\ud574\uc11c \uc2fc \uac83\uc774 \uc544\ub2c8\ub77c, \uc774\uc775\uc774 \uae09\uaca9\ud788 \ud655\ub300\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uae30 \ub54c\ubb38\uc5d0 \uc131\uc7a5 \ub300\ube44 \ub9e4\ub825\uc801\uc73c\ub85c \ud3c9\uac00\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. Foundayo\uc758 \ub77c\ubca8\uacfc \uc0c1\uc5c5\uc801 \uc804\ub9dd\uc774 \uac1c\uc120\ub41c\ub2e4\uba74, \uadf8 \ubc38\ub958\uc5d0\uc774\uc158 \ubc29\uc815\uc2dd\uc758 \ubd84\ubaa8\uac00 \ucee4\uc9d1\ub2c8\ub2e4. \uc0c1\uc2b9 \uc11c\ud504\ub77c\uc774\uc988\ub294 \ubc14\ub85c \uadf8 \uc9c0\uc810\uc5d0\uc11c \ub098\uc635\ub2c8\ub2e4.\n\nNovo Nordisk, Viking, Kailera \ubc0f \uae30\ud0c0 \uc5c5\uccb4\ub4e4\uacfc\uc758 \uacbd\uc7c1\uc740 \uc2e4\uc81c\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \uadf8\uac83\uc740 \ub610\ud55c \uc774 \uce74\ud14c\uace0\ub9ac\uc758 \uaddc\ubaa8\ub97c \uac80\uc99d\ud569\ub2c8\ub2e4. \uc911\ub9bd \ub610\ub294 \ubcf4\uc218 \uc9c4\uc601\uc740 \uacbd\uc7c1\uc744 \ub9c8\uc9c4 \uc555\ubc15\uc73c\ub85c \uaddc\uc815\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc800\ub294 \uc774\ub97c \ube44\ub9cc \ubc0f \ub300\uc0ac \uc758\ud559\uc774 \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \uac00\uce58 \uc788\ub294 \uce58\ub8cc \uc601\uc5ed \uc804\uc7c1\ud130 \uc911 \ud558\ub098\ub85c \ub0a8\uc544 \uc788\ub2e4\ub294 \uc99d\uac70\ub85c \ubd05\ub2c8\ub2e4. LLY\ub294 \uc774\ubbf8 \uaddc\ubaa8, \ube0c\ub79c\ub4dc \uc2e0\ub8b0\ub3c4, \uc81c\uc870 \ud22c\uc790, \uc784\uc0c1 \ubaa8\uba58\ud140, \uc560\ub110\ub9ac\uc2a4\ud2b8 \uc9c0\uc9c0\ub97c \uac16\ucd94\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2b9\uc790\ub3c5\uc2dd \ub610\ub294 \uc2b9\uc790\uac00 \ud070 \ubaab\uc744 \ucc28\uc9c0\ud558\ub294 \uc2dc\uc7a5\uc5d0\uc11c \uc120\ub3c4 \uae30\uc5c5\uc740 \ud504\ub9ac\ubbf8\uc5c4\uc744 \ubc1b\uc744 \uc790\uaca9\uc774 \uc788\uc73c\uba70, \ud2b9\ud788 \ub0b4\ub7ec\ud2f0\ube0c\uac00 \ub9c9 \uac1c\uc120\ub41c \uc0c1\ud669\uc5d0\uc11c\ub294 \ub354\uc6b1 \uadf8\ub807\uc2b5\ub2c8\ub2e4.\n\nCentessa \uc778\uc218 \ubcf4\ub3c4\ub3c4 \uc911\uc694\ud569\ub2c8\ub2e4. \ube44\ud310\ub860\uc790\ub4e4\uc740 $7.8B\ub97c \ud1b5\ud569 \uc704\ud5d8\uc774\ub098 \uc9c0\ucd9c \uaddc\uc728 \uc704\ud5d8\uc73c\ub85c \ubcfc \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc800\ub294 \uc804\ub7b5\uc801 \uc120\ud0dd\uad8c\uc73c\ub85c \ubd05\ub2c8\ub2e4. LLY\uc5d0 \ub300\ud55c \uac00\uc7a5 \ud070 \uc9c0\uc801\uc740 \ube44\ub9cc\uacfc \ub2f9\ub1e8 \uae30\ub300\uce58\uc5d0 \ub300\ud55c \uc758\uc874\ub3c4\uc785\ub2c8\ub2e4. \uc2e0\uacbd\uacfc\ud559 \uc790\uc0b0\uc73c\ub85c \ud655\uc7a5\ud558\ub294 \uac83\uc740 \uadf8 \uc9d1\uc911\ub3c4 \uc6b0\ub824\ub97c \uc9c1\uc811\uc801\uc73c\ub85c \ub2e4\ub8e8\ub294 \ud589\ubcf4\uc785\ub2c8\ub2e4. \uacf5\uaca9\uc801 \ud22c\uc790\uc790\ub4e4\uc740 \uacbd\uc601\uc9c4\uc774 \ud604\uc7ac \ud504\ub79c\ucc28\uc774\uc988\ub97c \ub2e8\uc21c\ud788 \uc218\ud655\ud558\ub294 \ub300\uc2e0 \uc131\uc7a5 \ud65c\uc8fc\ub85c\ub97c \uc5f0\uc7a5\ud558\ub824\ub294 \uc2dc\ub3c4\ub97c \ubcf4\uc0c1\ud574\uc57c \ud569\ub2c8\ub2e4.\n\n\ub530\ub77c\uc11c \uc81c \uc785\uc7a5\uc740 \uba85\ud655\ud569\ub2c8\ub2e4. \ud2b8\ub808\uc774\ub354\uc758 **\ube44\uc911\ud655\ub300(\ube44\uc911 \ud655\ub300)** \uc758\uacac\uc740 \uc633\uace0, \ud3ec\ud2b8\ud3f4\ub9ac\uc624\uc758 \uac15\uc138 \uc785\uc7a5\uc740 \uc815\ub2f9\ud569\ub2c8\ub2e4. 923-925, 939-955, 976-979\ub97c \ub458\ub7ec\uc2fc \uc81c\uc548\ub41c \ud2b8\ub9ac\uac70 \uaddc\uc728\uc740 \uc874\uc911\ud558\uaca0\uc9c0\ub9cc, \ubcf4\uc218\uc801 \ub450\ub824\uc6c0\uc774 \uacb0\uc815\uc744 \uc9c0\ubc30\ud558\uac8c \ub450\uc9c0\ub294 \uc54a\uaca0\uc2b5\ub2c8\ub2e4. \ucd5c\uc120\uc758 \uacbd\ub85c\ub294 902-903\uc744 \uc804\uc7a5\uc73c\ub85c, 888\uc744 \uc804\uc220\uc801 \uc2e4\ud328\uc120\uc73c\ub85c, 923-925\ub97c \uac00\uc18d \ud2b8\ub9ac\uac70\ub85c \ub2e4\ub8e8\ub294 \uac83\uc785\ub2c8\ub2e4. \uc774\uac83\uc740 \uc800\uc704\ud5d8 \uac70\ub798\uac00 \uc544\ub2d9\ub2c8\ub2e4. \uc774\ub294 \uc8fc\uc694 \uc784\uc0c1, \ud22c\uc790\uc2ec\ub9ac, \uc774\uc775 \uc131\uc7a5 \ucd09\ub9e4\uac00 \uc815\ub82c\ub41c \ubcc0\ub3d9\uc131 \ub192\uc740 \ubcc0\uace1\uc810\uc5d0 \ub193\uc778 \uace0\ud488\uc9c8 \uc131\uc7a5 \ub9ac\ub354\uc785\ub2c8\ub2e4. \ubc14\ub85c \uc774\ub7f0 \uacf3\uc5d0\uc11c \uacf5\uaca9\uc801 \uc790\uae08\uc740 \uc55e\uc73c\ub85c \uae30\uc6b8\uc5b4\uc57c \ud569\ub2c8\ub2e4.",
        "conservative_history": "\ubcf4\uc218\uc801 \ubd84\uc11d\uac00: \uc800\ub294 \uacf5\uaca9\uc801 \ubd84\uc11d\uac00\uc758 \ud504\ub808\uc774\ubc0d\uc5d0 \uac15\ud558\uac8c \ubc18\ub300\ud569\ub2c8\ub2e4. \ud575\uc2ec\uc740 LLY\uac00 \uc6b0\ub7c9 \uae30\uc5c5\uc778\uc9c0 \uc5ec\ubd80\uac00 \uc544\ub2d9\ub2c8\ub2e4. \uc6b0\ub7c9 \uae30\uc5c5\uc740 \ub9de\uc2b5\ub2c8\ub2e4. \ubb38\uc81c\ub294 \uc9c0\uae08\uc774 \uc775\uc2a4\ud3ec\uc800\ub97c \ucd94\uac00\ud558\uae30\uc5d0 \uc800\uc704\ud5d8 \uad6c\uac04\uc778\uc9c0 \uc5ec\ubd80\uc785\ub2c8\ub2e4. \uc81c\uacf5\ub41c \ub370\uc774\ud130 \uae30\uc900\uc73c\ub85c\ub294 \uadf8\ub807\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4.\n\n\uacf5\uaca9\uc801 \uad00\uc810\uc740 902-903 \ubd80\uadfc\uc758 200\uc77c \uc774\ub3d9\ud3c9\uade0\uc744 \ub9e4\ub825\uc801\uc778 \uaca9\uc804\uc9c0\ub85c \ubd05\ub2c8\ub2e4. \ubcf4\uc218\uc801 \ub9ac\uc2a4\ud06c \uad00\uc810\uc5d0\uc11c\ub294 \ubc14\ub85c \uadf8\uac83\uc774 \ubb38\uc81c\uc785\ub2c8\ub2e4. \ucd5c\uadfc \ud655\uc778\ub41c \uc885\uac00 905.03\uc740 200\uc77c SMA\ubcf4\ub2e4 \uc57d 2.40\ud3ec\uc778\ud2b8 \uc704\uc5d0 \ubd88\uacfc\ud55c \ubc18\uba74, ATR\uc740 28.13\uc785\ub2c8\ub2e4. \uc774\ub294 \uc8fc\uac00\uac00 \uc7a5\uae30 \uc9c0\uc9c0\uc120 \ubc14\ub85c \uc704\uc5d0 \uac70\uc758 \ubd99\uc5b4 \uc788\uc73c\uba70, \uc77c\uac04 \ubcc0\ub3d9\uc131\uc774 \uadf8 \uc9c0\uc9c0\uc120\uae4c\uc9c0\uc758 \uac70\ub9ac\ubcf4\ub2e4 10\ubc30 \uc774\uc0c1 \ud06c\ub2e4\ub294 \ub73b\uc785\ub2c8\ub2e4. \uc774\ub294 \uc548\uc815\uc801\uc778 \uae30\ubc18\uc774 \uc544\ub2c8\ub77c \ucde8\uc57d\ud55c \uc9c0\uc9c0\uc120 \ud14c\uc2a4\ud2b8\uc785\ub2c8\ub2e4. 902-903 \uc544\ub798\uc5d0\uc11c \uc885\uac00\uac00 \ud615\uc131\ub418\uba74 \uad6c\uc870\ub294 \u201c\uc9c0\uc9c0\uc120 \uadfc\ucc98\uc758 \uc870\uc815\u201d\uc5d0\uc11c \u201c\uc7a5\uae30 \uc9c0\uc9c0\uc120 \uc774\ud0c8 \uac00\ub2a5\uc131\u201d\uc73c\ub85c \ubc14\ub01d\ub2c8\ub2e4. \uc790\ubcf8 \ubcf4\uc804\uc744 \uc911\uc2dc\ud55c\ub2e4\uba74 \uadf8 \ub9ac\uc2a4\ud06c\uac00 \ud574\uc18c\ub418\uae30 \uc804\uc5d0\ub294 \ub9e4\uc218\ud558\uc9c0 \uc54a\uc544\uc57c \ud569\ub2c8\ub2e4.\n\n\uc800\ub294 \uc57d\ud55c \uae30\uc220\uc801 \ud750\ub984\uc774 \ub354 \uc800\ub834\ud55c \uc9c4\uc785 \uae30\ud68c\ub97c \ub9cc\ub4e0\ub2e4\ub294 \uc774\uc720\ub9cc\uc73c\ub85c \ub9e4\ub825\uc801\uc774\ub77c\ub294 \uc0dd\uac01\uc5d0\ub3c4 \ub3d9\uc758\ud558\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. LLY\ub294 10\uc77c EMA, 50\uc77c SMA, VWMA \uc544\ub798\uc5d0 \uc788\uc2b5\ub2c8\ub2e4. 50\uc77c SMA\ub294 1033.18\uc5d0\uc11c 976.71\ub85c \ud558\ub77d\ud588\uace0, 10\uc77c EMA\ub294 923.23\uae4c\uc9c0 \uaebe\uc600\uc73c\uba70, MACD\ub294 -14.38\ub85c \uc5ec\uc804\ud788 \uc74c\uc218\uc774\uace0, RSI\ub3c4 \uc544\uc9c1 39.85\uc5d0 \ubd88\uacfc\ud569\ub2c8\ub2e4. \uc774\ub294 \ub2e8\uc21c\ud55c \u201c\ud45c\uba74\uc801 \uc57d\uc138\u201d\uac00 \uc544\ub2d9\ub2c8\ub2e4. \ub2e8\uae30 \ubc0f \uc911\uae30 \ucd94\uc138\uac00 \ud6fc\uc190\ub41c \uc0c1\ud0dc\uc785\ub2c8\ub2e4. \uc8fc\uac00\uac00 923-925\ub97c \ud68c\ubcf5\ud558\uace0 \uadf8 \uc704\ub97c \uc720\uc9c0\ud558\uae30 \uc804\uae4c\uc9c0\ub294, \uc2dc\uc7a5\uc740 \uc5ec\uc804\ud788 \ub9e4\ub3c4\uc790\uac00 \ud750\ub984\uc744 \uc7a5\uc545\ud558\uace0 \uc788\ub2e4\uace0 \ub9d0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.\n\n\uacf5\uaca9\uc801 \ubd84\uc11d\uac00\ub294 ATR\uc744 \u201c\uae09\ubc18\ub4f1\uc758 \uc5f0\ub8cc\u201d\ub77c\uace0 \ub9d0\ud569\ub2c8\ub2e4. \uc774\ub294 \ubc18\ub4f1\uc774 \uc2e4\uc81c\ub85c \uc77c\uc5b4\ub0a0 \ub54c\uc5d0\ub9cc \ub9de\ub294 \ub9d0\uc785\ub2c8\ub2e4. \ub9ac\uc2a4\ud06c \uad00\ub9ac \uad00\uc810\uc5d0\uc11c \ub192\uc740 ATR\uc740 \uc6b0\uc120 \ub354 \ub113\uc740 \uc190\uc808\ud3ed, \ub354 \uc791\uc740 \ud3ec\uc9c0\uc158 \uaddc\ubaa8, \ub354 \ud070 \uac2d \ub9ac\uc2a4\ud06c\ub97c \uc758\ubbf8\ud569\ub2c8\ub2e4. \ud575\uc2ec \uc9c0\uc9c0\uc120 \ubd80\uadfc\uc5d0\uc11c 3.1%\uc758 ATR\uc740 \ud729\uc3d8\ub97c \ub2f9\ud558\uac70\ub098 \ube60\ub978 \uc190\uc2e4\uc744 \uacaa\uc744 \ud655\ub960\uc744 \ub192\uc785\ub2c8\ub2e4. \ud2b9\ud788 \uac70\ub798\ub7c9\uc774 \ub9ce\uc740 \uac00\uc6b4\ub370 \uae30\ub85d\ud55c \uc7a5\uc911 \uc800\uc810 888.03\uc740 \uc911\uc694\ud569\ub2c8\ub2e4. \uc8fc\uac00\ub294 \uc774\ubbf8 \uc804\uc220\uc801 \uc2e4\ud328 \uad6c\uac04\uc5d0 \uac00\uae4c\uc6b4 \uc218\uc900\uae4c\uc9c0 \uc2dc\ud5d8\ud588\uc2b5\ub2c8\ub2e4. \uac70\ub798\ub7c9\uc774 \uc804\uc77c 2,360,200\uc5d0\uc11c 4,233,400\uc73c\ub85c \uc99d\uac00\ud55c \uac83\uc740 \uc790\ub3d9\uc801\uc73c\ub85c \uac15\uc138 \uc2e0\ud638\uac00 \uc544\ub2d9\ub2c8\ub2e4. \uc774\ub294 \ubd84\uc0b0 \ub9e4\ub3c4\uc640 \uac15\uc81c \ub9ac\ud3ec\uc9c0\uc154\ub2dd\uc744 \ub098\ud0c0\ub0bc \uc218\ub3c4 \uc788\uc2b5\ub2c8\ub2e4.\n\nFoundayo\uc640 \uad00\ub828\ud574\uc11c\ub294 \uc2ec\ud608\uad00 \ubc0f \uc0ac\ub9dd\ub960 \ub370\uc774\ud130\uac00 \uae0d\uc815\uc801\uc774\ub77c\ub294 \uc810\uc5d0\ub294 \ub3d9\uc758\ud558\uc9c0\ub9cc, \uacf5\uaca9\uc801 \uad00\uc810\uc740 \uaddc\uc81c \ub9ac\uc2a4\ud06c\ub97c \ub108\ubb34 \ube60\ub974\uac8c \ubb34\uc2dc\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \u201c\uc608\uc0c1\uce58 \ubabb\ud55c \uc911\ub300\ud55c\u201d \ub9ac\uc2a4\ud06c \ud3c9\uac00\uc640 \uc5f0\uacb0\ub41c FDA \uc2dc\ud310 \ud6c4 \uc694\uac74\uc740 \uadf8 \uc790\uccb4\ub85c \ud22c\uc790 \ub17c\ub9ac\ub97c \uae68\ub728\ub9ac\ub294 \uc694\uc778\uc740 \uc544\ub2c8\uc9c0\ub9cc, \uadf8\ub807\ub2e4\uace0 \ubb34\uad00\ud55c \uac83\ub3c4 \uc544\ub2d9\ub2c8\ub2e4. \ud504\ub9ac\ubbf8\uc5c4 \uc131\uc7a5 \ubc38\ub958\uc5d0\uc774\uc158\uc744 \ubc1b\uace0 \uc788\ub294 \uc8fc\uc2dd\uc5d0\uc11c\ub294 \ud558\ubc29 \ub9ac\uc2a4\ud06c\uac00 \ubc18\ub4dc\uc2dc \uc644\uc804\ud55c \uc2e4\ud328\ub97c \ud544\uc694\ub85c \ud558\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \uc9c0\uc5f0, \ub354 \uc881\uc740 \uc801\uc751\uc99d, \uc548\uc804\uc131 \ub17c\uc7c1, \ub354 \ubd80\ub2f4\uc2a4\ub7ec\uc6b4 \ubaa8\ub2c8\ud130\ub9c1 \uc694\uac74\ub9cc\uc73c\ub85c\ub3c4 \uba40\ud2f0\ud50c\uc774 \uc555\ucd95\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uae30\ub300\uce58\uac00 \uc774\ubbf8 \ub192\uc740 \uc0c1\ud669\uc5d0\uc11c\ub294 \u201c\uae30\ub300\ub9cc\ud07c \uc644\ubcbd\ud558\uc9c0 \uc54a\ub2e4\u201d\ub294 \uac83\ub9cc\uc73c\ub85c\ub3c4 \ube44\uc6a9\uc774 \ud074 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n\uacf5\uaca9\uc801 \ubd84\uc11d\uac00\ub294 $1300\uacfc $1,200 \uc774\uc0c1\uc758 \ud3c9\uade0 \ubaa9\ud45c\uac00 \uac19\uc740 \uc560\ub110\ub9ac\uc2a4\ud2b8 \ubaa9\ud45c\uac00\uc5d0\ub3c4 \ud06c\uac8c \uc758\uc874\ud569\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uadf8\ub7f0 \ubaa9\ud45c\uac00\ub294 \ub9ac\uc2a4\ud06c \ud1b5\uc81c \uc7a5\uce58\uac00 \uc544\ub2d9\ub2c8\ub2e4. \uadf8\uac83\ub4e4\uc740 \uc9c0\uc18d\uc801\uc778 \uc2e4\ud589, \uc6b0\ud638\uc801\uc778 \uc2b9\uc778, \uc720\uc9c0\ub418\ub294 \uac00\uaca9 \uacb0\uc815\ub825, \uac15\ud55c \uc218\uc694\ub97c \uac00\uc815\ud55c \uc2dc\ub098\ub9ac\uc624 \ucd94\uc815\uce58\uc785\ub2c8\ub2e4. \uc8fc\uac00\uac00 200\uc77c SMA\ub97c \uc783\uac70\ub098, 878.24\ub97c \uc7ac\uc2dc\ud5d8\ud558\uac70\ub098, \uc131\uc7a5 \uae30\ub300\uce58\uac00 \ud558\ud5a5 \uc870\uc815\ub420 \uacbd\uc6b0 \uc6b0\ub9ac\ub97c \ubcf4\ud638\ud574 \uc8fc\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \ubcf4\uc218\uc801 \ud504\ub85c\uc138\uc2a4\ub77c\uba74 \uba3c \ubaa9\ud45c\uac00\ub97c \uae30\uc220\uc801 \ud655\uc778 \uc804 \uc9c4\uc785\uc744 \uc815\ub2f9\ud654\ud558\ub294 \ub370 \uc0ac\uc6a9\ud574\uc11c\ub294 \uc548 \ub429\ub2c8\ub2e4.\n\n\ud380\ub354\uba58\ud138 \uce21\uba74\uc5d0\uc11c \uc131\uc7a5\uc138\ub294 \uc778\uc0c1\uc801\uc774\uc9c0\ub9cc, \ub300\ucc28\ub300\uc870\ud45c\uc640 \ud604\uae08 \uc804\ud658 \ub9ac\uc2a4\ud06c\uac00 \uacfc\uc18c\ud3c9\uac00\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ucd5c\uadfc \ubd84\uae30\uc758 \uc789\uc5ec\ud604\uae08\ud750\ub984\uc740 \ub9e4\uc6b0 \uac15\ud55c \ubcf4\uace0 \uc774\uc775\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 254.2 million\uc5d0 \uadf8\ucce4\uc2b5\ub2c8\ub2e4. Capex\ub294 \uac70\uc758 3.0 billion\uc774\uc5c8\uace0, \ucd1d\ubd80\ucc44\ub294 42.5 billion, \uc21c\ubd80\ucc44\ub294 35.2 billion, \ubd80\ucc44\ube44\uc728\uc740 165.31\uc774\uc5c8\uc2b5\ub2c8\ub2e4. \uacf5\uaca9\uc801 \ubd84\uc11d\uac00\ub294 capex\ub97c \uc804\ub7b5\uc801\uc774\ub77c\uace0 \ubd80\ub974\uba70, \uadf8 \ub9d0\uc774 \ub9de\uc744 \uc218\ub3c4 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc804\ub7b5\uc801 \uc9c0\ucd9c\ub3c4 \uacb0\uad6d \ud604\uae08\uc744 \uc18c\ubaa8\ud569\ub2c8\ub2e4. \uacf5\uae09 \ud655\ub300, \uc778\uc218, \ubc30\ub2f9, \uc790\uc0ac\uc8fc \ub9e4\uc785, \ubd80\ucc44\uac00 \ubaa8\ub450 \uc790\ubcf8\uc744 \ub450\uace0 \uacbd\uc7c1\ud558\ub294 \uac00\uc6b4\ub370 \uc789\uc5ec\ud604\uae08\ud750\ub984\uc774 \uacc4\uc18d \uc587\ub2e4\uba74, \uc7ac\ubb34 \uc720\uc5f0\uc131\uc740 \uc2e4\uc81c \ub9ac\uc2a4\ud06c\uac00 \ub429\ub2c8\ub2e4.\n\nCentessa \uc778\uc218 \ubcf4\ub3c4 \uc5ed\uc2dc \ub099\uad00\ub860\uc5d0 \uc808\uc81c\uac00 \ud544\uc694\ud55c \ubd80\ubd84\uc785\ub2c8\ub2e4. $7.8 billion \uaddc\ubaa8\uc758 \ud30c\uc774\ud504\ub77c\uc778 \uac70\ub798\ub294 \ubbf8\ub798 \uc131\uc7a5\uc744 \ub2e4\ubcc0\ud654\ud560 \uc218 \uc788\uc9c0\ub9cc, \ub3d9\uc2dc\uc5d0 \ud1b5\ud569 \ub9ac\uc2a4\ud06c, \ubc38\ub958\uc5d0\uc774\uc158 \ub9ac\uc2a4\ud06c, \uc784\uc0c1 \uc2e4\ud589 \ub9ac\uc2a4\ud06c\ub97c \ub3c4\uc785\ud569\ub2c8\ub2e4. \uc774\ub97c \u201c\uc804\ub7b5\uc801 \uc120\ud0dd\uad8c\u201d\uc774\ub77c\uace0 \ubd80\ub978\ub2e4\uace0 \ud574\uc11c, \ub808\ubc84\ub9ac\uc9c0\uc640 capex\uac00 \uc774\ubbf8 \ub192\uc740 \uc2dc\uc810\uc5d0 \ud68c\uc0ac\uac00 \ubcf5\uc7a1\uc131\uacfc \uc790\ubcf8 \ud22c\uc785 \ubd80\ub2f4\uc744 \ucd94\uac00\ud558\uace0 \uc788\uc744 \uac00\ub2a5\uc131\uc774 \uc0ac\ub77c\uc9c0\ub294 \uac83\uc740 \uc544\ub2d9\ub2c8\ub2e4.\n\n\uacbd\uc7c1\ub3c4 \ub2e8\uc21c\ud788 \uc2dc\uc7a5 \uaddc\ubaa8\ub97c \uac80\uc99d\ud558\ub294 \uc694\uc18c\ub85c\ub9cc \uce58\ubd80\ud574\uc11c\ub294 \uc548 \ub429\ub2c8\ub2e4. Novo Nordisk, Viking, Kailera \ubc0f \uae30\ud0c0 \uae30\uc5c5\ub4e4\uc740 \uac00\uaca9, \ucc98\ubc29 \uae30\ub300, \uc784\uc0c1\uc2dc\ud5d8 \ube44\uad50, \ud22c\uc790\uc790 \uac00\uc815\uc5d0 \uc555\ubc15\uc744 \uc904 \uc218 \uc788\uc2b5\ub2c8\ub2e4. LLY\ub294 \uc5ec\uc804\ud788 \uc120\ub3c4 \uae30\uc5c5\uc73c\ub85c \ub0a8\uc744 \uc218 \uc788\uc9c0\ub9cc, \uc2dc\uc7a5\uc740 \uc774\ubbf8 \uc120\ub3c4 \uae30\uc5c5 \ud504\ub9ac\ubbf8\uc5c4\uc744 \ubd80\uc5ec\ud588\uc2b5\ub2c8\ub2e4. \uacbd\uc7c1\uc0ac\ub4e4\uc774 \uc778\uc9c0\ub41c \ucc28\ubcc4\ud654\ub97c \uc870\uae08\uc774\ub77c\ub3c4 \uc881\ud78c\ub2e4\uba74, \ubc38\ub958\uc5d0\uc774\uc158 \uc9c0\uc9c0\ub825\uc740 \uc57d\ud574\uc9c8 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n\ub530\ub77c\uc11c \uc81c \uad8c\uace0\ub294 \ud2b8\ub808\uc774\ub354\uc758 WAIT \uc6d0\uce59\uc744 \uc720\uc9c0\ud558\ub418, \ud604\uc7ac\uc758 \uac15\uc138\uc801 \ube44\uc911 \ud655\ub300 \ud45c\ud604\uc774 \uc2dc\uc0ac\ud558\ub294 \uac83\ubcf4\ub2e4 \ub9ac\uc2a4\ud06c \ud0dc\uc138\ub97c \ub354 \ubcf4\uc218\uc801\uc73c\ub85c \uac00\uc838\uac00\ub294 \uac83\uc785\ub2c8\ub2e4. 905\uac00 200\uc77c\uc120 \uadfc\ucc98\ub77c\ub294 \uc774\uc720\ub9cc\uc73c\ub85c \uc2e0\uaddc \uc775\uc2a4\ud3ec\uc800\ub97c \uc2dc\uc791\ud558\uc9c0\ub294 \uc54a\uaca0\uc2b5\ub2c8\ub2e4. \uc800\ub294 923-925 \uc704\uc5d0\uc11c \uc77c\uac04 \uc885\uac00\uac00 \ud615\uc131\ub418\uace0, \uac70\ub798\ub7c9\uc774 \ud3c9\uade0\uc744 \uc6c3\ub3cc\uba70, \uadf8 \ud6c4 \uac00\ub2a5\ud558\uba74 \ud574\ub2f9 \uad6c\uac04\uc744 \uc9c0\uc9c0\uc120\uc73c\ub85c \uc131\uacf5\uc801\uc73c\ub85c \uc7ac\uc2dc\ud5d8\ud558\ub294 \uac83\uc744 \ud655\uc778\ud55c \ub4a4\uc5d0\uc57c \uc808\ubc18 \uaddc\ubaa8 \ud3ec\uc9c0\uc158\uc744 \uc2dc\uc791\ud560 \uc218 \uc788\ub2e4\uace0 \ubd05\ub2c8\ub2e4. \uac00\uaca9\uc774 902-903 \uc544\ub798\uc5d0\uc11c \uc885\uac00\ub97c \ud615\uc131\ud558\uace0 \ube60\ub974\uac8c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud55c\ub2e4\uba74, \uc804\uc220\uc801 \ud3b8\ud5a5\uc740 \u201c\uc804\uac1c \uc911\uc778 \ube44\uc911 \ud655\ub300\u201d\uc5d0\uc11c \u201c\uc790\ubcf8 \ubcf4\uc804\u201d\uc73c\ub85c \uc804\ud658\ub418\uc5b4\uc57c \ud569\ub2c8\ub2e4. 888 \uc544\ub798\ub85c \uc774\ud0c8\ud558\uba74 \ub17c\uc7c1\uc774 \uc544\ub2c8\ub77c \uccad\uc0b0 \ub610\ub294 \ud68c\ud53c\ub97c \ucd09\ubc1c\ud574\uc57c \ud569\ub2c8\ub2e4.\n\n\uc694\uc57d\ud558\uba74, LLY\ub294 \uc5ec\uc804\ud788 \uc911\uae30\uc801\uc73c\ub85c \uac15\ud55c \uae30\uc5c5\uc77c \uc218 \uc788\uc9c0\ub9cc, \ud604\uc7ac\uc758 \uac70\ub798 \uc14b\uc5c5\uc740 \uc544\uc9c1 \uac15\ud558\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \uac00\uc7a5 \uc548\uc804\ud55c \uc870\uc815\uc740 \ub2e8\uae30 \ud589\ub3d9\uc744 \uac15\uc138 \uc900\ube44\uc5d0\uc11c \uc5c4\uaca9\ud55c \uc870\uac74\ubd80 \uad00\ucc30 \ubaa9\ub85d\uc73c\ub85c \ub0ae\ucd94\ub294 \uac83\uc785\ub2c8\ub2e4. \uc9c0\uc9c0\uac00 \uc785\uc99d\ub418\uace0, \ubaa8\uba58\ud140\uc774 \uac1c\uc120\ub418\uba70, \uc8fc\uac00\uac00 923-925\uc758 \uc720\ub3d9\uc131 \ubc0f \ucd94\uc138 \uad6c\uac04\uc744 \ud68c\ubcf5\ud558\uae30 \uc804\uae4c\uc9c0\ub294 \uc2e0\uaddc \uc790\ubcf8\uc744 \ud22c\uc785\ud558\uc9c0 \uc54a\uc544\uc57c \ud569\ub2c8\ub2e4. \ud68c\uc0ac\ub294 \uba3c\uc800 \uc790\ubcf8\uc744 \ubcf4\ud638\ud574\uc57c \ud558\uba70, \uaddc\uc81c, \ubc38\ub958\uc5d0\uc774\uc158, \ud604\uae08\ud750\ub984, \uacbd\uc7c1 \ub9ac\uc2a4\ud06c\uac00 \uc544\uc9c1 \ud574\uc18c\ub418\uc9c0 \uc54a\uc740 \ud558\ub77d \uc911\uc758 \ubcc0\ub3d9\uc131 \ub192\uc740 \uc9c0\uc9c0\uc120 \ud14c\uc2a4\ud2b8\ub97c \ub9e4\uc218\ud558\uae30\ubcf4\ub2e4\ub294, \uc57d\uac04 \ub354 \ub192\uc740 \ud655\uc778\ub41c \uc9c4\uc785\uac00\ub97c \uc9c0\ubd88\ud558\ub294 \ud3b8\uc774 \ub0ab\uc2b5\ub2c8\ub2e4.",
        "neutral_history": "\uc911\ub9bd \ubd84\uc11d\uac00: \uc911\ub9bd\uc801 \uc704\ud5d8 \ubd84\uc11d\uac00\ub85c\uc11c \uc800\ub294 \uc591\ucabd \ubaa8\ub450 \ud0c0\ub2f9\ud55c \uc9c0\uc810\uc744 \uc81c\uc2dc\ud558\uace0 \uc788\uc9c0\ub9cc, \uac01\uc790 \uc120\ud638\ud558\ub294 \ud3b8\ud5a5\uc5d0 \uc9c0\ub098\uce58\uac8c \uae30\uc6b8\uc5b4\uc838 \uc788\ub2e4\uace0 \ubd05\ub2c8\ub2e4. \uacf5\uaca9\uc801 \ubd84\uc11d\uac00\ub294 LLY\uac00 \ub9dd\uac00\uc9c4 \uc0ac\uc5c5\uc774 \uc544\ub2c8\ub77c\uace0 \ubcf4\ub294 \uc810\uc5d0\uc11c \ub9de\uace0, \ubcf4\uc218\uc801 \ubd84\uc11d\uac00\ub294 \uc544\uc9c1 \uae54\ub054\ud55c \ub9e4\ub9e4 \uad6c\uac04\uc774 \uc544\ub2c8\ub77c\uace0 \ubcf4\ub294 \uc810\uc5d0\uc11c \ub9de\uc2b5\ub2c8\ub2e4. \uade0\ud615 \uc7a1\ud78c \uacb0\ub860\uc740 \ud2b8\ub808\uc774\ub354\uc758 \ud604\uc7ac \ube44\uc911 \ud655\ub300, \uc911\uae30 \uac15\uc138 \uad00\uc810\uc740 \uc720\uc9c0\ud560 \uc218 \uc788\uc9c0\ub9cc, \uc9c4\uc785 \ud589\ub3d9\uc740 WAIT\ub85c \uc720\uc9c0\ud558\ub418 \ud6e8\uc52c \ub354 \uaddc\uce59 \uae30\ubc18\uc73c\ub85c \ub9cc\ub4e4\uc5b4\uc57c \ud55c\ub2e4\ub294 \uac83\uc785\ub2c8\ub2e4.\n\n\uba3c\uc800 \uacf5\uaca9\uc801 \uad00\uc810\uc5d0 \ubc18\ub860\uc744 \uc81c\uae30\ud558\uc790\uba74, 200\uc77c SMA \ubd80\uadfc\uc5d0\uc11c \ube44\ub300\uce6d\uc801 \uae30\ud68c\ub77c\uace0 \ubd80\ub974\ub294 \uac83\uc740 \ubd88\uc644\uc804\ud569\ub2c8\ub2e4. \uc8fc\uac00\ub294 \ub2e8\uc21c\ud788 \u201c\uc9c0\uc9c0\uc120 \uadfc\ucc98\u201d\uc5d0 \uc788\ub294 \uac83\uc774 \uc544\ub2c8\ub77c \uac70\uc758 \uadf8 \uc704\uc5d0 \uc62c\ub77c\uc549\uc544 \uc788\uc2b5\ub2c8\ub2e4. \ucd5c\uadfc \ud655\uc778\ub41c \uc885\uac00 905.03\uc740 902-903 \ubd80\uadfc\uc758 200\uc77c SMA\ubcf4\ub2e4 \uc57d\uac04 \ub192\uc744 \ubfd0\uc774\uba70, ATR\uc740 28.13\uc785\ub2c8\ub2e4. \uc774\ub294 \uc815\uc0c1\uc801\uc778 \uc77c\uac04 \ubcc0\ub3d9\uc131\ub9cc\uc73c\ub85c\ub3c4 \uc8fc\uac00\uac00 \uc774\ub978\ubc14 \uc9c0\uc9c0 \uad6c\uac04\uc744 \uc27d\uac8c \ud558\ud5a5 \uc774\ud0c8\ud560 \uc218 \uc788\uc74c\uc744 \uc758\ubbf8\ud569\ub2c8\ub2e4. 902-903\uc744 \uad00\ucc30\ud574\uc57c \ud560 \uc804\uc7a5\uc73c\ub85c \ubcf4\ub294 \uac83\uc740 \uc801\uc808\ud558\uc9c0\ub9cc, \ud655\uc778 \uc804\uc5d0 \uc2e0\uaddc \uc790\ubcf8\uc744 \ud22c\uc785\ud560 \ucda9\ubd84\ud55c \uc774\uc720\ub294 \uc544\ub2d9\ub2c8\ub2e4. \uc9c0\uc9c0\uc120 \uc2dc\ud5d8\uc740 \uc2dc\uc7a5\uc774 \ub9e4\uc218\uc790\ub4e4\uc774 \uc774\ub97c \ubc29\uc5b4\ud560 \uc218 \uc788\uc74c\uc744 \uc99d\uba85\ud55c \ub4a4\uc5d0\uc57c \ud22c\uc790 \uac00\ub2a5\ud55c \uc2e0\ud638\uac00 \ub429\ub2c8\ub2e4.\n\n\uacf5\uaca9\uc801 \ubd84\uc11d\uac00\ub294 \uc870\uae30 \uc9c4\uc785\uc758 \uac00\uce58\ub3c4 \uacfc\ub300\ud3c9\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubb3c\ub860 RSI\ub294 \uacfc\ub9e4\ub3c4 \uc218\uc900\uc5d0\uc11c \ud68c\ubcf5\ud588\uace0 MACD\ub3c4 \ucd5c\uc545\uc758 \uc218\uce58\uc5d0\uc11c \uac1c\uc120\ub410\uc9c0\ub9cc, RSI 39.85\ub294 \uc5ec\uc804\ud788 50 \uc544\ub798\uc774\uace0, MACD\ub294 -14.38\ub85c \uc5ec\uc804\ud788 \uc74c\uc218\uc774\uba70, MACD \ud788\uc2a4\ud1a0\uadf8\ub7a8\uc740 8.42\uc5d0\uc11c 1.75\ub85c \uc2dd\uc5c8\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ud558\ub77d \ubaa8\uba58\ud140\uc774 \uac1c\uc120\ub418\uace0 \uc788\ub2e4\ub294 \ub73b\uc774\uc9c0, \uc0c1\uc2b9 \ubaa8\uba58\ud140\uc774 \ud655\uc778\ub410\ub2e4\ub294 \ub73b\uc740 \uc544\ub2d9\ub2c8\ub2e4. \u201c\ub9e4\ub3c4 \uc555\ub825\uc774 \uc57d\ud574\uc9c0\uace0 \uc788\ub2e4\u201d\uc640 \u201c\ub9e4\uc218\uc790\uac00 \uc8fc\ub3c4\uad8c\uc744 \uc7a1\uc558\ub2e4\u201d \uc0ac\uc774\uc5d0\ub294 \ucc28\uc774\uac00 \uc788\uc2b5\ub2c8\ub2e4. 923-925 \uad6c\uac04\uc774 \uc911\uc694\ud55c \uc774\uc720\ub294 \ubc14\ub85c \uc774 \uad6c\uac04\uc774 10\uc77c EMA \ubc0f VWMA \uc601\uc5ed\uacfc \uacb9\uce58\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. LLY\uac00 \uc2e0\ub8b0\ud560 \ub9cc\ud55c \uac70\ub798\ub7c9\uc744 \ub3d9\ubc18\ud574 \uc774 \uad6c\uac04 \uc704\uc5d0\uc11c \uc885\uac00\ub97c \ud615\uc131\ud558\uae30 \uc804\uae4c\uc9c0, \uacf5\uaca9\uc801 \ub17c\ub9ac\ub294 \uae30\ub300\uc5d0 \uc9c0\ub098\uce58\uac8c \uc758\uc874\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.\n\n\uc560\ub110\ub9ac\uc2a4\ud2b8 \ubaa9\ud45c\uac00\ub97c \uacf5\uaca9\uc801\uc73c\ub85c \ud65c\uc6a9\ud558\ub294 \uc810\uc5d0\ub3c4 \ubc18\ubc15\ud558\uace0 \uc2f6\uc2b5\ub2c8\ub2e4. BMO\uc758 \ubaa9\ud45c\uac00 1300\uacfc 1200\uc744 \ub118\ub294 \ud3c9\uade0 \ubaa9\ud45c\uac00\ub294 \uc7a5\uae30 \uc11c\uc0ac\ub97c \ub4b7\ubc1b\uce68\ud558\uc9c0\ub9cc, \ub2e8\uae30 \ub9ac\uc2a4\ud06c\ub97c \uc815\uc758\ud558\uc9c0\ub294 \uc54a\uc2b5\ub2c8\ub2e4. \uadf8\uac83\ub4e4\uc740 200\uc77c SMA \uc2dc\ud5d8 \uc2e4\ud328, 888\ub85c\uc758 \uc7ac\ud558\ub77d, \ub610\ub294 878.24 \uc7ac\uc2dc\ud5d8\uae4c\uc9c0\ub3c4 \ub9c9\uc544\uc8fc\uc9c0 \ubabb\ud569\ub2c8\ub2e4. \ubaa9\ud45c\uac00\ub294 \ud22c\uc790 \ub17c\ub9ac\uac00 \uc791\ub3d9\ud560 \uacbd\uc6b0\uc758 \uc0c1\uc2b9 \uc5ec\ub825\uc744 \uac00\ub2a0\ud558\ub294 \ub370 \uc720\uc6a9\ud558\uc9c0\ub9cc, \uc9c4\uc785 \uaddc\uc728\uc744 \ub300\uccb4\ud560 \uc218\ub294 \uc5c6\uc2b5\ub2c8\ub2e4.\n\n\ud380\ub354\uba58\ud138 \uce21\uba74\uc5d0\uc11c \uacf5\uaca9\uc801 \ubd84\uc11d\uac00\ub294 CAPEX\uac00 \ubcf8\uc9c8\uc801\uc73c\ub85c \ub098\uc05c \uac83\uc740 \uc544\ub2c8\ub77c\ub294 \uc810\uc5d0\uc11c \ub9de\uc2b5\ub2c8\ub2e4. LLY\ub294 \uc608\uc678\uc801\uc778 \uc218\uc694\ub97c \ub4b7\ubc1b\uce68\ud558\uae30 \uc704\ud574 \ud22c\uc790\ud558\uace0 \uc788\uc73c\uba70, \uc131\uc7a5 \ud504\ub85c\ud544\ub3c4 \uc778\uc0c1\uc801\uc785\ub2c8\ub2e4. \ubd84\uae30 \ub9e4\ucd9c\uc740 2025\ub144 \ub3d9\uc548 \uc99d\uac00\ud588\uace0, \uc601\uc5c5\uc774\uc775\uc740 8.9874 billion\uc5d0 \ub3c4\ub2ec\ud588\uc73c\uba70, \ud76c\uc11d EPS\ub294 7.39\ub85c \uc0c1\uc2b9\ud588\uace0, \ub9c8\uc9c4\uc740 \uc5ec\uc804\ud788 \ucd5c\uc0c1\uc704 \uc218\uc900\uc785\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uacf5\uaca9\uc801 \uce21\uc740 \uc57d\ud55c \uc789\uc5ec\ud604\uae08\ud750\ub984\uc744 \ub108\ubb34 \uc27d\uac8c \uc815\ub2f9\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ucd5c\uadfc \ubd84\uae30 \uc789\uc5ec\ud604\uae08\ud750\ub984\uc774 \uac70\uc758 3.0 billion\uc758 CAPEX \ub300\ube44 254.2 million\uc5d0 \ubd88\uacfc\ud558\uace0, \ucd1d\ubd80\ucc44\uac00 42.5 billion, \uc21c\ubd80\ucc44\uac00 35.2 billion\uc774\ub77c\ub294 \uc810\uc740 \uc2e4\ud589\ub825\uc774 \uacc4\uc18d \ub9e4\uc6b0 \uac15\ud574\uc57c \ud568\uc744 \ub73b\ud569\ub2c8\ub2e4. \uc804\ub7b5\uc801 \ud22c\uc790\ub77c \ud574\ub3c4 \ud604\uae08 \uc804\ud658\uc774 \ub4a4\ucc98\uc9c0\uac70\ub098, \uc6b4\uc804\uc790\ubcf8\uc774 \ub108\ubb34 \ub9ce\uc740 \uc790\ubcf8\uc744 \ud761\uc218\ud558\uac70\ub098, \uc778\uc218\uac00 \ubcf5\uc7a1\uc131\uc744 \ub354\ud558\uba74 \uc8fc\uac00 \ub9ac\uc2a4\ud06c\uac00 \ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.\n\n\uc774\uc81c \ubcf4\uc218\uc801 \uad00\uc810\uc5d0 \ubc18\ub860\uc744 \uc81c\uae30\ud558\uaca0\uc2b5\ub2c8\ub2e4. \uc800\ub294 \uc2e0\uc911\ub860\uc5d0\ub294 \ub3d9\uc758\ud558\uc9c0\ub9cc, \ubcf4\uc218\uc801 \ubd84\uc11d\uac00\ub294 \uc870\uac74\ubd80 \uae30\ud68c\ub97c \uc9c0\ub098\uce58\uac8c \ubc29\uc5b4\uc801\uc778 \uad00\ub9dd \ubaa9\ub85d\uc73c\ub85c \ubc14\uafd4\ubc84\ub9b4 \uc704\ud5d8\uc774 \uc788\ub2e4\uace0 \ubd05\ub2c8\ub2e4. LLY\uc758 \ud380\ub354\uba58\ud138\uc740 \uc21c\uc218\ud55c \ud68c\ud53c \uc785\uc7a5\uc774 \uc554\uc2dc\ud558\ub294 \ubc29\uc2dd\uc73c\ub85c \uc545\ud654\ub418\uace0 \uc788\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \ub9e4\ucd9c \uc131\uc7a5, \uc601\uc5c5\uc774\uc775\ub960, EPS \ud655\ub300, \uadf8\ub9ac\uace0 \uc120\ud589 \ubc38\ub958\uc5d0\uc774\uc158 \uc9c0\uc9c0\ub294 \uc5ec\uc804\ud788 \uac15\ud569\ub2c8\ub2e4. \uc57d 21.47\uc758 \uc120\ud589 PE\uc640 0.98 \ubd80\uadfc\uc758 PEG\ub294 \ubd80\uc2e4 \uac00\uce58\uc8fc \uc9c0\ud45c\ub294 \uc544\ub2c8\uc9c0\ub9cc, \uc131\uc7a5 \ucd94\uc815\uce58\uac00 \uc720\uc9c0\ub41c\ub2e4\uba74 \ud604\uc7ac\uc758 \uc870\uc815\uc774 \uba85\ubc31\ud788 \ube44\ud569\ub9ac\uc801\uc774\uc9c0\ub294 \uc54a\uc74c\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.\n\n\ubcf4\uc218\uc801 \ubd84\uc11d\uac00\uac00 FDA \uc2dc\ud310 \ud6c4 \uc694\uad6c\uc0ac\ud56d\uc744 \uac15\uc870\ud55c \uac83\ub3c4 \ub9de\uc9c0\ub9cc, \uc774\ub97c \uc2ec\uac01\ud55c \ubd80\uc815\uc801 \uc784\uc0c1 \uc2e0\ud638\uc640 \ub3d9\ub4f1\ud558\uac8c \ucde8\uae09\ud574\uc11c\ub294 \uc548 \ub429\ub2c8\ub2e4. Foundayo \ub370\uc774\ud130\ub294 \uc758\ubbf8 \uc788\uac8c \uae0d\uc815\uc801\uc778 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4. \uc2ec\ud608\uad00 \ubc0f \uc0ac\ub9dd\ub960 \uacb0\uacfc\uac00 \uac1c\uc120\ub410\uace0, \ubcf4\uace0\uc11c\ub294 \uc0ac\ub9dd \uc704\ud5d8 57% \uac10\uc18c\ub97c \uc5b8\uae09\ud588\uc73c\uba70, \uac04 \uc548\uc804\uc131 \uc2e0\ud638\ub294 \ub098\ud0c0\ub098\uc9c0 \uc54a\uc558\uc2b5\ub2c8\ub2e4. \uc62c\ubc14\ub978 \uc911\ub9bd\uc801 \ud574\uc11d\uc740 \u201c\uaddc\uc81c \ub9ac\uc2a4\ud06c\ub97c \ubb34\uc2dc\ud558\ub77c\u201d\ub3c4 \uc544\ub2c8\uace0 \u201c\uadf8 \ub9ac\uc2a4\ud06c\ub97c \ud22c\uc790 \ub17c\ub9ac \ud6fc\uc190 \uc694\uc778\uc73c\ub85c \ubcf4\ub77c\u201d\ub3c4 \uc544\ub2d9\ub2c8\ub2e4. \ud575\uc2ec\uc740 \ucd09\ub9e4\ub294 \uc2e4\uc81c\ub85c \uc874\uc7ac\ud558\uc9c0\ub9cc, \uc2dc\uc7a5\uc774 \uc774\ub97c \uc644\uc804\ud788 \ubc18\uc601\ud558\uae30 \uc804\uae4c\uc9c0\ub294 \ub77c\ubca8, \uc2dc\uae30, \uc2dc\ud310 \ud6c4 \uc694\uad6c \ubc94\uc704, \uc758\uc0ac\ub4e4\uc758 \ucc44\ud0dd \uc5ec\ubd80\uac00 \uc544\uc9c1 \ud655\uc778\ub418\uc5b4\uc57c \ud55c\ub2e4\ub294 \uac83\uc785\ub2c8\ub2e4.\n\n\uacbd\uc7c1\uc5d0 \ub300\ud55c \ubcf4\uc218\uc801 \ud574\uc11d\uc5d0\ub3c4 \uade0\ud615\uc774 \ud544\uc694\ud569\ub2c8\ub2e4. Novo Nordisk, Viking, Kailera \ub4f1\uc740 \uac00\uaca9 \uacb0\uc815\ub825\uacfc \uc2dc\uc7a5\uc810\uc720\uc728 \uae30\ub300\uc5d0 \uc2e4\uc9c8\uc801\uc778 \uc704\ud611\uc774\uc9c0\ub9cc, \ube44\ub9cc \ubc0f \ub2f9\ub1e8 \uc2dc\uc7a5\uc758 \uaddc\ubaa8\ub294 \uc5ec\ub7ec \ub300\ud615 \uc2b9\uc790\ub97c \uc218\uc6a9\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uacbd\uc7c1\uc740 \ud655\uc2e4\uc131\uc744 \ub0ae\ucd94\uc9c0\ub9cc, LLY\uc758 \ub9ac\ub354\uc2ed, \uc81c\uc870 \uaddc\ubaa8, \ube0c\ub79c\ub4dc \ud30c\uc6cc, \uc784\uc0c1 \ubaa8\uba58\ud140\uc744 \uc9c0\uc6cc\ubc84\ub9ac\uc9c0\ub294 \uc54a\uc2b5\ub2c8\ub2e4. \uc628\uac74\ud55c \uc804\ub7b5\uc740 LLY\uac00 \ud504\ub9ac\ubbf8\uc5c4\uc744 \ubc1b\uc744 \uc790\uaca9\uc774 \uc788\uc74c\uc744 \uc778\uc815\ud558\ub418, \uc5b4\ub5a4 \uac00\uaca9\uc774\ub4e0 \uc9c0\ubd88\ud558\uac70\ub098 \uae30\uc220\uc801 \ubd88\uc548\uc815 \uad6c\uac04\uc5d0\uc11c \uc9c4\uc785\ud558\ub294 \uac83\uc740 \uac70\ubd80\ud574\uc57c \ud569\ub2c8\ub2e4.\n\n\ub530\ub77c\uc11c \ud2b8\ub808\uc774\ub354\uc758 \uacc4\ud68d\uc5d0 \ub300\ud55c \uc81c \uc870\uc815\uc740 \uadf9\uc801\uc774\uae30\ubcf4\ub2e4 \uc644\ub9cc\ud574\uc57c \ud569\ub2c8\ub2e4. \uc911\uae30 \ube44\uc911 \ud655\ub300 \ud6c4\ubcf4 \uc9c0\uc704\ub294 \uc720\uc9c0\ud558\ub418, \ud3ec\ud2b8\ud3f4\ub9ac\uc624 \uad00\uc810\uc740 \uc2e4\ud589 \uce21\uba74\uc5d0\uc11c \uad11\ubc94\uc704\ud55c \uac15\uc138\uac00 \uc544\ub2c8\ub77c \u201c\uac74\uc124\uc801\uc774\uc9c0\ub9cc \uc870\uac74\ubd80\u201d\ub85c \uc124\uc815\ud574\uc57c \ud569\ub2c8\ub2e4. \uc8fc\uac00\uac00 200\uc77c SMA \uadfc\ucc98\uc5d0 \uc788\ub2e4\ub294 \uc774\uc720\ub9cc\uc73c\ub85c 905\uc5d0\uc11c \ucd94\uac00 \ub9e4\uc218\ud574\uc11c\ub294 \uc548 \ub429\ub2c8\ub2e4. \ub354 \ub098\uc740 \uccab \ubc88\uc9f8 \ud2b8\ub9ac\uac70\ub294 \uc5ec\uc804\ud788 \ucd5c\uadfc \ud3c9\uade0\uc744 \uc6c3\ub3c4\ub294 \uac70\ub798\ub7c9\uc744 \ub3d9\ubc18\ud55c 923-925 \uc0c1\ud5a5 \uc885\uac00\uc785\ub2c8\ub2e4. \uc774\ub294 \ub2e8\uae30 \ucd94\uc138 \uc601\uc5ed\uacfc VWMA \uad6c\uac04\uc744 \ubaa8\ub450 \ud68c\ubcf5\ud588\ub2e4\ub294 \uc758\ubbf8\uac00 \ub418\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \uadf8 \uacbd\uc6b0\uc5d0\ub3c4 \ucd5c\ub300 \uc808\ubc18 \uaddc\ubaa8\uc758 \ud3ec\uc9c0\uc158\uc73c\ub85c \uc2dc\uc791\ud574\uc57c \ud569\ub2c8\ub2e4.\n\n\ub610\ud55c \ub450 \uac00\uc9c0 \uac00\ub2a5\ud55c \uc9c4\uc785 \uacbd\ub85c\ub97c \ubd84\ub9ac\ud558\uaca0\uc2b5\ub2c8\ub2e4. \ub354 \uac15\ud55c \uacbd\ub85c\ub294 923-925 \uc704\uc5d0\uc11c \uc885\uac00\ub97c \ud615\uc131\ud55c \ub4a4, 939-955\ub85c\uc758 \ucd94\uac00 \uc0c1\uc2b9\uc774 \uc774\uc5b4\uc9c0\uac70\ub098 923-925\ub97c \uc9c0\uc9c0\uc120\uc73c\ub85c \uc131\uacf5\uc801\uc73c\ub85c \uc7ac\uc2dc\ud5d8\ud558\ub294 \uac83\uc785\ub2c8\ub2e4. \ub354 \uae30\ud68c\uc8fc\uc758\uc801\uc778 \uacbd\ub85c\ub294 902-903 \ubc29\uc5b4\uc774\uc9c0\ub9cc, \uac00\uaca9\uc774 \ub354 \ub192\uc740 \uc800\uc810\uc744 \ud615\uc131\ud558\uace0 \ubaa8\uba58\ud140\uc774 \uac1c\uc120\ub420 \ub54c\uc5d0\ub9cc \uac00\ub2a5\ud569\ub2c8\ub2e4. 200\uc77c SMA\uac00 \uac00\uae4c\uc774 \uc788\ub2e4\ub294 \uc774\uc720\ub9cc\uc73c\ub85c \ub9e4\uc218\ud558\ub294 \uac83\uc740 \uc9c0\ub098\uce58\uac8c \uacf5\uaca9\uc801\uc785\ub2c8\ub2e4. LLY\uac00 902-903 \uc544\ub798\uc5d0\uc11c \uc885\uac00\ub97c \ub0b4\uace0 \uc774\ub97c \ube60\ub974\uac8c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud55c\ub2e4\uba74, \uc124\uc815\uc740 \u201c\uc9c4\ud589 \uc911\uc778 \ube44\uc911 \ud655\ub300\u201d\uc5d0\uc11c \u201c\uad00\ucc30 \uc804\uc6a9\u201d\uc73c\ub85c \ubc14\ub00c\uc5b4\uc57c \ud569\ub2c8\ub2e4. \uac70\ub798\ub7c9 \uc99d\uac00\uc640 \ud568\uaed8 888\uc744 \uc774\ud0c8\ud55c\ub2e4\uba74 \uc804\uc220\uc801 \ub178\ucd9c\uc740 \ud53c\ud558\uac70\ub098 \uccad\uc0b0\ud574\uc57c \ud569\ub2c8\ub2e4.\n\n\ud3ec\uc9c0\uc158 \uaddc\ubaa8\ub294 \ubd88\uc548\uc815\ud55c \uad6d\uba74\uc744 \ubc18\uc601\ud574\uc57c \ud569\ub2c8\ub2e4. ATR\uc740 \uac00\uaca9\uc758 \uc57d 3.1%\uc774\ubbc0\ub85c, \ud0c0\uc774\ud2b8\ud55c \uc190\uc808\uc744 \ub454 \uc815\uc0c1 \uaddc\ubaa8 \ud3ec\uc9c0\uc158\uc740 \ubcc0\ub3d9\uc131\uacfc \uc798 \ub9de\uc9c0 \uc54a\uc2b5\ub2c8\ub2e4. \uade0\ud615 \uc7a1\ud78c \uc811\uadfc\uc740 \ub354 \uc791\uc740 \ucd08\uae30 \uaddc\ubaa8, ATR\uc744 \uace0\ub824\ud55c \uc190\uc808, \uadf8\ub9ac\uace0 939-955 \uc704 \ud655\uc778 \uc774\ud6c4 \ub610\ub294 \uac74\uc124\uc801\uc778 \uc7ac\uc2dc\ud5d8 \uc774\ud6c4\uc758 \ub2e8\uacc4\uc801 \ucd94\uac00 \ub9e4\uc218\ub97c \uc0ac\uc6a9\ud558\ub294 \uac83\uc785\ub2c8\ub2e4. \ud2b8\ub808\uc774\ub354\ub294 \ud5e4\ub4dc\ub77c\uc778 \uc8fc\ub3c4 \ub7a0\ub9ac\ub97c \ucd94\uaca9\ud574\uc11c\ub294 \uc548 \ub418\uc9c0\ub9cc, \uac1c\uc120\uc744 \uc778\uc815\ud558\uae30 \uc804\uc5d0 976-979 \ubd80\uadfc\uc758 50\uc77c SMA\uae4c\uc9c0 \uc644\ubcbd\ud55c \ud655\uc778\uc744 \uc694\uad6c\ud574\uc11c\ub3c4 \uc548 \ub429\ub2c8\ub2e4.\n\n\uc81c \ucd5c\uc885 \uc785\uc7a5\uc740 \ud2b8\ub808\uc774\ub354\uc758 \uc6d0\ub798 \uacb0\uc815\uc774 \ub300\uccb4\ub85c \ud0c0\ub2f9\ud558\uc9c0\ub9cc, \uac15\uc870\uc810\uc740 \uc870\uc815\ub418\uc5b4\uc57c \ud55c\ub2e4\ub294 \uac83\uc785\ub2c8\ub2e4. LLY\ub294 \uc2e4\uc81c \uc784\uc0c1 \ubc0f \uc2e4\uc801 \ucd09\ub9e4\ub97c \uac00\uc9c4 \uace0\ud488\uc9c8 \uc131\uc7a5 \ub9ac\ub354\ub85c \ub0a8\uc544 \uc788\uc73c\ubbc0\ub85c, \uad81\uadf9\uc801\uc778 OVERWEIGHT\ub294 \ud569\ub9ac\uc801\uc785\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc2dc\uc7a5 \uad6d\uba74\uc740 \uc544\uc9c1 \ud655\uc778\ub41c \ud68c\ubcf5\uc774 \uc544\ub2c8\ub77c \uace0\ubcc0\ub3d9\uc131 \ud558\ub77d \uc870\uc815\uc785\ub2c8\ub2e4. \uac00\uc7a5 \uc9c0\uc18d \uac00\ub2a5\ud55c \uc804\ub7b5\uc740 LLY\ub97c \ube44\uc911 \ud655\ub300 \uad00\ucc30 \ubaa9\ub85d\uc5d0 \uc720\uc9c0\ud558\uace0, 923-925 \uc704 \ud655\uc778 \ub610\ub294 \uba85\ud655\ud788 \ubc29\uc5b4\ub41c 902-903 \uc9c0\uc9c0 \uad6c\uc870\ub97c \uc694\uad6c\ud558\uba70, \uccab \uc9c4\uc785 \uaddc\ubaa8\ub97c \ubcf4\uc218\uc801\uc73c\ub85c \uc124\uc815\ud558\uace0, 888\uc744 \uac15\ud55c \uc804\uc220\uc801 \uc2e4\ud328 \uc218\uc900\uc73c\ub85c \ucde8\uae09\ud558\ub294 \uac83\uc785\ub2c8\ub2e4. \uc774\ub294 Foundayo\uac00 \uc8fc\ub3c4\ud558\ub294 \ud68c\ubcf5\uc774 \ud798\uc744 \uc5bb\uc744 \uacbd\uc6b0 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\uac00 \ucc38\uc5ec\ud560 \uc218 \uc788\uac8c \ud558\uba74\uc11c\ub3c4, \ud655\uc778\ub418\uc9c0 \uc54a\uc740 \uc9c0\uc9c0\uc120 \uc2dc\ud5d8\uc744 \ub9e4\uc218\ud558\ub294 \uacf5\uaca9\uc801 \uc2e4\uc218\uc640 \ud380\ub354\uba58\ud138\uc774 \uac15\ud55c \ubc18\ub4f1 \ud6c4\ubcf4\ub97c \ub108\ubb34 \uc77c\ucc0d \ubc30\uc81c\ud558\ub294 \ubcf4\uc218\uc801 \uc2e4\uc218\ub97c \ubaa8\ub450 \ud53c\ud558\uac8c \ud574\uc90d\ub2c8\ub2e4.",
        "history": "\nAggressive Analyst: I support the trader\u2019s OVERWEIGHT and bullish medium-term stance, and I would argue the only thing too cautious here is the WAIT posture. The setup is developing, but the risk-reward is exactly the kind of asymmetric opportunity aggressive capital should be preparing to exploit: LLY is sitting near its rising 200-day moving average around 902-903 after a sentiment-positive clinical catalyst, with a forward PE near 21.5 and PEG below 1.0 for a company still compounding revenue, margins, and EPS at exceptional rates.\n\nIf the conservative analyst\u2019s objection is that the chart is weak, I agree only on the surface. Yes, the stock is below the 10-day EMA, 50-day SMA, VWMA, and MACD remains negative. But that is precisely why the opportunity exists. A clean, obvious uptrend would not offer this entry window. The 200-day SMA has continued rising from 887.62 to 902.63, and the latest close near 905.03 means LLY is testing long-term trend support, not breaking down in a confirmed way. A high-quality growth leader pulling back into long-term support after a major clinical narrative improvement is not a reason to hide; it is a reason to get ready before the crowd demands confirmation at higher prices.\n\nIf the conservative view emphasizes the 888 downside risk and elevated ATR, that is a risk-control point, not a bearish thesis. ATR at 28.13, about 3.1% of price, means position sizing must be intelligent, but volatility is also the fuel for a sharp rebound. From the 905 area, reclaiming 923-925 would quickly put the stock back above the 10-day EMA and VWMA, opening a move toward 939-955. Beyond that, a repair toward 976-979 would represent meaningful upside before even discussing the analyst target framework. The BMO target of $1300 and average target around $1,224.59 show that the market\u2019s informed upside case remains far above the current price.\n\nIf the conservative analyst argues the Foundayo FDA post-marketing requirement is a major red flag, I think that is overstated. The available sentiment data says the dominant update was positive: Foundayo showed cardiovascular benefit characteristics, no liver safety signal, and a reported 57% reduction in mortality risk. Post-marketing surveillance is not the same thing as a failed safety profile. In a massive diabetes and obesity market, regulators asking for continued monitoring does not erase the commercial significance of mortality and cardiovascular data. Conservative analysis often treats regulatory uncertainty as a reason to discount the upside too heavily; aggressive analysis recognizes that if labeling and uptake come through, estimates may need to move higher, not lower.\n\nIf the neutral analyst\u2019s likely point is that the technicals are mixed and therefore the trader should wait for 923-925, that is reasonable as a tactical framework, but too balanced for the opportunity. Neutrality can miss the first leg of a reversal. RSI has already recovered from 29.19 to 39.85, MACD improved from -35.49 to -14.38, and the MACD histogram remains positive at 1.75 despite cooling. That is not a full bull signal yet, but it is evidence that downside momentum has already weakened. Waiting for every indicator to confirm means accepting a worse entry after the highest-conviction buyers have already acted.\n\nOn fundamentals, the bearish caution around free cash flow and debt ignores why those numbers look pressured. Capex near $3B is not waste; it is capacity build-out for extraordinary demand in obesity and diabetes. LLY\u2019s latest revenue trajectory is powerful: quarterly revenue rose from 12.7285B to 15.5577B to 17.6008B to 19.292B through 2025, with operating income reaching 8.9874B and diluted EPS climbing to 7.39. Operating margin of 44.896% and net margin of 31.667% are elite. A company with that margin structure investing heavily into capacity is not simply burning cash; it is scaling a franchise that the market may continue to reward with premium multiples.\n\nThe valuation concern also deserves pushback. A trailing PE near 39 can look expensive in isolation, but the forward PE of 21.47 and PEG of 0.9769 are exactly what aggressive investors want to see: the stock is not cheap because it is mediocre; it is attractively valued relative to growth because earnings are expected to expand sharply. If Foundayo\u2019s label and commercial prospects improve, the denominator in that valuation equation rises. That is where upside surprises come from.\n\nCompetition from Novo Nordisk, Viking, Kailera, and others is real, but it also validates the size of the category. The neutral or conservative camp may frame competition as margin pressure. I frame it as proof that obesity and metabolic medicine remain one of the most valuable therapeutic battlegrounds in the market. LLY already has scale, brand credibility, manufacturing investment, clinical momentum, and analyst support. In winner-take-most or winner-take-large markets, the leader deserves a premium, especially when the narrative just improved.\n\nThe Centessa acquisition report also matters. Critics may see $7.8B as integration risk or spending discipline risk. I see strategic optionality. The biggest knock on LLY is dependence on obesity and diabetes expectations; expanding into neuroscience assets directly addresses that concentration concern. Aggressive investors should reward management for trying to extend the growth runway instead of simply harvesting the current franchise.\n\nSo my stance is clear: the trader\u2019s OVERWEIGHT call is correct, and the bullish portfolio stance is justified. I would respect the proposed trigger discipline around 923-925, 939-955, and 976-979, but I would not let conservative fear dominate the decision. The best path is to treat 902-903 as the battlefield, 888 as the tactical fail line, and 923-925 as the acceleration trigger. This is not a low-risk trade; it is a high-quality growth leader at a volatile inflection point with major clinical, sentiment, and earnings-growth catalysts aligned. That is exactly where aggressive capital should be leaning forward.\nConservative Analyst: I would push back strongly on the aggressive analyst\u2019s framing. The issue is not whether LLY is a high-quality company. It is. The issue is whether this is a low-risk point to add exposure. On the data provided, it is not.\n\nThe aggressive case treats the 200-day moving average near 902-903 as an attractive battlefield. From a conservative risk perspective, that is exactly the problem. The latest confirmed close of 905.03 is only about 2.40 points above the 200-day SMA, while ATR is 28.13. That means the stock is sitting almost directly on long-term support with daily volatility more than ten times the distance to that support line. This is not a stable base; it is a fragile support test. A close below 902-903 would change the structure from \u201cpullback near support\u201d to \u201cpossible long-term support failure.\u201d Preserving capital means we should not buy before that risk is resolved.\n\nI also disagree with the idea that weak technicals are attractive merely because they create a cheaper entry. LLY is below the 10-day EMA, the 50-day SMA, and the VWMA. The 50-day SMA has been falling from 1033.18 to 976.71, the 10-day EMA has rolled down to 923.23, MACD remains negative at -14.38, and RSI is still only 39.85. That is not just \u201csurface weakness.\u201d It is a damaged short- and medium-term trend. Until the stock can reclaim 923-925 and hold it, the market is telling us sellers still control the tape.\n\nThe aggressive analyst says ATR is \u201cfuel for a sharp rebound.\u201d That is true only if the rebound happens. For risk management, elevated ATR first means wider stop requirements, smaller position sizing, and greater gap risk. A 3.1% ATR around a key support level increases the probability of being whipsawed or suffering a fast drawdown. The intraday low of 888.03 on heavy volume is especially important: price already probed close to the tactical failure zone. The rise in volume to 4,233,400 versus 2,360,200 the prior day is not automatically bullish; it can also signal distribution and forced repositioning.\n\nOn Foundayo, I agree the cardiovascular and mortality data are positive, but the aggressive view is too quick to dismiss regulatory risk. FDA post-marketing requirements tied to \u201cunexpected serious\u201d risk evaluation are not thesis-breaking by themselves, but they are not irrelevant. For a stock carrying a premium growth valuation, the downside does not require outright failure. A delay, narrower label, safety debate, or more burdensome monitoring requirement could be enough to compress the multiple. When expectations are already high, \u201cless perfect than hoped\u201d can still be costly.\n\nThe aggressive analyst also leans heavily on analyst targets such as $1300 and average target levels above $1,200. Those targets are not risk controls. They are scenario estimates that assume continued execution, favorable approvals, sustained pricing power, and strong demand. They do not protect us if the stock loses the 200-day SMA, retests 878.24, or if growth expectations are revised down. A conservative process should not use distant price targets to justify entering before technical confirmation.\n\nOn fundamentals, the growth is impressive, but the balance sheet and cash conversion risks are being underweighted. Free cash flow was only 254.2 million in the latest quarter despite very strong reported earnings. Capex was nearly 3.0 billion, total debt was 42.5 billion, net debt was 35.2 billion, and debt-to-equity was 165.31. The aggressive analyst calls capex strategic, and that may be right, but strategic spending still consumes cash. If supply expansion, acquisitions, dividends, buybacks, and debt all compete for capital while free cash flow remains thin, financial flexibility becomes a real risk.\n\nThe Centessa acquisition report is another place where optimism needs discipline. A $7.8 billion pipeline deal may diversify future growth, but it also introduces integration risk, valuation risk, and clinical execution risk. Calling it \u201cstrategic optionality\u201d does not remove the possibility that the firm is adding complexity and capital commitments at a time when leverage and capex are already elevated.\n\nCompetition should also not be dismissed as merely validating the market size. Novo Nordisk, Viking, Kailera, and others can pressure pricing, prescribing expectations, trial comparisons, and investor assumptions. LLY may remain a leader, but the market has already awarded it a leader\u2019s premium. If competitors narrow perceived differentiation, even modestly, the valuation support can weaken.\n\nSo my recommendation is to keep the trader\u2019s WAIT discipline, but make the risk posture more conservative than the current bullish overweight language implies. I would not initiate new exposure at 905 simply because it is near the 200-day line. I would require a daily close above 923-925 on above-average volume, then preferably a successful retest of that zone as support before even starting a half-sized position. If price closes below 902-903 and fails to reclaim it quickly, the tactical bias should shift from \u201cdeveloping overweight\u201d to \u201ccapital preservation.\u201d A break below 888 should trigger exit or avoidance, not debate.\n\nIn short, LLY may still be a strong medium-term company, but the current trade setup is not yet strong. The safest adjustment is to downgrade the near-term action from bullish preparation to strict conditional watchlist: no new capital until support is proven, momentum improves, and the stock reclaims the 923-925 liquidity and trend zone. The firm should protect capital first and pay a slightly higher confirmed entry price rather than buy a falling, volatile support test with regulatory, valuation, cash-flow, and competitive risks still unresolved.\nNeutral Analyst: As the Neutral Risk Analyst, I think both sides are making valid points, but each is leaning too far into its preferred bias. The aggressive analyst is right that LLY is not a broken business, and the conservative analyst is right that this is not yet a clean trade. The balanced conclusion is that the trader\u2019s current OVERWEIGHT, bullish medium-term stance can remain intact, but the WAIT entry action should be preserved and made even more rules-based.\n\nTo challenge the aggressive view first: calling this an asymmetric opportunity near the 200-day SMA is incomplete. The stock is not simply \u201cnear support\u201d; it is almost sitting on it. The latest confirmed close of 905.03 is only slightly above the 200-day SMA near 902-903, while ATR is 28.13. That means normal daily volatility can easily push the stock through the supposed support zone. Treating 902-903 as a battlefield is acceptable for monitoring, but not enough reason to deploy new capital before confirmation. A support test becomes investable only after the market proves buyers can defend it.\n\nThe aggressive analyst also overstates the value of being early. Yes, RSI has recovered from oversold levels and MACD has improved from its worst reading, but RSI at 39.85 is still below 50, MACD remains negative at -14.38, and the MACD histogram has cooled from 8.42 to 1.75. That is improving downside momentum, not confirmed upside momentum. There is a difference between \u201cselling pressure is fading\u201d and \u201cbuyers are in control.\u201d The 923-925 zone matters precisely because it overlaps the 10-day EMA and VWMA area. Until LLY can close above that zone with credible volume, the aggressive argument is relying too much on anticipation.\n\nI would also push back on the aggressive use of analyst targets. A BMO target of 1300 and average targets above 1200 are supportive of the long-term narrative, but they do not define near-term risk. They do not prevent a failed 200-day SMA test, a move back to 888, or even a retest of 878.24. Price targets are useful for framing upside if the thesis works; they are not a substitute for entry discipline.\n\nOn fundamentals, the aggressive analyst is right that capex is not inherently bad. LLY is investing behind exceptional demand, and the growth profile is impressive: quarterly revenue rose through 2025, operating income reached 8.9874 billion, diluted EPS climbed to 7.39, and margins remain elite. But the aggressive side is too quick to excuse weak free cash flow. Latest-quarter free cash flow of only 254.2 million against nearly 3.0 billion of capex, total debt of 42.5 billion, and net debt of 35.2 billion means execution must stay very strong. Strategic investment can still become a stock risk if cash conversion lags, working capital absorbs too much capital, or acquisitions add complexity.\n\nNow to challenge the conservative view: I agree with the caution, but I think the conservative analyst risks turning a conditional opportunity into an overly defensive watchlist. LLY\u2019s fundamentals are not deteriorating in the way a pure avoidance stance would imply. Revenue growth, operating margin, EPS expansion, and forward valuation support remain strong. A forward PE around 21.47 and PEG near 0.98 are not distressed-value metrics, but they do suggest the current pullback is not obviously irrational if growth estimates hold.\n\nThe conservative analyst is also right to highlight the FDA post-marketing requirement, but that should not be treated as equivalent to a serious negative clinical signal. The Foundayo data appear meaningfully positive: cardiovascular and mortality outcomes improved, the report referenced a 57% reduction in mortality risk, and no liver safety signal was noted. The right neutral interpretation is not \u201cignore regulatory risk\u201d and not \u201ctreat the risk as thesis-breaking.\u201d It is: the catalyst is real, but the label, timing, post-marketing scope, and physician uptake still need confirmation before the market assigns full credit.\n\nThe conservative framing of competition also needs balance. Novo Nordisk, Viking, Kailera, and others are real threats to pricing power and market-share expectations, but the size of the obesity and diabetes market can support multiple large winners. Competition reduces certainty; it does not erase LLY\u2019s leadership, manufacturing scale, brand strength, and clinical momentum. A moderate strategy should acknowledge that LLY deserves a premium, while refusing to pay any price or enter during technical instability.\n\nSo my adjustment to the trader\u2019s plan would be modest, not dramatic. Keep the medium-term OVERWEIGHT candidate status, but make the portfolio stance \u201cconstructive but conditional\u201d rather than broadly bullish in execution. Do not add at 905 simply because the stock is near the 200-day SMA. The better first trigger remains a daily close above 923-925 with volume above recent average, because that would reclaim both the short-term trend area and the VWMA region. Even then, start with no more than a half-sized position.\n\nI would also separate the two possible entry paths. The stronger path is a close above 923-925, followed by either continuation into 939-955 or a successful retest of 923-925 as support. The more opportunistic path is a defense of 902-903, but only if price forms higher lows and momentum improves; buying merely because the 200-day SMA is nearby is too aggressive. If LLY closes below 902-903 and cannot quickly reclaim it, the setup should shift from \u201cdeveloping overweight\u201d to \u201cwatch only.\u201d If it breaks 888 with expanding volume, tactical exposure should be avoided or exited.\n\nPosition sizing should reflect the unstable regime. ATR is about 3.1% of price, so a normal-sized position with a tight stop would be poorly matched to the volatility. A balanced approach would use smaller initial size, ATR-aware stops, and staged adds only after confirmation above 939-955 or after a constructive retest. The trader should not chase a headline-driven rally, but also should not demand perfect confirmation all the way to the 50-day SMA near 976-979 before recognizing improvement.\n\nMy final stance is that the trader\u2019s original decision is broadly sound, but the emphasis should be adjusted. LLY remains a high-quality growth leader with real clinical and earnings catalysts, so an eventual overweight is reasonable. But the market regime is still a high-volatility downward correction, not a confirmed recovery. The most sustainable strategy is to keep LLY on the overweight watchlist, require confirmation above 923-925 or a clearly defended 902-903 support structure, size the first entry conservatively, and treat 888 as the hard tactical failure level. That gives the portfolio participation if the Foundayo-driven recovery gains traction, while avoiding the aggressive mistake of buying an unconfirmed support test and the conservative mistake of dismissing a fundamentally strong rebound candidate too early.",
        "judge_decision": "{\n  \"rating\": \"OVERWEIGHT\",\n  \"portfolio_stance\": \"BULLISH\",\n  \"entry_action\": \"WAIT\",\n  \"setup_quality\": \"DEVELOPING\",\n  \"confidence\": 0.68,\n  \"time_horizon\": \"medium\",\n  \"entry_logic\": \"LLY\uc758 \uc911\uae30 \ubc30\ubd84 \uad00\uc810\uc740 OVERWEIGHT\ub85c \uc720\uc9c0\ud55c\ub2e4. \uacf5\uaca9\uc801 \ubd84\uc11d\uac00\uac00 \uac15\uc870\ud55c \uac83\ucc98\ub7fc 2025\ub144 \ub9e4\ucd9c\uc774 12.7285B\uc5d0\uc11c 19.292B\uae4c\uc9c0 \ud655\ub300\ub418\uace0, \uc601\uc5c5\uc774\uc775 8.9874B, \ud76c\uc11d EPS 7.39, \uc601\uc5c5\uc774\uc775\ub960 44.896%, \uc21c\uc774\uc775\ub960 31.667%\ub85c \uc131\uc7a5\uc131\uacfc \uc218\uc775\uc131\uc774 \uac15\ud558\ub2e4. Foundayo\uc758 \uc2ec\ud608\uad00 \ubc0f \uc0ac\ub9dd\ub960 \uac1c\uc120 \ub370\uc774\ud130, \uac04 \uc548\uc804\uc131 \uc2e0\ud638 \ubd80\uc7ac, \uc0ac\ub9dd\uc704\ud5d8 57% \uac10\uc18c \uc5b8\uae09\ub3c4 \ud22c\uc790 \ub17c\ub9ac\ub97c \uc9c0\uc9c0\ud55c\ub2e4. \ub2e4\ub9cc \ubcf4\uc218\uc801\u00b7\uc911\ub9bd\uc801 \ubd84\uc11d\uac00\uc758 \uc9c0\uc801\ucc98\ub7fc \ucd5c\uadfc \uc885\uac00 905.03\uc740 200\uc77c\uc120 902-903 \ubc14\ub85c \uc704\uc5d0 \uc788\uace0 ATR 28.13\uc774 \uc9c0\uc9c0\uc120\uacfc\uc758 \uac70\ub9ac\ubcf4\ub2e4 \ud6e8\uc52c \ucee4\uc11c \uc624\ub298 \uc989\uc2dc \uc9c4\uc785\ud558\uae30\uc5d0\ub294 \uae30\uc220\uc801 \ud655\uc778\uc774 \ubd80\uc871\ud558\ub2e4. \uc2e0\uaddc \ub9e4\uc218\ub294 923-925\ub97c \uac70\ub798\ub7c9 \uc99d\uac00\uc640 \ud568\uaed8 \uc77c\ubd09 \uc885\uac00\ub85c \ud68c\ubcf5\ud558\uac70\ub098, 902-903 \ubc29\uc5b4 \ud6c4 \uace0\uc810\u00b7\uc800\uc810\uc774 \ub192\uc544\uc9c0\uace0 RSI/MACD\uac00 \uac1c\uc120\ub418\ub294 \uacbd\uc6b0\ub85c \uc81c\ud55c\ud55c\ub2e4. \ub530\ub77c\uc11c \ubc29\ud5a5\uc131\uc740 BULLISH\uc774\ub098 \uc989\uc2dc \uc2e4\ud589\uc740 WAIT\uc774\ub2e4.\",\n  \"exit_logic\": \"LLY\uac00 902-903 \uc544\ub798\ub85c \uc77c\ubd09 \uc885\uac00 \uc774\ud0c8\ud55c \ub4a4 \ube60\ub974\uac8c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud558\uba74 200\uc77c\uc120 \uc9c0\uc9c0 \uc2e4\ud328\ub85c \ubcf4\uace0 \uc2e0\uaddc \uc9c4\uc785\uc744 \uc911\ub2e8\ud558\uba70 \uc804\uc220\uc801 \ub178\ucd9c\uc744 \uc904\uc778\ub2e4. 888\uc744 \uac70\ub798\ub7c9 \uc99d\uac00\uc640 \ud568\uaed8 \uacb0\uc815\uc801\uc73c\ub85c \uc774\ud0c8\ud558\uba74 878.24 \uc7ac\uc2dc\ud5d8 \uc704\ud5d8\uc774 \ucee4\uc9c0\ubbc0\ub85c \uc804\uc220 \ud3ec\uc9c0\uc158\uc740 \uccad\uc0b0\ud558\uac70\ub098 \ud68c\ud53c\ud55c\ub2e4. Foundayo \uc2b9\uc778 \uc77c\uc815 \uc9c0\uc5f0, \uc81c\ud55c\uc801 \ub77c\ubca8, \uc608\uc0c1\ubcf4\ub2e4 \ubd80\ub2f4\uc2a4\ub7ec\uc6b4 \uc2dc\ud310 \ud6c4 \uc694\uad6c, \uc548\uc804\uc131 \ub17c\ub780, \uacbd\uc7c1 \uc2ec\ud654, \ub610\ub294 \uac15\ud55c \uc774\uc775 \uc131\uc7a5\uc5d0\ub3c4 \uc790\uc720\ud604\uae08\ud750\ub984 \ubd80\uc9c4\uc774 \uc9c0\uc18d\ub418\uba74 \uc911\uae30 \ube44\uc911 \ud655\ub300 \ub17c\ub9ac\ub97c \uc7ac\ud3c9\uac00\ud55c\ub2e4.\",\n  \"position_sizing\": \"\ud604\uc7ac\ub294 \uc2e0\uaddc \ud3ec\uc9c0\uc158\uc744 \uc5f4\uc9c0 \uc54a\ub294\ub2e4. 923-925 \ud68c\ubcf5\uc774 \uac70\ub798\ub7c9\uc73c\ub85c \ud655\uc778\ub418\uba74 \ucd5c\ub300 \uc808\ubc18 \uaddc\ubaa8\uc758 \ucd08\uae30 \ud3ec\uc9c0\uc158\ub9cc \ud5c8\uc6a9\ud558\uace0, 923-925 \uc9c0\uc9c0 \uc7ac\ud655\uc778 \ub610\ub294 939-955 \ub3cc\ud30c \ud6c4\uc5d0\ub9cc \ub2e8\uacc4\uc801\uc73c\ub85c \ucd94\uac00\ud55c\ub2e4. 902-903 \ubc29\uc5b4\ud615 \uc9c4\uc785\uc740 \uace0\uc810\u00b7\uc800\uc810 \uc0c1\uc2b9\uacfc RSI 50 \ud68c\ubcf5, MACD \uac1c\uc120\uc774 \ub3d9\ubc18\ub420 \ub54c\ub9cc \uc791\uc740 \uc120\ubc1c \ud3ec\uc9c0\uc158\uc73c\ub85c \uc815\ub2f9\ud654\ub420 \uc218 \uc788\ub2e4. ATR\uc774 \uc57d 28\ud3ec\uc778\ud2b8, \uac00\uaca9 \ub300\ube44 \uc57d 3.1%\uc774\ubbc0\ub85c \uc190\uc808 \ud3ed\uc740 \uc815\uc0c1 \ubcc0\ub3d9\uc131\uc5d0 \ud729\uc4f8\ub9ac\uc9c0 \uc54a\ub3c4\ub85d \ucd5c\uc18c 1 ATR \uc774\uc0c1\uc744 \ubc18\uc601\ud558\ub418 \ud3ec\uc9c0\uc158 \ud06c\uae30\ub294 \uadf8\ub9cc\ud07c \ucd95\uc18c\ud55c\ub2e4.\",\n  \"risk_limits\": \"923-925 \uc544\ub798\uc5d0\uc11c\ub294 \ud655\uc778 \uc5c6\ub294 \ucd94\uaca9 \ub9e4\uc218\ub97c \uae08\uc9c0\ud55c\ub2e4. 902-903\uc740 \uc7a5\uae30 \ucd94\uc138 \ubc29\uc5b4\uc120, 888\uc740 \uc804\uc220\uc801 \uc2e4\ud328\uc120\uc73c\ub85c \ub454\ub2e4. ATR 28.13\uacfc 3.1% \uc218\uc900\uc758 \ubcc0\ub3d9\uc131, FDA\u00b7\ub77c\ubca8\u00b7\uacbd\uc7c1 \uc774\ubca4\ud2b8 \uc704\ud5d8\uc744 \ubc18\uc601\ud574 \uac70\ub798\ub2f9 \uc704\ud5d8\uc744 \ub0ae\uac8c \uc720\uc9c0\ud55c\ub2e4. \ucd5c\uc2e0 \ubd84\uae30 \uc790\uc720\ud604\uae08\ud750\ub984 254.2M, capex \uc57d 3.0B, \ucd1d\ubd80\ucc44 42.5B, \uc21c\ubd80\ucc44 35.2B, debt-to-equity 165.31\uc740 \uc131\uc7a5 \ud22c\uc790\uc758 \uacb0\uacfc\uc77c \uc218 \uc788\uc9c0\ub9cc \ud604\uae08 \uc804\ud658\uacfc \uc7ac\ubb34 \uc720\uc5f0\uc131 \uac10\uc2dc\uac00 \ud544\uc694\ud558\ub2e4.\",\n  \"catalysts\": [\n    \"Foundayo\uc758 \uc2ec\ud608\uad00 \ubc0f \uc0ac\ub9dd\ub960 \uac1c\uc120 \ub370\uc774\ud130\uc640 \uac04 \uc548\uc804\uc131 \uc2e0\ud638 \ubd80\uc7ac\uac00 \ub2f9\ub1e8\u00b7\ube44\ub9cc \ud504\ub79c\ucc28\uc774\uc988 \ud655\uc7a5 \uae30\ub300\ub97c \uc9c0\uc9c0\",\n    \"2\ud615 \ub2f9\ub1e8 \uc801\uc751\uc99d\uc5d0 \ub300\ud55c Q2 \ub9d0\uae4c\uc9c0\uc758 \ubbf8\uad6d \uc2b9\uc778 \uc2e0\uccad \uacc4\ud68d\",\n    \"Foundayo \ub77c\ubca8, \uc2b9\uc778 \uc77c\uc815, \uc758\uc0ac \ucc44\ud0dd \uae30\ub300\uac00 \uc6b0\ud638\uc801\uc73c\ub85c \ud655\uc778\ub420 \uacbd\uc6b0 \uc2e4\uc801 \ucd94\uc815\uce58 \uc0c1\ud5a5 \uac00\ub2a5\uc131\",\n    \"2025\ub144 \ub9e4\ucd9c \ud655\ub300, \ub192\uc740 \uc601\uc5c5\uc774\uc775\ub960, EPS \uc131\uc7a5 \uc9c0\uc18d\",\n    \"Centessa \uc778\uc218 \ubcf4\ub3c4\uac00 \uc7a5\uae30 \ud30c\uc774\ud504\ub77c\uc778 \ub2e4\ubcc0\ud654 \uc120\ud0dd\uc9c0\ub97c \uc81c\uacf5\ud560 \uac00\ub2a5\uc131\",\n    \"923-925 \ud68c\ubcf5 \ud6c4 939-955 \ubc0f 976-979 \uc800\ud56d\ub300 \ub3cc\ud30c \uc2dc \uae30\uc220\uc801 \ud68c\ubcf5 \uc2e0\ub8b0\ub3c4 \uc0c1\uc2b9\"\n  ],\n  \"invalidators\": [\n    \"902-903 \uc544\ub798 \uc77c\ubd09 \uc885\uac00 \uc774\ud0c8 \ud6c4 \ube60\ub978 \ud68c\ubcf5 \uc2e4\ud328\",\n    \"\uac70\ub798\ub7c9 \uc99d\uac00\ub97c \ub3d9\ubc18\ud55c 888 \ud558\ud5a5 \uc774\ud0c8\uacfc 878.24 \uc7ac\uc2dc\ud5d8 \uc704\ud5d8 \ud655\ub300\",\n    \"Foundayo \uad00\ub828 FDA \uc9c0\uc5f0, \uc81c\ud55c\uc801 \ub77c\ubca8, \ub354 \uc2ec\uac01\ud55c \uc548\uc804\uc131 \uc6b0\ub824 \ub610\ub294 \ubd80\ub2f4\uc2a4\ub7ec\uc6b4 \uc2dc\ud310 \ud6c4 \uc694\uad6c\",\n    \"Novo Nordisk, Viking Therapeutics, Kailera \ub4f1 \uacbd\uc7c1\uc0ac\uac00 \uac00\uaca9, \uc2dc\uc7a5\uc810\uc720\uc728, \ucc98\ubc29 \uae30\ub300\uce58, \uc784\uc0c1\uc801 \ube44\uad50\uc6b0\uc704\uc5d0 \uc555\ubc15\uc744 \uac00\ud558\uace0 \uc788\ub2e4\ub294 \uc99d\uac70\",\n    \"capex, \ubd80\ucc44, \ubc30\ub2f9, \uc790\uc0ac\uc8fc \ub9e4\uc785, \uc778\uc218 \uc9c0\ucd9c\uc774 \ub298\uc5b4\ub098\ub294 \uac00\uc6b4\ub370 \uc790\uc720\ud604\uae08\ud750\ub984 \ubd80\uc9c4 \uc9c0\uc18d\",\n    \"\uc131\uc7a5\ub960 \uc804\ub9dd \ud558\ud5a5\uc73c\ub85c forward PE 21.47 \ubc0f PEG 0.9769\uc758 \ubc38\ub958\uc5d0\uc774\uc158 \uc9c0\uc9c0\uac00 \uc57d\ud654\"\n  ],\n  \"watchlist_triggers\": [\n    \"923-925 \uc704 \uc77c\ubd09 \uc885\uac00 \ud68c\ubcf5\uacfc \ucd5c\uadfc \ud3c9\uade0\uc744 \uc6c3\ub3c4\ub294 \uac70\ub798\ub7c9\",\n    \"923-925 \ud68c\ubcf5 \ud6c4 \ud574\ub2f9 \uad6c\uac04\uc744 \uc9c0\uc9c0\ub85c \uc7ac\ud655\uc778\",\n    \"RSI 50 \ud68c\ubcf5 \ubc0f MACD\uac00 0\uc120 \ubc29\ud5a5\uc73c\ub85c \uac1c\uc120\",\n    \"939-955 \uc704 \uc885\uac00\ub85c \ub2e8\uae30 \ubc18\ub4f1 \ubaa8\uba58\ud140 \uac15\ud654 \ud655\uc778\",\n    \"976-979 \uc704 \uc885\uac00\ub85c \uc911\uae30 \ucd94\uc138 \ubcf5\uad6c \uc2e0\ud638 \ud655\uc778\",\n    \"902-903 \uc544\ub798 \uc885\uac00 \ub610\ub294 888 \ud558\ud5a5 \uc555\ub825 \ubc1c\uc0dd \uc2dc \ud558\ubc29 \uacbd\uace0\",\n    \"Foundayo \uc2b9\uc778 \uc2e0\uccad, FDA \uc2dc\ud310 \ud6c4 \uc5f0\uad6c \ubc94\uc704, \ub77c\ubca8 \ubb38\uad6c \uad00\ub828 \uc5c5\ub370\uc774\ud2b8\",\n    \"\ub2e4\uc74c \uc2e4\uc801\uc5d0\uc11c \uc790\uc720\ud604\uae08\ud750\ub984, capex, \uc7ac\uace0, \ub9e4\ucd9c\ucc44\uad8c, \uacf5\uae09\ub2a5\ub825 \uac00\uc774\ub358\uc2a4 \ud655\uc778\"\n  ],\n  \"data_coverage\": {\n    \"company_news_count\": 4,\n    \"disclosures_count\": 0,\n    \"social_source\": \"news_derived\",\n    \"macro_items_count\": 1\n  }\n}"
    },
    "investment_plan": "{\n  \"rating\": \"OVERWEIGHT\",\n  \"portfolio_stance\": \"BULLISH\",\n  \"entry_action\": \"WAIT\",\n  \"setup_quality\": \"DEVELOPING\",\n  \"confidence\": 0.68,\n  \"time_horizon\": \"medium\",\n  \"entry_logic\": \"LLY remains investable on strong fundamentals, high margins, accelerating 2025 revenue/EPS, constructive Foundayo cardiovascular and mortality data, and supportive analyst sentiment. However, immediate entry is not confirmed because price is below the 10-day EMA/VWMA area near 923-925 and the 50-day SMA near 976-979, while it is testing the 200-day SMA near 902-903 with elevated ATR. Wait for a daily close back above 923-925 with volume confirmation, or a successful hold of 902-903 followed by higher lows, before initiating or adding exposure.\",\n  \"exit_logic\": \"Reduce or avoid new exposure if LLY closes below the 200-day SMA near 902-903 and fails to reclaim it quickly. Exit tactical exposure on a decisive break below 888, especially if volume expands, because that would raise the probability of a retest of 878.24 and confirm failed long-term support. Reassess the medium-term overweight thesis if Foundayo approval timing slips materially, safety labeling becomes restrictive, or free cash flow remains weak despite continued earnings growth.\",\n  \"position_sizing\": \"Use partial sizing until technical confirmation improves. For new money, start no more than a half-sized position only after the 923-925 reclaim is confirmed; otherwise maintain watchlist status or hold existing strategic exposure. Size stops using at least one ATR, about 28 points, to avoid being shaken out by normal volatility.\",\n  \"risk_limits\": \"Do not chase below 923-925 without confirmed support. Keep risk per trade modest because ATR is about 3.1% of price and event risk is high. Use 888 as the key tactical failure level and 902-903 as the long-term trend defense level. Monitor leverage, capex, free cash flow conversion, FDA post-marketing requirements, and competitive GLP-1 data as thesis risks.\",\n  \"catalysts\": [\n    \"Foundayo cardiovascular and mortality data supporting diabetes and obesity franchise expansion\",\n    \"Planned US approval submission for the type 2 diabetes indication by the end of Q2\",\n    \"Potential upward estimate revisions if Foundayo label and uptake expectations improve\",\n    \"Continued high revenue growth, strong operating margin, and EPS expansion\",\n    \"Centessa acquisition report suggesting longer-term pipeline diversification\",\n    \"Recovery of 923-925 followed by 939-955 and 976-979 technical resistance zones\"\n  ],\n  \"invalidators\": [\n    \"Daily close below 902-903 followed by failure to reclaim the 200-day SMA\",\n    \"Break below 888 with expanding volume, increasing risk of a retest of 878.24\",\n    \"FDA delay, restrictive label, or more serious safety concern tied to Foundayo post-marketing requirements\",\n    \"Evidence that competition from Novo Nordisk, Viking Therapeutics, Kailera, or others is pressuring pricing, share, or prescribing expectations\",\n    \"Free cash flow remains weak while capex, debt, buybacks, dividends, and acquisition spending continue to rise\",\n    \"Forward growth expectations are revised lower enough to make PE and PEG support less credible\"\n  ],\n  \"watchlist_triggers\": [\n    \"Close above 923-925 with volume above recent average\",\n    \"Successful retest of 923-925 as support after reclaiming it\",\n    \"RSI recovery above 50 and MACD improvement toward the zero line\",\n    \"Close above 939-955 to confirm stronger rebound momentum\",\n    \"Close above 976-979 to indicate medium-term trend repair\",\n    \"Close below 902-903 or intraday pressure through 888 as downside warning\",\n    \"Updates on Foundayo approval filing, FDA post-marketing study scope, and label language\",\n    \"Next earnings details on free cash flow, capex, inventory, receivables, and supply capacity guidance\"\n  ],\n  \"data_coverage\": {\n    \"company_news_count\": 4,\n    \"disclosures_count\": 0,\n    \"social_source\": \"news_derived\",\n    \"macro_items_count\": 1\n  }\n}",
    "final_trade_decision": "{\n  \"rating\": \"OVERWEIGHT\",\n  \"portfolio_stance\": \"BULLISH\",\n  \"entry_action\": \"WAIT\",\n  \"setup_quality\": \"DEVELOPING\",\n  \"confidence\": 0.68,\n  \"time_horizon\": \"medium\",\n  \"entry_logic\": \"LLY\uc758 \uc911\uae30 \ubc30\ubd84 \uad00\uc810\uc740 OVERWEIGHT\ub85c \uc720\uc9c0\ud55c\ub2e4. \uacf5\uaca9\uc801 \ubd84\uc11d\uac00\uac00 \uac15\uc870\ud55c \uac83\ucc98\ub7fc 2025\ub144 \ub9e4\ucd9c\uc774 12.7285B\uc5d0\uc11c 19.292B\uae4c\uc9c0 \ud655\ub300\ub418\uace0, \uc601\uc5c5\uc774\uc775 8.9874B, \ud76c\uc11d EPS 7.39, \uc601\uc5c5\uc774\uc775\ub960 44.896%, \uc21c\uc774\uc775\ub960 31.667%\ub85c \uc131\uc7a5\uc131\uacfc \uc218\uc775\uc131\uc774 \uac15\ud558\ub2e4. Foundayo\uc758 \uc2ec\ud608\uad00 \ubc0f \uc0ac\ub9dd\ub960 \uac1c\uc120 \ub370\uc774\ud130, \uac04 \uc548\uc804\uc131 \uc2e0\ud638 \ubd80\uc7ac, \uc0ac\ub9dd\uc704\ud5d8 57% \uac10\uc18c \uc5b8\uae09\ub3c4 \ud22c\uc790 \ub17c\ub9ac\ub97c \uc9c0\uc9c0\ud55c\ub2e4. \ub2e4\ub9cc \ubcf4\uc218\uc801\u00b7\uc911\ub9bd\uc801 \ubd84\uc11d\uac00\uc758 \uc9c0\uc801\ucc98\ub7fc \ucd5c\uadfc \uc885\uac00 905.03\uc740 200\uc77c\uc120 902-903 \ubc14\ub85c \uc704\uc5d0 \uc788\uace0 ATR 28.13\uc774 \uc9c0\uc9c0\uc120\uacfc\uc758 \uac70\ub9ac\ubcf4\ub2e4 \ud6e8\uc52c \ucee4\uc11c \uc624\ub298 \uc989\uc2dc \uc9c4\uc785\ud558\uae30\uc5d0\ub294 \uae30\uc220\uc801 \ud655\uc778\uc774 \ubd80\uc871\ud558\ub2e4. \uc2e0\uaddc \ub9e4\uc218\ub294 923-925\ub97c \uac70\ub798\ub7c9 \uc99d\uac00\uc640 \ud568\uaed8 \uc77c\ubd09 \uc885\uac00\ub85c \ud68c\ubcf5\ud558\uac70\ub098, 902-903 \ubc29\uc5b4 \ud6c4 \uace0\uc810\u00b7\uc800\uc810\uc774 \ub192\uc544\uc9c0\uace0 RSI/MACD\uac00 \uac1c\uc120\ub418\ub294 \uacbd\uc6b0\ub85c \uc81c\ud55c\ud55c\ub2e4. \ub530\ub77c\uc11c \ubc29\ud5a5\uc131\uc740 BULLISH\uc774\ub098 \uc989\uc2dc \uc2e4\ud589\uc740 WAIT\uc774\ub2e4.\",\n  \"exit_logic\": \"LLY\uac00 902-903 \uc544\ub798\ub85c \uc77c\ubd09 \uc885\uac00 \uc774\ud0c8\ud55c \ub4a4 \ube60\ub974\uac8c \ud68c\ubcf5\ud558\uc9c0 \ubabb\ud558\uba74 200\uc77c\uc120 \uc9c0\uc9c0 \uc2e4\ud328\ub85c \ubcf4\uace0 \uc2e0\uaddc \uc9c4\uc785\uc744 \uc911\ub2e8\ud558\uba70 \uc804\uc220\uc801 \ub178\ucd9c\uc744 \uc904\uc778\ub2e4. 888\uc744 \uac70\ub798\ub7c9 \uc99d\uac00\uc640 \ud568\uaed8 \uacb0\uc815\uc801\uc73c\ub85c \uc774\ud0c8\ud558\uba74 878.24 \uc7ac\uc2dc\ud5d8 \uc704\ud5d8\uc774 \ucee4\uc9c0\ubbc0\ub85c \uc804\uc220 \ud3ec\uc9c0\uc158\uc740 \uccad\uc0b0\ud558\uac70\ub098 \ud68c\ud53c\ud55c\ub2e4. Foundayo \uc2b9\uc778 \uc77c\uc815 \uc9c0\uc5f0, \uc81c\ud55c\uc801 \ub77c\ubca8, \uc608\uc0c1\ubcf4\ub2e4 \ubd80\ub2f4\uc2a4\ub7ec\uc6b4 \uc2dc\ud310 \ud6c4 \uc694\uad6c, \uc548\uc804\uc131 \ub17c\ub780, \uacbd\uc7c1 \uc2ec\ud654, \ub610\ub294 \uac15\ud55c \uc774\uc775 \uc131\uc7a5\uc5d0\ub3c4 \uc790\uc720\ud604\uae08\ud750\ub984 \ubd80\uc9c4\uc774 \uc9c0\uc18d\ub418\uba74 \uc911\uae30 OVERWEIGHT \ub17c\ub9ac\ub97c \uc7ac\ud3c9\uac00\ud55c\ub2e4.\",\n  \"position_sizing\": \"\ud604\uc7ac\ub294 \uc2e0\uaddc \ud3ec\uc9c0\uc158\uc744 \uc5f4\uc9c0 \uc54a\ub294\ub2e4. 923-925 \ud68c\ubcf5\uc774 \uac70\ub798\ub7c9\uc73c\ub85c \ud655\uc778\ub418\uba74 \ucd5c\ub300 \uc808\ubc18 \uaddc\ubaa8\uc758 \ucd08\uae30 \ud3ec\uc9c0\uc158\ub9cc \ud5c8\uc6a9\ud558\uace0, 923-925 \uc9c0\uc9c0 \uc7ac\ud655\uc778 \ub610\ub294 939-955 \ub3cc\ud30c \ud6c4\uc5d0\ub9cc \ub2e8\uacc4\uc801\uc73c\ub85c \ucd94\uac00\ud55c\ub2e4. 902-903 \ubc29\uc5b4\ud615 \uc9c4\uc785\uc740 \uace0\uc810\u00b7\uc800\uc810 \uc0c1\uc2b9\uacfc RSI 50 \ud68c\ubcf5, MACD \uac1c\uc120\uc774 \ub3d9\ubc18\ub420 \ub54c\ub9cc \uc791\uc740 \uc120\ubc1c \ud3ec\uc9c0\uc158\uc73c\ub85c \uc815\ub2f9\ud654\ub420 \uc218 \uc788\ub2e4. ATR\uc774 \uc57d 28\ud3ec\uc778\ud2b8, \uac00\uaca9 \ub300\ube44 \uc57d 3.1%\uc774\ubbc0\ub85c \uc190\uc808 \ud3ed\uc740 \uc815\uc0c1 \ubcc0\ub3d9\uc131\uc5d0 \ud729\uc4f8\ub9ac\uc9c0 \uc54a\ub3c4\ub85d \ucd5c\uc18c 1 ATR \uc774\uc0c1\uc744 \ubc18\uc601\ud558\ub418 \ud3ec\uc9c0\uc158 \ud06c\uae30\ub294 \uadf8\ub9cc\ud07c \ucd95\uc18c\ud55c\ub2e4.\",\n  \"risk_limits\": \"923-925 \uc544\ub798\uc5d0\uc11c\ub294 \ud655\uc778 \uc5c6\ub294 \ucd94\uaca9 \ub9e4\uc218\ub97c \uae08\uc9c0\ud55c\ub2e4. 902-903\uc740 \uc7a5\uae30 \ucd94\uc138 \ubc29\uc5b4\uc120, 888\uc740 \uc804\uc220\uc801 \uc2e4\ud328\uc120\uc73c\ub85c \ub454\ub2e4. ATR 28.13\uacfc 3.1% \uc218\uc900\uc758 \ubcc0\ub3d9\uc131, FDA\u00b7\ub77c\ubca8\u00b7\uacbd\uc7c1 \uc774\ubca4\ud2b8 \uc704\ud5d8\uc744 \ubc18\uc601\ud574 \uac70\ub798\ub2f9 \uc704\ud5d8\uc744 \ub0ae\uac8c \uc720\uc9c0\ud55c\ub2e4. \ucd5c\uc2e0 \ubd84\uae30 \uc790\uc720\ud604\uae08\ud750\ub984 254.2M, capex \uc57d 3.0B, \ucd1d\ubd80\ucc44 42.5B, \uc21c\ubd80\ucc44 35.2B, debt-to-equity 165.31\uc740 \uc131\uc7a5 \ud22c\uc790\uc758 \uacb0\uacfc\uc77c \uc218 \uc788\uc9c0\ub9cc \ud604\uae08 \uc804\ud658\uacfc \uc7ac\ubb34 \uc720\uc5f0\uc131 \uac10\uc2dc\uac00 \ud544\uc694\ud558\ub2e4.\",\n  \"catalysts\": [\n    \"Foundayo\uc758 \uc2ec\ud608\uad00 \ubc0f \uc0ac\ub9dd\ub960 \uac1c\uc120 \ub370\uc774\ud130\uc640 \uac04 \uc548\uc804\uc131 \uc2e0\ud638 \ubd80\uc7ac\uac00 \ub2f9\ub1e8\u00b7\ube44\ub9cc \ud504\ub79c\ucc28\uc774\uc988 \ud655\uc7a5 \uae30\ub300\ub97c \uc9c0\uc9c0\",\n    \"2\ud615 \ub2f9\ub1e8 \uc801\uc751\uc99d\uc5d0 \ub300\ud55c Q2 \ub9d0\uae4c\uc9c0\uc758 \ubbf8\uad6d \uc2b9\uc778 \uc2e0\uccad \uacc4\ud68d\",\n    \"Foundayo \ub77c\ubca8, \uc2b9\uc778 \uc77c\uc815, \uc758\uc0ac \ucc44\ud0dd \uae30\ub300\uac00 \uc6b0\ud638\uc801\uc73c\ub85c \ud655\uc778\ub420 \uacbd\uc6b0 \uc2e4\uc801 \ucd94\uc815\uce58 \uc0c1\ud5a5 \uac00\ub2a5\uc131\",\n    \"2025\ub144 \ub9e4\ucd9c \ud655\ub300, \ub192\uc740 \uc601\uc5c5\uc774\uc775\ub960, EPS \uc131\uc7a5 \uc9c0\uc18d\",\n    \"Centessa \uc778\uc218 \ubcf4\ub3c4\uac00 \uc7a5\uae30 \ud30c\uc774\ud504\ub77c\uc778 \ub2e4\ubcc0\ud654 \uc120\ud0dd\uc9c0\ub97c \uc81c\uacf5\ud560 \uac00\ub2a5\uc131\",\n    \"923-925 \ud68c\ubcf5 \ud6c4 939-955 \ubc0f 976-979 \uc800\ud56d\ub300 \ub3cc\ud30c \uc2dc \uae30\uc220\uc801 \ud68c\ubcf5 \uc2e0\ub8b0\ub3c4 \uc0c1\uc2b9\"\n  ],\n  \"invalidators\": [\n    \"902-903 \uc544\ub798 \uc77c\ubd09 \uc885\uac00 \uc774\ud0c8 \ud6c4 \ube60\ub978 \ud68c\ubcf5 \uc2e4\ud328\",\n    \"\uac70\ub798\ub7c9 \uc99d\uac00\ub97c \ub3d9\ubc18\ud55c 888 \ud558\ud5a5 \uc774\ud0c8\uacfc 878.24 \uc7ac\uc2dc\ud5d8 \uc704\ud5d8 \ud655\ub300\",\n    \"Foundayo \uad00\ub828 FDA \uc9c0\uc5f0, \uc81c\ud55c\uc801 \ub77c\ubca8, \ub354 \uc2ec\uac01\ud55c \uc548\uc804\uc131 \uc6b0\ub824 \ub610\ub294 \ubd80\ub2f4\uc2a4\ub7ec\uc6b4 \uc2dc\ud310 \ud6c4 \uc694\uad6c\",\n    \"Novo Nordisk, Viking Therapeutics, Kailera \ub4f1 \uacbd\uc7c1\uc0ac\uac00 \uac00\uaca9, \uc810\uc720\uc728, \ucc98\ubc29 \uae30\ub300, \uc784\uc0c1 \ube44\uad50 \uc6b0\uc704\ub97c \uc555\ubc15\ud55c\ub2e4\ub294 \uc99d\uac70\",\n    \"capex, \ubd80\ucc44, \ubc30\ub2f9, \uc790\uc0ac\uc8fc \ub9e4\uc785, \uc778\uc218 \uc9c0\ucd9c\uc774 \ub298\uc5b4\ub098\ub294 \uac00\uc6b4\ub370 \uc790\uc720\ud604\uae08\ud750\ub984 \ubd80\uc9c4 \uc9c0\uc18d\",\n    \"\uc131\uc7a5\ub960 \uc804\ub9dd \ud558\ud5a5\uc73c\ub85c forward PE 21.47 \ubc0f PEG 0.9769\uc758 \ubc38\ub958\uc5d0\uc774\uc158 \uc9c0\uc9c0\uac00 \uc57d\ud654\"\n  ],\n  \"watchlist_triggers\": [\n    \"923-925 \uc704 \uc77c\ubd09 \uc885\uac00 \ud68c\ubcf5\uacfc \ucd5c\uadfc \ud3c9\uade0\uc744 \uc6c3\ub3c4\ub294 \uac70\ub798\ub7c9\",\n    \"923-925 \ud68c\ubcf5 \ud6c4 \ud574\ub2f9 \uad6c\uac04\uc744 \uc9c0\uc9c0\ub85c \uc7ac\ud655\uc778\",\n    \"RSI 50 \ud68c\ubcf5 \ubc0f MACD\uac00 0\uc120 \ubc29\ud5a5\uc73c\ub85c \uac1c\uc120\",\n    \"939-955 \uc704 \uc885\uac00\ub85c \ub2e8\uae30 \ubc18\ub4f1 \ubaa8\uba58\ud140 \uac15\ud654 \ud655\uc778\",\n    \"976-979 \uc704 \uc885\uac00\ub85c \uc911\uae30 \ucd94\uc138 \ubcf5\uad6c \uc2e0\ud638 \ud655\uc778\",\n    \"902-903 \uc544\ub798 \uc885\uac00 \ub610\ub294 888 \ud558\ud5a5 \uc555\ub825 \ubc1c\uc0dd \uc2dc \ud558\ubc29 \uacbd\uace0\",\n    \"Foundayo \uc2b9\uc778 \uc2e0\uccad, FDA \uc2dc\ud310 \ud6c4 \uc5f0\uad6c \ubc94\uc704, \ub77c\ubca8 \ubb38\uad6c \uad00\ub828 \uc5c5\ub370\uc774\ud2b8\",\n    \"\ub2e4\uc74c \uc2e4\uc801\uc5d0\uc11c \uc790\uc720\ud604\uae08\ud750\ub984, capex, \uc7ac\uace0, \ub9e4\ucd9c\ucc44\uad8c, \uacf5\uae09\ub2a5\ub825 \uac00\uc774\ub358\uc2a4 \ud655\uc778\"\n  ],\n  \"data_coverage\": {\n    \"company_news_count\": 4,\n    \"disclosures_count\": 0,\n    \"social_source\": \"news_derived\",\n    \"macro_items_count\": 1\n  }\n}"
}